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ABSTRACT 
 
Sickle cell disease (SCD) is a genetic disorder affecting over 100,000 
African Americans.  While once lethal, medical treatment now allows those with 
SCD to lead comparatively normal lives, and these children are more frequently 
seeking orthodontic treatment.  We report here on a cephalometric study of a 
contemporary cohort of 62 children with SCD (27 SC and 35 SS genotypes).  This 
was a cross-sectional study of children from the MidSouth between 3 and 16 
years of age, and results were compared to standards in Richardson’s Atlas of 
growth of American Black children in Nashville, TN.  Raw values were 
converted to age- and sex-specific standard deviations and were tested with 
analysis of variance.  Six conclusions were drawn:  (1) Craniofacial dimensions 
are reduced, subjects’ faces are small at all ages, probably as a result of chronic 
hypoxia due to hemolytic anemia.  (2) There was no discernible difference in 
severity between SC and SS genotypes.  (3) In contrast, females regardless of 
genotype typically were more severely affected than males.  (4) Children became 
progressively more affected with age.  Adolescents were disproportionately 
affected compared to children (larger SDs), so the linear and angular deviations 
were greater in the young adult dentitions when most subjects seek orthodontic 
treatment.  (6) SCD causes the face to become hyperdivergent.  We do not know 
the process, but the planes of the face—palatal plane, occlusal plane, mandibular 
 v
plane (including Y-axis, gonial angle, and FMA)—progressively steepen with 
age, especially in adolescence.  This combination of small linear dimensions and 
progressive hyperdivergence creates several dental compensations.  And, 
importantly, they create special challenges for the orthodontist.  Understanding 
the altered craniofacial growth in sickle cell disease will aid health care providers 
in the treatment of these children. 
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CHAPTER I 
 
INTRODUCTION 
  
According to the US 2000 Census, there were 281.4 million people in the 
United States, of which 36.4 million, or 12.9%, were African American 
(McKinnon, 2000).  About 10% of African Americans are heterozygous for the 
sickle cell gene (Serjeant, 2001), and approximately 0.3% of African Americans in 
the US are homozygous for the sickle cell gene (Beers and Berkow, 1999).  A 
rough estimate is, then, that there are about 110,000 people in the United States 
with sickle cell disease.  This means that sickle cell disease is one of the most 
common genetic diseases in the United States (Lin-Fu, 1972).  Sickle cell disease 
results collectively from several genetic abnormalities that produce aberrant 
hemoglobin molecules.  There has been extensive research on the treatment and 
the systemic growth and development of individuals with sickle cell disease; 
however, little research has evaluated the craniofacial growth and development 
of children with this growth-retarding genetic disease.  The purpose of the 
present study was to examine the craniofacial growth and development of 
African American children and adolescents with sickle cell disease compared to 
African Americans without this disease. 
1
There are several reasons to suppose that sickle cell disease will have a 
ponderable effect on children’s craniofacial growth.  Perhaps foremost is the 
observation that these children are chronically hypoxic because of their 
hemolytic anemia (Homi et al., 1997).  This reduced oxygen tension, along with 
other processes of sickle cell disease, results in physiological alterations and 
adaptations (Serjeant, 2001).  Certainly this is the case for stature that has been 
well studied.  Likewise, these children have a characteristic habitus (Serjeant, 
2001).  It also is well known that enhanced erythropoiesis in response to rapid 
hemolysis and the elaboration of red blood cell production into diplöic and 
marrow spaces alters bone morphology.  This is what causes the so-called tower-
skulls seen classically in uncontrolled sickle cell disease (now rare), but also 
gnathopathy, which is the apparent invasion of red blood cell production into the 
maxillae, with resulting loss of incisor anchorage (e.g., Shnorhokian et al., 1984; 
Brown and Sebes, 1986).  There also have been documented case studies 
suggestive of craniofacial changes in children with sickle cell disease (e.g., 
Mourshed and Tuckson, 1974; Williams et al., 1975; Sebes and Diggs, 1979; Faber 
et al., 2002).  Studies on related hemoglobinopathies, such as thalassemia (Alhaija 
et. al., 2002), have also been suggestive of craniofacial changes.  Finally, some 
girls with sickle cell disease have been shown to have “a hypothalamopituitary 
axis dysfunction that give rise to a delay in menarcheal achievement and 
metabolic adaptations to stress of illness” suggesting possible growth 
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impairment (Abbiyesuku and Osotimehin, 1999:65).  For these several reasons it 
seemed likely that children with sickle cell disease would exhibit craniofacial 
changes in size and/or proportionality in response to this chronic genetic 
disease. 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
Structure of Hemoglobin 
 Hemoglobin is the complex molecule responsible for blood’s high 
solubility for oxygen.  Hemoglobin is found in the cytoplasm of red blood cells, 
erythrocytes, and consists of two pairs of unlike protein subunits, termed 
globins, bound into a single molecule.  Each globin contains an iron molecule, 
heme, to which oxygen can bind for transport to the body’s tissues (Fig. 1).  
Oxygen diffuses through the erythrocyte membrane and is bound to 
hemoglobin.  Each hemoglobin molecule, with its four globin subunits and 
corresponding heme rings, can bind a total of four molecules of oxygen.  The 
tertiary structure of globin is such that polar amino acid residues are on the 
external surface of the globin molecule, and there is a hydrophobic niche that 
exists between two of the helices where the heme ring is situated (Hoffman et al., 
1995).   
The several types of hemoglobin are classified according to their specific 
globin components.  Of the many types of globins are alpha (α), beta (β), gamma 
(γ), delta (δ), epsilon (ε), and zeta (ζ).  About 96% of hemoglobin in adults is 
hemoglobin A.  There are two identical α globins and two identical β globins in 
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Fig. 1. The three-dimensional (tertiary) structure of a β-globin subunit.  The
eight helices, or bends, of the β-globin protein are labeled A through H.  The
sequence of the amino acids is numbered starting at the N-terminus, so the
amino acid substitutions at location 6 that create HbS anbd HbC are in the AB
nonhelical part of the molecule.  Figure modified from: Perutz MF. Molecular
anatomy, physiology, and pathology of hemoglobin.  In: Stammatoyannopoulos
G, Nienhuis AW, Leder P, Majerus PW.  The molecular basis of blood diseases.
Philadelphia:  WB Saunders, 1987, p 127.
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hemoglobin A (Serjeant, 2001).  The α and non-α globins exhibit coordinated 
expression, meaning that approximately equal amounts of α and non-α globins 
are produced in the erythroid tissues of the bone marrow throughout life.  
Globin production is regulated primarily at the level of transcription (Hoffman et 
al., 1995).  Hemoglobin is assembled intracellularly in erythroblasts that later 
become erythrocytes. 
 Hemoglobin is commonly abbreviated Hb.  Hemoglobin A is abbreviated 
as HbA.  Since each individual possesses two alleles for hemoglobin, an 
individual with two alleles for HbA would be denoted HbAA.  Variations of 
hemoglobin alleles such as hemoglobin C and hemoglobin S, which are 
allelomorphs of hemoglobin that will be discussed later, are denoted as HbC and 
HbS, respectively.  These common genotypes can, then, be coded as HbAA, 
HbAS, HbAC, HbSS, HbSC, and HbCC. 
The distribution and types of globins vary with age so the types of 
hemoglobin constructed vary with age depending on the specific globin 
production (Fig. 2).  Fetal hemoglobin, abbreviated HbF, consists of two alpha (α) 
and two gamma globins (γ).  HbF is the primary hemoglobin during the first 
stages of life.  Fetal hemoglobin occurs in high levels during fetal development 
until it drops in concentration around five or six months of age, down to its adult 
concentration of about 1% of all hemoglobin (Allison, 1954a; Serjeant, 2001).  The 
purpose of fetal hemoglobin may be that it has a higher affinity for oxygen than 
6
Fig. 2. The succession of human hemoglobin chains during ontogeny. ε is
an embryonic globin.  Fetal globin is γ.  Adult globins that make HbA are
α and β, which account for nearly 50% each of the total globin production
in adults.  Graph redrawn from:  Levitan M. Textbook of human genetics,
2nd ed. New York:  Oxford University Press, 1977, p 216.
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HbA, meaning that HbF “will be oxygenated at the expense of the maternal 
HbA” (Hoffman et al., 1995:461):  a beneficial condition for the fetus. 
 
Hemolytic Anemias 
 There are multiple genetic conditions known to produce hemolytic 
anemias.  In hemolytic anemias, erythrocytes have shortened survival times 
and/or experience premature hemolysis.   Sickle cell disease is, then, a problem 
of hemolysis, not of inadequate production.  Some of the other conditions that 
fall into the category of hemolytic anemias are the thalassemias, glucose-6-
phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis, and the 
hemoglobinopathies including sickle cell disease (Kumar et al., 1997).   
 
Thalassemia 
Thalassemias are a group of autosomal codominant genetic disorders 
where there is an inhibition in the production of globin chains resulting in 
varying levels of anemia (Kumar et al., 1997; Alhaija et al., 2002).  Thalassemias 
are classified in three ways; first, as Alpha or Beta, where Alpha thalassemia 
affects the α-globin chains and Beta thalassemia affects the β-globin chains; 
second, by clinical observation of the severity; and third, by subclassification 
according to the specific mutation site on the gene (Stamatoyannopoulos et al., 
2001). 
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Alpha thalassemia is caused by deletion mutations.  Alpha globin is coded 
on chromosome 16 in two locations, so there are four alleles for alpha globin.   
These account for four levels of severity of Alpha thalassemia depending on how 
many of the four alleles of the alpha globin gene are of the deleterious form on 
the individual’s pair of number 16 chromosomes.  When only one of the four 
alleles for alpha globin is of the deleterious form, there seem to be no symptoms; 
however, when all four are of the deleterious form, death occurs in utero.  The 
severity of having two or three alpha globin alleles of the deleterious form ranges 
between these two extremes (Kumar et al., 1997).  
The other type of thalassemia, Beta thalassemia, presents as thalassemia 
minor or major.  The Beta thalassemia mutation is the consequence of a single 
base change on chromosome 11.   Beta thalassemia minor is a heterozygous 
condition and is often asymptomatic or only mildly symptomatic.  Beta 
thalassemia major is the homozygous condition and is associated with severe 
hemolytic anemia.  In Beta thalassemia major, both alleles for β-globin on 
chromosome 11 are of the deleterious form.  There are two types of Beta 
thalassemia major.  The first is β0, where there is a complete absence of the β-
globin chain production.   The second is β+, where there is some β-globin chain 
production, but it is significantly decreased.  A third notation, β++, can be used 
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when the defect in the β chain is extremely mild (Stamatoyannopoulos et al., 
2001).   
 
Glucose-6-phosphate Dehydrogenase Deficiency 
 Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a condition 
where there is a lack of G6PD, which is the catalyst of the first step of the pentose 
phosphate pathway of glycolysis.  In the pentose phosphate pathway, 
nicotinamide adenine dinucleotide phosphate, NADP, is reduced to NADPH 
that, in turn, is used to oxidize glutathione.  Oxidized glutathione, GSH, is 
responsible “for the detoxification of hydrogen peroxide and organic peroxides” 
(Lee et al., 1993:1007).  Therefore, G6PD is an important enzyme in processes 
responsible for protecting erythrocytes from oxidation injuries.  In red blood cells 
deficient in G6PD, hydrogen peroxide levels rise and oxidize the globin chains of 
the hemoglobin molecules (Lee et al., 1993).  Affected red blood cells are more 
susceptible to destruction by hemolysis (Hoffman et al., 1995).   
In African Americans, G6PD deficiency only becomes symptomatic when 
an affected individual is exposed to specific stresses such as certain drugs, toxins, 
or infections, but, in contrast, Mediterranean subjects with G6PD deficiency have 
chronic anemia not related to a particular stress.  Males typically are affected 
more severely by this condition than females because the gene for G6PD occurs 
on the X chromosome (Lee et al., 1993).  In the United States, an asymptomatic 
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type of G6PD deficiency known as G6PD deficiency A- affects about 10% of black 
males and is not clinically significant.  Due to the gene’s location on the X 
chromosome, females with G6PD deficiency are heterozygous and tend to be 
asymptomatic (Kumar et al., 1997).   
G6PD deficiency offers some protection from malaria.  Historically, 
Livingstone found that, “Whenever there are high frequencies of the G6PD 
deficiency there is evidence of endemic malaria” (1966:47).  Deficiency of G6PD is 
the most common metabolic disorder of red blood cells; a conservative estimate 
is that 130 million people are affected worldwide.  The greatest frequencies are in 
the tropical and subtropical areas of the Eastern Hemisphere (Lee et al., 1993).  
 
Hereditary Spherocytosis 
 Another of the hemolytic anemias is hereditary spherocytosis.  
“Hereditary spherocytosis is considered the most common of the hereditary 
hemolytic anemias among people of Northern European decent,” but it has been 
found in American blacks as well (Lee et al., 1993:966).  Hereditary spherocytosis 
is a condition in which there is a reduced amount of lipids in the cell membrane 
of erythrocytes causing a loss of surface area.  With the loss of surface area, the 
erythrocytes are not the typical, durable biconcave shape and, therefore, they are 
more susceptible to distention injuries in hypoosmolar solutions.  This 
susceptibility of the erythrocytes is termed osmotic fragility.  As a result of their 
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abnormal shape, erythrocytes also tend to be trapped in fenestrations in the walls 
of spleenic sinuses, which may lead to spleenic engorgement (splenomegaly) and 
early sequestration of the erythrocytes by spleenic macrophages.  Hereditary 
spherocytosis is an autosomal dominant condition, but some subjects from North 
Carolina have a recessive form that has proven to be much more severe (Lee et 
al., 1993).   
Clinically, subjects with hereditary spherocytosis are at risk of aplastic 
crises, which are followed by an increased risk of parvovirus infection of the 
erythroblasts in the bone marrow.  Some subjects need blood transfusions to 
recover from these events.  There is no current treatment for hereditary 
spherocytosis other than splenectomy, and this procedure presents risks of its 
own (Kumar et al., 1997). 
Cases of hereditary spherocytosis are not always hereditary.  “Molecular 
studies of hereditary spherocytosis have demonstrated that there is an unusually 
high occurrence of spontaneous mutations in the genes responsible for 
hereditary spherocytosis” resulting in a high frequency of new non-hereditary 
cases (Stamatoyannopoulos et al., 2001:296). 
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Hemoglobinopathies:  Sickle Cell Disease 
The hemoglobinopathies are a family of hereditary disorders involving 
structural abnormalities of the hemoglobin molecule.  Over 300 
hemoglobinopathies have been identified; one of the most notable of these is 
sickle cell disease, which involves the beta globin of hemoglobin (Kumar et al., 
1997).  Sickle cell disease is one of the most common genetic diseases in the 
United States (Lin-Fu, 1972).  According to Livingstone (1967), J. B. Herrick (1910) 
was the first to describe sickle cell disease in an article titled “Peculiar, elongated 
and sickle-shaped red corpuscles in a case of severe anemia.”  Herrick’s 
publication was a case report.  Upon light microscopic examination of his ill 
subject’s blood, Herrick stated, “Whether the blood picture represents merely a 
freakish poikilocytosis or is dependent on some peculiar physical disease, I 
cannot presently answer” (Herrick, 1910:517).   Often, sickle cell disease presents 
near the end of the first year after birth as fever, pallor, abdominal and joint pain, 
and swelling of the liver, spleen, hands and feet (Samuels-Reid, 1994). 
Sickle cell disease is the result of any of a number of genetic abnormalities 
that produce aberrant hemoglobin structures, such as hemoglobin S (HbS) and 
hemoglobin C (HbC).  In sickle cell disease, the two alpha globins of hemoglobin 
are normal, but there are substitutions in the beta chain.  In HbS, a substitution of 
valine for glutamic acid occurs at the sixth amino acid of the beta chain of 
hemoglobin.  In HbC, lysine is substituted for glutamic acid at the sixth amino 
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acid in the beta chain.  β-globin is a 145 amino acid sequence.  A single 
substitution mutation in the sequence produces a change in the tertiary structure 
of the beta globin such that the oxygen carrying capacity of HbS and HbC is 
significantly lower than that of HbA (Becker et al., 1996).  HbS is the more severe 
form of the disease.  Subjects possessing the HbSS genotype tend to exhibit more 
severe symptoms than those possessing an HbS and an HbC allele, HbSC, since 
the alleles involved are co-dominant and HbC by itself is not as serious (Levitan, 
1977; Nagel et al., 2003).  “HbC enhances, by dehydrating the SC red cell, the 
pathogenic properties of HbS” by an unknown mechanism involving a red blood 
cell’s K:Cl transport (Nagel et al., 2003:167).  Subjects with HbCC disease have a 
mild hemolytic anemia (Nagel et al., 2003). 
Subjects who are homozygous for sickle cell disease with either HbSS or 
HbSC alleles comprise approximately 0.3% of African Americans in the United 
States (Beers and Berkow, 1999).  According to the US 2000 Census, there were 
281.4 million people in the United States, of which 36.4 million, or 12.9%, were 
African American (McKinnon, 2000).  So, ignoring differential mortality of 
children with sickle cell disease, there ought to be about 110,000 people in the US 
with sickle cell disease due to the HbS or HbC alleles (0.003 x 0.129 x 281,000,000 
≈ 110,000). 
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Physiology 
 
Protective Effects of HbF 
Sickle cell disease involves the β-globins of HbA, so fetal hemoglobin, 
HbF, is normal.  Fetal hemoglobin is not affected by sickle cell disease because it 
contains two alpha and two gamma globins but no beta globin.  The effects of 
sickle cell disease are often not noticed until the fifth or sixth month of life after 
birth because, up to that time, HbF is the primary type of hemoglobin carrying 
the blood’s oxygen (Allison, 1954a; Kumar et al., 1997).  As mentioned, at five or 
six months after birth, HbF concentrations drop and HbA, which is altered to 
HbS in sickle cell disease, becomes the predominate type of hemoglobin (Fig. 2).  
HbF actually retards the pathogenic polymerization of HbS in erythrocytes 
where it is present (Kumar et al., 1997).  Fetal hemoglobin levels tend to drop 
more slowly with progressing age in HbSS than in HbSC individuals (Brown et 
al., 1994).  Hydroxyurea is a common cancer chemotherapeutic agent that 
increases the amount of HbF found in newly formed erythrocytes, and, as a 
result, it is commonly used in the treatment of sickle cell disease (Charache et al., 
1992). 
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Pathophysiology of Sickling 
When oxygen levels drop, HbS tends to polymerize, which brings about a 
morphological change in the erythrocytes.  The erythrocytes containing HbS will 
distort into elongated sickle shapes.  An increase in oxygen levels typically 
reverses the process, but local cell membrane damage and altered cellular 
chemistry experienced during repeated sickling episodes eventually results in 
irreversible sickling of the erythrocytes containing HbS (Kumar et al., 1997).  
These sickled erythrocytes can clog arterioles and small vessels due to their 
altered morphology.  These entanglements of the sickled erythrocytes cause 
localized ischemic events and, being more fragile and of abnormal morphology, 
the sickled erythrocytes tend to be selected for hemolysis during circulation 
through the spleen (Beers and Berkow, 1977).  Increased destruction of 
erythrocytes in sickle cell disease is associated with hemoglobinemia, 
bilirubinemia, hemosiderosis, and an increase in urobilinogen in feces and urine 
(Diggs, 1967).  The expected life cycle of the affected erythrocytes is reduced 
from about 120 days down to about 20 days (Lee et al., 1993). 
 
Origin of HbS and HbC genes
 The HbS allele originated in equatorial Africa.  According to Serjeant, 
“there is now substantial evidence that the sickle cell mutation has occurred as 
several independent events” (2001:16).  Multiple haplotypes that are versions of 
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the gene for HbS have been discovered and named after where they were found 
such as Benin, Senegal, Bantu, Cameroon, and Asian (Livingstone, 1967).  It is 
thought that each haplotype represents an independent mutation event.  The 
Bantu haplotype accounts for the majority of the HbS gene in east and central 
Africa, while the Benin haplotype accounts for the majority in western and 
northern Africa (Serjeant, 2001).    
From AD 1650 to 1830, the slave trade was responsible for the migration of 
the HbS gene from equatorial Africa to North and South America and into the 
Caribbean (Serjeant, 2001).  As a result, about 8% of Blacks in North America 
(Bunn and Forget, 1986; Serjeant, 2001), about 10% of Blacks in the Caribbean 
(Serjeant, 2001), and about 8% of Blacks in Central and South America (Bunn and 
Forget, 1986) are heterozygous for the HbS gene.  Blacks in North America and 
the Caribbean tend to carry the Benin haplotype from western and northern 
Africa (Serjeant, 2001).  The HbS allele is found throughout Africa and currently 
is most common in West Central Africa in Nigeria, Ghana, Gabon, and Zaire at 
frequencies of about 14% (Bunn and Forget, 1986). 
HbS also is found in Saudi Arabia and India; however, homozygotes from 
Africa or of African descent, are reported to have more severe symptoms of 
sickle cell anemia than their Arabian and Indian counterparts.  This presumably 
is because the Arabian and Indian individuals are more likely to have 
heterocellular hereditary persistence of fetal hemoglobin, HPFH, in combination with 
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HbS.  HPFH is a hereditary condition in which HbF is present in elevated levels 
in adults.  This results in diminution of the full effects of sickle cell disease since 
HbF is unaffected by sickle cell disease (Bunn and Forget, 1986).  Historical 
accounts indicate that slave trading from East Africa to the Persian Gulf (from 
AD 200 to 1500) and to India (until the 19th century) may be responsible for the 
incidence of sickle cell anemia in those regions (Bunn and Forget, 1986).  
 The mutations responsible for the HbC allele are thought to have occurred 
much more recently, and its geographical distribution is not as widespread as 
that of the HbS allele.  HbC is thought to have originated in Equatorial Africa 
and is found in about 2% to 5% of Blacks in the Caribbean.  In North America, 
the HbAC genotype occurs in about 2% of Blacks and the predicted prevalence of 
HbSC is about 1 in 1,000 (0.1%) births in the Black population (Serjeant, 2001).  
 
Heterozygotes:  Sickle Cell Trait 
Subjects who are heterozygotes for HbS or HbC are said to have sickle cell 
trait, rather than sickle cell disease.  According to Bunn and Forget (1986), Lemuel 
Diggs was the first to gather postmortem data on subjects with sickle cell disease 
that he published in 1934 (Diggs and Ching, 1934).  It is noteworthy that Diggs 
was one of the first people to make a distinction between sickle cell disease and 
sickle cell trait.  He was the Director of Clinical Pathology at the University of 
Tennessee, Memphis, and he spent his long professional life gathering data from 
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subjects with sickle cell disease to gain insights into the pathophysiology of the 
disease (Bunn and Forget, 1986).  An archive of Diggs’ work can be found at the 
University of Tennessee, Memphis, campus library.  Informative bony 
consequences of sickle cell disease are included in the present study (cited as 
Diggs and Bell, 2003). 
Individuals who are either homozygous or heterozygous for the HbS gene 
comprise 13% (Beers and Berkow, 1999) or 8% (Kumar et al., 1997; Serjeant, 2001) 
of African Americans in the United States, depending on the source.  
Heterozygotes are not anemic but may be at risk for rhabdomyolysis and sudden 
death upon strenuous exercise (Beers and Berkow, 1999).  Under the stress of a 
low oxygen environment (such as high altitude and unpressurized airplane trips, 
heterozygotes may experience sickling effects similar to those of a homozygote 
(Levitan, 1977).   
Quality of life for heterozygous carriers of HbS is relatively normal 
according to multiple studies.  Kramer et al. (1978) established that 50 subjects 
heterozygous for HbS had normal growth and development at 3 to 5 years of 
age.  There is not an increase in morbidity or mortality in pregnant women with 
sickle cell trait, and their babies are of normal birth weights (Blattner et al., 1977).  
Individuals with sickle cell trait have a normal capacity for exercise (Robinson et 
al., 1976).  Also, the mortality of individuals with sickle cell trait is equivalent to 
individuals who are homozygous for HbA (Stark, 1980).  
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In contrast to the aforementioned studies by Kramer et al. (1978), an earlier 
study from Philadelphia, Pennsylvania, by McCormack et al. (1975) documented 
a delay in the skeletal maturity, lower body weight, smaller upper arm 
circumference, lesser skin fold thickness, and lower intellect of subjects with 
HbAS.  Subjects with HbAS, 12 males and 7 females, were compared to subjects 
with normal hemoglobin (HbAA):  103 males and 138 females from 155 twin 
pairs.  Diagnosis of sickle cell trait (not disease) was performed by cellulose 
acetate electrophoresis as part of a larger zygosity study of twin pairs from 
which the sample for the sickle cell trait study was drawn.  Skeletal age was 
measured, first by comparing radiographs of the hand-wrist with the Greulich 
and Pyle Atlas (1959) and, second, by comparing measurements of the subjects 
with the control group (McCormack et al., 1975).   Subjects with sickle cell trait 
had a statistically significant delay in skeletal growth at P < 0.01.  Also, subjects 
with sickle cell trait scored significantly lower on an intellectual skills test by 20% 
to 33%.  There was no sex difference on the intellectual skills test, so, “the 
differences between HbAS and HbAA groups reflected the effects of sickle-cell 
trait alone” (McCormack et al., 1975:1023).    
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Protection from Malaria:  Biological Benefits of HbS 
  Sickle cell trait, HbAS, produces mild hematological symptoms but 
provides protection against malaria mortality and severe malaria symptoms 
(Akide-Ndunge et al., 2003).   
Allison (1954b:291) asked the question, “How can the sickle-cell gene be 
maintained at such a high frequency among so many peoples in spite of the 
constant elimination of the genes through deaths from the anemia?”  When a 
person homozygous for sickle cell disease dies, two copies of the gene are lost 
from the population.  Since homozygous subjects usually fail to reproduce due to 
the high early mortality of sickle cell disease, the sickle cell alleles must be 
replaced in order to maintain a state of balance in the rate of sickle cell genes 
found in a population.  If, hypothetically, sickle cell trait (HbAS) is considered to 
be neutral in terms of reproductive fitness and selection, then a rate of 10-1 
mutations would be required to maintain the current frequency of sickle cell 
genes found in the world.  Allison (1954a) stated that such a mutation rate would 
be about 3,000 times the mutation rates found elsewhere in man.  Allison (1954a) 
also noted that Haldane (1947) determined that the mutation rates for the well-
known disorder of hemophilia to be only 3.2 x 10-5.   Assuming that sickle cell 
disease would have a mutation rate similar to other conditions such as 
hemophilia and that the reproductive fitness is neutral, a mutation rate of the 
order of magnitude necessary to sustain sickle cell trait “can reasonably be 
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excluded as an explanation of the remarkably high frequencies of the sickle-cell 
trait observed in Africa and elsewhere” (Allison, 1954b:291).   
Allison (1954b) suggested that sickle cell trait offers a “selective 
advantage” in that it provides protection from malaria.  To test this idea, he 
conducted a study of 30 Africans, 15 with and 15 without sickle cell trait.  
Subjects were purposely inoculated with Plasmodium falciparum (the causative 
parasite of malaria), only 2 of the sickle cell subjects contracted malaria, while 14 
of the 15 non-sickle cell trait subjects contracted malaria.  “It is concluded that the 
abnormal erythrocytes of individuals with the sickle-cell trait are less easily 
parasitized by P. falciparum than are normal erythrocytes,” which may help to 
explain the relatively constant frequency of the sickle cell gene despite the loss of 
genes due to the high mortality of sickle cell disease (Allison, 1954b:294). 
Balanced polymorphism is a genetic term defined by Serjeant as “the balance 
of deleterious and advantageous effects of a gene which allows it to remain at a 
relatively constant level in a population” (2001:19).  Until rather recently, subjects 
homozygous for the HbS gene, without significant medical intervention, did not 
live to reproductive age, but the gene has persisted due to its increased fitness in 
heterozygous subjects.  The advantage of the HbAS genotype (and other 
heterozygous genotypes) is that it aids in resistance to malaria.  In a 
heterozygous state (HbAS or HbAC), it does not result in the life shortening 
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condition that is sickle cell disease; instead the subject benefits from reduced 
mortality related to malaria (Serjeant, 2001). 
 Historically, the distribution of malaria and of the HbS gene followed a 
similar geographic distribution (Bunn and Forget, 1986).  According to Serjeant 
(2001), it was Raper (1949) who first noted that there must be a survival 
advantage to having sickle cell trait in tropical regions, but according to Bunn 
and Forget (1986), it was Haldane (1949) instead of Raper (1949) who first 
recognized the connection.  Following Raper (1949) and Haldane (1949), Mackey 
and Vivarelli (1954) suggested that the advantage came specifically from 
resistance to malaria.  Allison (1954b) published findings in the British Medical 
Journal stating that HbS offered protection from malaria.  Serjeant (2001) noted 
several studies where subjects’ sickle cell trait produced lower parasite densities 
and, therefore, less severe malaria compared to samples homozygous for HbA.  
It appears that sickle cell trait “confers some protection against malaria during 
the critical period in early childhood between the loss of passively acquired 
maternal immunity and the development of active immunity” (Serjeant, 2001:21). 
A study performed in Nigeria revealed that 24% of newborns were 
heterozygous for HbS, while 29% of children over 5 years of age were 
heterozygous for HbS (Fleming et al., 1979).  This documented the preferential 
survivorship of heterozygotes.  Bunn and Forget (1986:5) reviewed the results 
from Fleming et al. (1979:5) and stated, “It appears that the presence of sickle cell 
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trait confers a relative improved fitness of 0.20 compared with normal AA 
individuals.”  HbAS infants can be infected with Plasmodium falciparum, the 
causative parasite of malaria, but their infections will be shorter in duration and 
less severe than malaria in an infant homozygous for HbA (Allison, 1954b).  
Bunn and Forget (1986:508) offer this in summary:  “There is convincing 
epidemiological and experimental evidence that infants with sickle cell trait are 
endowed with partial protection against falciparum malaria.”   
 The specific mechanism by which hemoglobin variants provide protection 
from P. falciparum is unclear, but several theories exist.  In vitro studies have 
shown that erythrocytes containing both HbS and HbA (HbAS) in an anaerobic 
environment sickle more readily when infected with P. falciparum than when not 
infected.  The conjecture drawn from this observation is that infected cells will be 
more likely to sickle in vivo and be destroyed in the reticuloendothelial system, 
which would aid in fighting the infection (Luzzato et al., 1970).   
Erythrocytes containing both HbS and HbA sickle more readily when 
infected with P. falciparum infection than erythrocytes containing only HbA (Roth 
et al., 1978).  In HbAS erythrocytes, in heterozygous individuals, there is a pH 
reduction of about 0.4 units in an infected erythrocyte compared to a non-
parasitized erythrocyte, and this difference causes a 20 fold increase sickling 
(Friedman et al., 1979). Regardless of the initiating mechanism, when a cell 
sickles, hemoglobin S polymerizes, and there is a drop in intracellular potassium 
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concentration.  It is the drop in intracellular potassium that appears to cause the 
death of parasites in a sickled cell.  P. falciparum in erythrocytes cultured in a 
high potassium media remained vital.  In concept, this is due to the lack of drop 
in potassium concentration that usually accompanies sickling (Friedman et al., 
1979).   
With modern efforts to eliminate malaria, the survival advantages 
(increased fitness) provided by the hemoglobin variants have been reduced.  
According to Allison (1954b), there are two reasons for the drop in prevalence of 
sickle cell trait in North America from over 20% to the current frequency of about 
8%.  First, there has been “genetic admixture” of the sickle cell genes as Blacks of 
African origins have produced offspring with non-Black individuals.  Second, the 
lack of selective pressure due to the reduction of malaria has led to the loss of 
fitness of the heterozygotes.  This seems largely due to change in environment as 
Barclay and Splaine (1972) found that, in Zambia, a decrease in the frequency of 
sickle cell trait has occurred over a period coincident with the urbanization of 
tribes.  Barclay and Splaine’s (1972) assumption is that urbanization results in an 
environment where malaria is less prevalent. 
 
Shortcomings of the Literature 
 While there is considerable literature concerning “sickle cell disease”, 
many authors have failed to distinguish between sickle cell disease (specifically 
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those individuals homozygous for HbS or HbC) and sickle cell trait (individuals 
who are heterozygous, namely HbAS or HbAC).  Clarification is provided where 
possible as to the genotype of the subjects mentioned in the following review of 
the literature.  Many of the samples described in the literature are of mixed 
genotypes including homozygous and heterozygous subjects with HbS and/or 
HbC.  The primary focus of the present review is to address sickle cell disease as 
the homozygous conditions of HbSS and HbSC, with distinctions between the 
growth capacities of these two genotypes when possible.  
 
Modern Treatment of Sickle Cell Disease 
Treatment of sickle cell disease has had many advances, but “management 
of sickle cell anemia continues to be primarily palliative in nature, including 
supportive, symptomatic and preventative approaches to therapy” (Ballas, 
2002:143).  Transfusions, antibiotics, hydroxyurea, and pain medications are 
common forms of treatment (Miller, 1994).  Combining hydroxyurea with other 
medications such as butyrate to induce fetal hemoglobin production has shown 
promising therapeutic results “for complete amelioration of the clinical 
manifestations” (Atweh et al., 2003:14).  Transfusions have been successfully used 
as preventative treatment for the complications of sickle cell disease (Fullerton et 
al., 2004), especially in patients with progressive acute chest syndrome (Liem et 
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al., 2004), but chronic transfusions involve complications of their own (Miller, 
1994).   
New approaches in attempts to find a cure are being examined in test tube 
and transgenic mouse models (Noguchi et al., 1993; Ballas, 2002; Atweh et al., 
2003).  Gene therapy is a promising goal that would permanently correct defects 
in hematopoietic stem cells, but attainment of this goal is currently impeded by 
problems of vector instability (Puthenveetil and Malik, 2004).  Unfortunately, 
“curative therapies are currently available only to a small minority of patients” 
(Atweh et al., 2003). 
It is possible to screen blood from the umbilical cord of newborn infants to 
diagnose individuals prior to clinical manifestations of the disease (O’Brien et al., 
1976).  Subjects with sickle cell disease are living longer with the efforts of 
modern medicine (Quinn et al., 2004), so examination of the growth and 
development of children with sickle cell disease is now possible where it was 
historically impossible due to the significant early mortality tied to sickle cell 
disease.  To obtain contemporary data on survival rates of children with sickle 
cell disease, Quinn et al. (2004) examined 711 subjects with sickle cell disease 
diagnosed by newborn screening programs from the Dallas Pediatric Sickle Cell 
Program in Texas.  A total of 5,648 patient years of observation were obtained.  
Quinn et al. (2004:4023) concluded that, “Childhood mortality from sickle cell 
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disease is decreasing, the mean age at death is increasing, and a smaller 
proportion of deaths are from infection.” 
Bunn and Forget (1986:539) note that the prognosis of individuals with 
sickle cell disease is improving in developed nations and that a view skewed 
towards pessimism exists stemming from early, antiquated accounts of sickle cell 
disease. 
Only patients with relatively severe disease tend to require 
frequent emergency room visits and hospital admissions.  A 
surprisingly large group of SS homozygotes remain relatively 
symptom-free and do not solicit medical attention.  Furthermore, 
during the past 30 years, there has been a marked improvement in 
the care of patients with sickle cell anemia.  Infections are treated 
more promptly with increasingly effective antibiotics.  More careful 
attention is devoted to the maintenance of fluid balance and the 
prevention of dehydration.  In addition, maternal mortality among 
pregnant SS patients has decreased in recent years.  In 
underdeveloped nations, particularly in Africa, the mortality rate 
for sickle cell anemia remains high…. In the United States, the 
prognosis for children with sickle cell disease continues to improve. 
 
 
Manifestations of Sickle Cell Disease 
Bunn and Forget (1986) grouped the manifestations of sickle cell disease 
into four main categories:  (1) chronic hemolytic anemia, (2) systemic 
manifestations such as altered growth and development, (3) vaso-occlusive 
crises, and (4) organ damage resulting from chronic anemia and vaso-occlusive 
events. 
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Impaired Growth and Development 
 Subjects with sickle cell trait and sickle cell disease have impaired physical 
growth.  They tend to be smaller, delayed in tempos of their growth, and 
experience their pubertal growth spurts later as shown by the following studies. 
Phebus et al. (1984) examined 133 Black children from the Sickle Cell 
Anemia Program at Children’s Hospital of Pittsburgh.  Eighty-three children of 
the 133 had sickle cell disease and the remaining 50 were heterozygous for HbS 
combined with another variant allele such as HbC, HbO, or one of the 
thalassemias.  Phebus et al. (1984:28) found that “median height and weight 
curves constructed from serial growth data available for all 133 children 
demonstrated impairment in height and weight at all ages and in both sexes.”  A 
trend towards greater cumulative impairment with increasing age was found in 
both males and females, with males experiencing greater total growth 
impairment than females.  Also, the onset of the pubertal growth spurt was 
delayed as compared to averages established by Tanner and Whitehouse (1976).  
In this sample of sickle cell individuals, the maximum velocity for increase in 
height in males occurred at 16.3 years of age, later by more than 2 standard 
deviations than the Tanner Whitehouse mean.  Also in males, maximum velocity 
of weight gain occurred 2.7 years after the mean.  For females, the maximum 
velocity for height and weight gain was delayed by 2.4 and 2.5 years, 
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respectively, but both were within 2 standard deviations of the established 
means (Phebus et al., 1984).   
 Another study examined subjects with HbSS sickle cell disease from the 
Comprehensive Sickle Cell Center at The Children’s Hospital of Philadelphia.  
Children with sickle cell disease (n = 36) were compared to a healthy control 
group matched for age and ethnicity.  The subjects were analyzed in three 
groups:  (1) prepubertal males and females, (2) pubertal females, and (3) pubertal 
males.  Subjects with sickle cell disease had significantly lower weight, shorter 
stature, smaller arm circumference, and less upper arm fat and muscle (Barden et 
al., 2002).  Barden et al. (2002:218) stated one reason subjects with SS disease lag 
developmentally might be due to nutritional deficits as indicated by “low free fat 
mass coupled with low upper arm muscle area.”   In other words, the negative 
impact of sickle cell disease on growth in combination with the additional 
negative impact of poor nutrition may collectively have produced the depressed 
values in the sickle cell subjects.  It should be noted, though, that Barden et al. 
(2002) did not collect nutritional intake to determine the actual nutritional status 
of the subjects.   
 Luban et al. (1982) described a longitudinal study of children with sickle 
cell anemia at six month intervals for a period of three years.  They found that 
sexual age, as determined by the onset of puberty, and skeletal age were 
approximately equal, but skeletal age was significantly delayed compared to 
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chronological age.  This indicates that sexual age was also delayed compared to 
chronological age. 
Lowry et al. (1978) performed a cross-sectional study of 120 Jamaican 
subjects ages 2 to 13 years with HbSS and found a delay of about one year in 
skeletal growth compared to their HbAA sample.  The children were examined 
by radiographs of the left hand-wrist and compared to the Greulich and Pyle 
atlas (1959).  In females, a delay was evident from age 2 years and later and from 
age 8 years and later in males.  Blood tests were performed on the subjects, but 
other than a general delay in skeletal growth, no consistent relationship could be 
found between the magnitude of the delay and total hemoglobin, fetal 
hemoglobin, reticulocyte count or the percentage of irreversibly sickled cells 
(Lowry et al., 1978).   
Serjeant and Ashcroft (1973), in a study similar to Lowry et al. (1978), had 
comparable findings except that they found that increased HbF levels were 
associated with less-delayed skeletal development.   
Platt et al. (1994) stated that according to a life expectancy study of sickle 
cell disease subjects, high levels of HbF improved survival, and it is probably a 
reliable childhood forecaster of adult life expectancy. 
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Life Expectancy 
Individuals with sickle cell disease have statistically shorter life 
expectancies.  Platt et al. (1994) followed 3764 patients with sickle cell disease 
ranging in age from birth to 66 years of age from 23 clinics in the continental 
United States.  Examinations occurred between 1978 and 1988 during which 
individuals were seen at regular intervals for laboratory and physical 
examinations.  50% of the patients with sickle cell disease lived past 50 years of 
age.  HbSS individuals had a median age at death of 42 years for males and 48 
years for females.  HbSC individuals had a median age at death of 60 years for 
males and 68 years for females (Platt et al., 1994).  Of those individuals who died 
during the study, 18% of the deaths were from organ failure, most of which were 
specifically kidney failure.  One-third (33%) did not have organ failure, but died 
during an acute sickle crisis, involving pain, chest symptoms, stroke, or some 
combination of the three (Platt et al., 1994).   
 
Acute Chest Syndrome 
The leading cause of death in sickle cell disease patients is Acute Chest 
Syndrome (Lombardo et al., 2003).  Rates of postoperative acute chest syndrome 
(ACS) were reported at 10.4% in children with sickle cell disease following a 
variety of procedures (e.g., choleocystectomy, splenectomy, biopsy, skin graft, 
central venous access) performed under general anesthesia in a study from the 
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Medical University of South Carolina (Delatte et al., 1999).  Lombardo et al. 
(2003:39) hypothesized that “Acute Chest Syndrome episodes are secondary to 
pulmonary damage and a gradual worsening related to age.” Sylvester et al. 
(2004:67) stated that, “Lung function differs significantly in children with sickle 
cell disease compared with ethnic matched controls of a similar age [and] 
restrictive abnormalities may become more prominent with increasing age.“  
Acute chest syndrome in individuals with sickle cell disease is sometimes 
referred to as sickle cell chest (Zar, 2004).  Children with ACS commonly present 
with fever and cough, while adults commonly present with chest pain (Taylor et 
al., 2004). 
Acute chest syndrome in patients with sickle cell disease is often not 
responsive to conventional treatments (Wratney et al., 2004); however, bi-level 
positive airway pressure can be used to treat subjects with ACS and sickle cell 
disease and “may become a standard of care for children with acute chest 
syndrome” (Padman and Henry, 2004:199).  
Heart complications may compound the pulmonary complications of 
sickle cell disease.  The chronic anemia of an individual with sickle cell disease 
will cause increased cardiac output, left ventricular enlargement, and cardiac 
insufficiency (de Montalembert et al., 2004).  Boussaada et al. (2004) published a 
case report of a 33-year-old woman with sickle cell anemia with pulmonary 
hypertension, right heart ventricular failure, cardiomegaly, moderate renal 
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failure, and chronic anemia.  Boussaada et al. (2004:180) stated:  “Pulmonary 
hypertension is a common complication of adult patients with sickle cell 
anemia.”  Gladwin et al. (2004:886) found pulmonary hypertension in 32% of 195 
consecutively examined patients with sickle cell disease and stated, “It appears 
to be a complication of chronic hemolysis.” 
 
Pregnancy Outcomes 
Sickle cell disease can affect pregnancy.  Patients with sickle cell disease 
are now living longer and are more likely to be in need of medical care not 
directly related to sickle cell disease, such as obstetrics (Rajab and Skerman, 
2004).  Infants born to mothers with sickle cell disease are more likely to be 
preterm and to be small for gestational age, have low birth weight, and have 
neonatal jaundice (Athale and Chintu, 1994).  Aluoch et al. (1990), when 
examining mortality rates at birth from the perspective of the mother’s genotype 
in a hospital in Nairobi, Kenya, found high mortality rates, at 36% maternal and 
45% fetal death with HbSS mothers and 7% fetal death in HbAS mothers. On the 
other hand, Athale and Chintu (1994) examined subjects in Lusaka, Zambia and 
found that the genotype of the infant did not influence mortality rates of the 
mother or the infant during birth.  They reported mortality rates for HbSS infants 
and for their mothers during birth that were not statistically different than those 
of normal infants and their mothers. 
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Serjeant et al. (2004:1278) examined 94 pregnancies in 52 subjects from 
their Jamaican cohort study to determine trends in pregnancy outcomes that 
were not “biased by hospital-based, more severely affected subjects” as previous 
studies had been.  Serjeant et al. (2004) found that only 57% of pregnancies with 
HbSS mothers resulted in live newborns compared to 89% in controls.  Also 2.1% 
of mothers with HbSS died during pregnancy.  Serjeant et al. (2004:1278) 
concluded:  “The increased fetal loss and maternal morbidity in mothers with 
homozygous sickle cell disease is confirmed,” but they could not comment as to 
whether these rates reflected decreased mortality compared to previous studies 
since previous studies were not based on cohorts followed longitudinally. 
 
Increased Erythropoiesis 
Sickle cell disease creates an increased demand for erythropoiesis, and 
there often is a compensatory expansion of bone marrow cavities (Onuba, 1993).  
In young children without sickle cell disease, the process of erythropoiesis can be 
found in almost all of the bones (Serjeant, 2001).  In subjects without sickle cell 
disease, there is a decrease in total marrow space with maturation.  
Erythropoiesis becomes more restricted in location until it occurs primarily in the 
epiphyseal regions of long bones (Serjeant, 2001).    
In rare cases, increased erythropoiesis can manifest itself in unusual 
locations rather than being confined to the traditional location of the 
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hematopoietic tissues within the bones.  There are documented cases of 
intrathoracic extramedullary hematopoietic nodules that are usually 
asymptomatic but can occasionally be fatal (Chute and Fowler, 2004). 
The duration of erythrocyte survival is reduced seven-fold in sickle cell 
disease, but anemia occurs despite compensatory increases in erythropoiesis 
(Bunn and Forget, 1986).  The body is capable of an eight-fold increase in 
erythropoiesis in the bone marrow to compensate for physiological demands; 
however, according to studies based on the rate of iron used for erythropoiesis in 
sickle cell disease, the bone marrow compensates in sickle cell disease by 
increasing only three to six times normal rates.   This three to six-fold increase 
does not fully compensate for the stated seven-fold decrease in erythrocyte 
survival, leaving individuals with sickle cell disease in an anemic state (Bothwell 
et al., 1957; McCurdy, 1962).   
 
Aplastic Crisis 
 Aplastic crisis is a significant threat to an individual with sickle cell 
disease.  Systemic bacterial or viral infection in an individual with sickle cell 
disease can cause a rapid drop in hematocrit.  Infection will cause suppression of 
erythropoiesis, which, when combined with the already low erythrocyte levels, 
leads to a condition known as an aplastic crisis (MacIver and Parker-Williams, 
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1961).  Aplastic crisis is found in hereditary spherocytosis, sickle cell disease, and 
other hemolytic anemias.  
 
Bone Involvement 
 
Long Bones 
In sickle cell disease, there is a tendency for bone marrow expansion and 
proliferation throughout the skeletal system to compensate for the increased rate 
of hemolysis.  Figure 3 shows an example of the erythropoietic expansion in the 
tibia of an adult with sickle cell disease.  In HbSS disease, the erythropoietic 
expansion is more severe than in HbSC disease (Serjeant, 2001).  This expansion 
now can be visualized non-invasively through magnetic resonance imaging 
(Mankad et al., 1990) or by 99mTc sulphur colloid whole body imaging (Milner 
and Brown, 1982). 
When the long bones are affected by erythropoietic expansion, there may 
be clinical concerns.   With thinning of the cortical plate from erythropoietic 
expansion, fractures can occur spontaneously or with light trauma (Middlemiss, 
1958; Bohrer, 1981).   
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 Fig. 3. Cross sections of diaphysis of tibia.  A and C are from an adult subject 
with sickle cell disease and exhibit resulting expansion of marrow space.  B is of 
a healthy, non-sickle cell adult subject.  Note the darkness in A and C indicative 
of active bone marrow compared to the medullary cavity of the healthy subject in 
B.  Photograph from:  Diggs LW, Bell A.  Sickle cell disease:  photographs and 
photomicrographs from 60 years of study 1932-1993. Division of 
Hematology/Oncology, Department of Medicine, College of Medicine, 
University of Tennessee Health Science Center, Memphis, Tennessee.  Health 
Sciences Historical Collection, 2003. CD-ROM.   
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Cranium 
Erythropoietic expansion, often referred to as diplöic expansion in the 
calvaria, can also be seen in the bones of the cranium, specifically in the enlarged 
diplöic spaces of the so called ‘flat’ bones of the calvaria.   In the cranial vault, the 
diplöic spaces increase and the outer ectocranial tables of the bones thin with the 
expansion, sometimes causing clinically evident frontal and parietal bossing 
(Cockshot, 1961).  Bones of the cranium that usually are not affected by diplöic 
expansion include the basal occipital bone and the petrous part of the occipital 
bone (Sebes and Diggs, 1979).  Diplöic expansion was found in 22% of subjects 
examined in a retrospective study by Sebes and Diggs (1979) and in 20 of 61 of 
subjects by Ennis et al. (1973).  We suppose that these high frequencies were due 
to the less effective treatment and reduced access to health care in these older 
cohorts.   
Altered trabecular patterns, visible radiographically, may accompany 
diplöic expansion (Williams et al., 1975).  When the trabecular pattern is 
perpendicular to the cortical plates, a hair-on-end appearance may result.  The 
typical hair-on-end appearance is shown in Figure 4.  While this hair-on-end 
appearance is common in subjects with Beta thalassemia, it is uncommon in 
subjects with sickle cell disease (Williams et al., 1975).  According to Diggs (1973) 
only 5% of subjects with HbSS have the hair-on-end trabecular pattern.   
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Fig. 4. Hair-on-end trabecular pattern in a 16-year-old male with HbSS disease.  
Note the extensive erosion of the ectocranial table with expansive growth of the 
diplöe, especially on the parietal bone.  In comparison, the frontal and occipital 
bones appear to be largely unaffected.   Photograph courtesy of E. F. Harris. 
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A different appearance occurs when the dominant trabecular pattern is 
parallel with the cortical plates. It is described as onion-peel and is called 
intradiplöic curvilinear lamellation (Williams et al., 1975).  In a study by Williams 
et al. (1975), the onion-peel appearance was found in 35% of 17 HbSS subjects.   
Williams et al. (1975:951) noted that the onion-peel appearance was “relatively rare 
after 10 years of age.”  Also, a selection bias toward more severe cases of sickle 
cell disease may have been present because they examined deceased individuals.  
Serjeant (2001) noted that the specific causes or etiology for the hair-on-end and 
the onion-peel appearances are unknown.   
Some subjects with sickle cell disease present with tower skull.  This is 
characterized by prominence of the forehead and dome of the skull, and this is 
likely to be a consequence of the hair-on-end trabecular pattern (Diggs, 1967).  
Diggs estimated the incidence at about 5%, but we suppose it is much less 
common today in the United States because of more effective medical 
management of sickle cell disease.  Diggs (1967:131) stressed that the frequent 
presentation of tower skull and altered trabecular patterns in journal articles gives 
the “erroneous impression that they are characteristic and usual” when, in fact, 
they are rare and are the noteworthy exception.  Theoretically, because similar 
presentations have been found in cases of iron deficiency, tower skull and altered 
cranial trabecular patterns may be the result of sickle cell disease combined with 
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an additional anemia resulting in a severe enough state that these conditions are 
exhibited (Diggs, 1967). 
 
Maxillae 
The maxillae can be adversely affected in sickle cell disease.  A 
presentation of orthodontic relevance termed gnathopathy is ”evidenced by 
maxillary prominence and malocclusion and has been described as the main jaw 
abnormality seen in SCD patients” (Oredugba and Savage, 2002:321-322).  The 
lateral cephalometric radiograph and the posterior-anterior cephalometric 
radiograph of a 16-year-old HbSS male with a classic presentation of 
gnathopathy are shown in Figures 5 and 6.  Individuals with untreated sickle cell 
disease have chronic hemolysis and may present with progressive gnathopathy, 
worsening with age (Oredugba and Savage, 2002).  In a study of Nigerian 
children, prominent maxillae were more common in those children with sickle 
cell disease than in a control group (Oredugba and Savage, 2002).  The 
erythropoietic expansion of the maxilla found in gnathopathy may cause flaring 
of the maxillary incisors (Konotey-Ahulu, 1969).    In contrast, Shnorhokian et al. 
(1984) examined 27 subjects with sickle cell disease and found that while both the 
maxillae and mandible were protrusive, the maxillary and mandibular incisors 
were retrusive relative to the protrusive maxillae and mandible.  Shnorhokian et 
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Fig. 5. Lateral cephalometric radiograph of a 16-year-old HbSS male with classic 
presentation of gnathopathy.  Note the enlarged maxillae and accompanying 
dental protrusion. 
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Fig. 6. Posterior-anterior cephalometric radiograph of a 16-year-old HbSS male 
with classic presentation of gnathopathy.   
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al. (1984) speculated that increased lip pressure from the protrusive maxillae and 
mandible might have caused the retrusion of the incisors.  
The maxillary alveolar ridge is more prominent in HbSS subjects than in 
individuals with normal genotypes.  Brown and Sebes (1986) examined 50 HbSS 
subjects and 25 control subjects.  The groups were matched for sex and age.  
They measured the length of the hard palate, the angle of the hard palate to the 
alveolar ridge (termed the PAR angle for palate-alveolar ridge), and Sella-
Nasion-A Point (SNA) angle.  No statistically significant difference was found for 
SNA angle or length of the hard palate between the groups, but the PAR angle 
was significantly larger in the HbSS sample (P < 0.01) (Brown and Sebes, 1986).  
According to Brown and Sebes (1986:655), PAR angles of greater than 120 
degrees represent “significant maxillofacial deformity.” 
 
Trabecular Patterns in the Maxillae 
Altered trabecular patterns may accompany gnathopathy.  White et al. 
(2000) showed bony expansion of the jaws resulting from bone marrow 
expansion in conjunction with trabecular changes.  Mourshed and Tuckson 
(1974:818) stated that subjects with sickle cell disease exhibited “increased 
radiolucency of the jaws and the presence of a coarse trabecular pattern.”  This 
description of the trabecular pattern also has been described in case reports 
(Gillis and West, 2004).  Clinically, however, Mourshed and Tuckson (1974) 
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found that the increased radiolucency and coarse trabecular pattern also 
occurred in many healthy non-sickle cell disease subjects, so the noted 
appearance was not a pathognomonic criterion.   
Faber et al. (2002) found that subjects with sickle cell anemia exhibit 
increased trabecular spacing that can be seen by analyzing dental periapical 
radiographs with computer aided Fourier analysis.  The increased trabecular 
spacing, due to resorption of finer bony elements, results in the ground glass 
appearance commonly described in the literature.   
 
Vertebrae 
In subjects with sickle cell disease, the vertebrae may exhibit altered 
morphology resulting from marrow expansion, especially when the expansion 
undermines the structural integrity of the bony elements.  The corpus of the 
vertebrae may have enhanced radiolucencies with few pronounced trabeculae.  
Historically, in untreated sickle cell disease, this altered appearance was often 
striking enough that diagnosis of sickle cell disease was made from radiographic 
analysis alone (Diggs et al., 1937).  The vertebral bodies may be biconcave or have 
a “step-like” depression (Figs. 7 and 8), also known as fish vertebrae deformity 
(Diggs, 1967).   
While altered vertebral morphology may be seen early in life, the 
tendency for this presentation increases with age (Riggs and Rockett, 1968).  
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 Fig. 7. Vertebral bodies with “step-like” or biconcave depressions.  Photograph 
from:  Diggs LW, Bell A.  Sickle cell disease:  photographs and photomicrographs 
from 60 years of study 1932-1993. Division of Hematology/Oncology, 
Department of Medicine, College of Medicine, University of Tennessee Health 
Science Center, Memphis, Tennessee.  Health Sciences Historical Collection, 2003. 
CD-ROM.   
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 Fig. 8. Vertebral bodies with “step-like” or biconcave depressions at their cranial 
and caudal aspects.  Photograph from:  Diggs LW, Bell A.  Sickle cell disease:  
photographs and photomicrographs from 60 years of study 1932-1993. Division 
of Hematology/Oncology, Department of Medicine, College of Medicine, 
University of Tennessee Health Science Center, Memphis, Tennessee.  Health 
Sciences Historical Collection, 2003. CD-ROM.   
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Ennis et al. (1973) examined 61 subjects over 12 years of age, 33 male and 28 
female, from a group of 420 subjects with HbSS disease at the sickle cell clinic of 
the University Hospital of the West Indies.  They found that 43% of the 61 adults 
had biconcave vertebral bodies and 40% had “step-like” depressions.  In severe 
cases, the vertebrae will collapse or experience loss of vertical height, which can 
cause spinal cord compression (Sadat-Ali et al., 1993).  Vertebral collapse had 
occurred in 9 of 34 individuals examined by Sadat-Ali et al. (1993).  Pain may be 
associated with vaso-occlusal events in the vertebrae, and pain is most common 
in the lower back, but can occur in the cervical, thoracic, or lumbar vertebrae 
(Diggs, 1967).  Radiographic focal lesions in the vertebrae are usually evident 
several weeks after the onset of pain or discomfort (Diggs, 1967). 
 
Localized Avascular Necrosis 
 Localized avascular necrosis can occur due to vaso-occlusion by sickled 
red blood cells.  Avascular necrosis can, in some cases, affect heterozygotic 
subjects (sickle cell trait) as well as homozygous subjects (Nachamie and 
Dorfman, 1974).  Avascular necrosis and the resulting inflammatory response is 
often a painful event that may be anatomically localized or may affect an entire 
bone (Serjeant, 2001) An example of localized necrosis in a child’s metacarpal is 
shown in Figure 9.  Vaso-occlusion occurs as a microcirculatory event, where 
local adhesion by “normal” erythrocytes is compounded by less deformable 
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Fig. 9. Necrosis of distal aspect of metacarpal in a subject with dactylitis.  Note 
the pale necrotic marrow on the left in the metacarpal compared to the phalanx 
on the right.  Also note the new bone development evident at the lower border of 
the metacarpal at the periosteal interface on the lower left of the slide.  
Photograph from:  Diggs LW, Bell A.  Sickle cell disease:  photographs and 
photomicrographs from 60 years of study 1932-1993. Division of 
Hematology/Oncology, Department of Medicine, College of Medicine, 
University of Tennessee Health Science Center, Memphis, Tennessee.  Health 
Sciences Historical Collection, 2003. CD-ROM.   
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sickled SS erythrocytes to create an obstruction (Kaul and Nagel, 1993).  Some of 
the conditions that increase the tendency for sickling are hypoxia, hypothermia, 
and acidosis.  While the primary focus of the present thesis is the effects on the 
skeletal system, it is of note that vaso-occlusive events are destructive to many 
vital organs such as the spleen, kidneys, lungs, heart, and parts of the central 
nervous system (Ware and Filston, 1992).  Subjects with sickle cell disease have 
increased “fibrous connective tissue and changes in muscle that vary with age 
and vessel size” (Manci et al., 2004). 
 
Dactylitis 
When avascular necrosis of bone marrow with the associated 
inflammatory response occurs in the metacarpals, metatarsals, or phalanges, it is 
termed dactylitis (Sergeant, 2001).  The onset of dactylitis frequently is early in 
life.  In a study of subjects in Jamaica, 45% of subjects examined with sickle cell 
disease had been affected by dactylitis by 2 years of age (Stevens et al., 1981).  It is 
noteworthy that percentages of subjects with dactylitis vary according to the 
geographical location of studies performed.  In Africa, an estimated 80% of 
subjects with sickle cell disease exhibited dactylitis (Lambotte, 1962), while in the 
United States, the rate has been estimated at a much lower 11% (Booker et al., 
1964).    
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Clinically, dactylitis presents as a non-pitting swelling (does not dent 
upon pressure or palpation) of the fingers that lasts about a week and is often 
accompanied by a fever (Serjeant, 2001).  An example of dactylitis in an infant is 
shown in Figure 10.  Localized necrosis is a common occurrence (Fig. 9).  
Dactylitis can result in premature fusion of epiphyseal plates causing shortened 
digits that often are deformed as seen in Figure 11 (Cockshot, 1963).  Multiple 
episodes of dactylitis are common.  Radiographic change (Fig. 12) is evident 
about 10 to 14 days after the initial presentation of swelling and pain, at the point 
when the symptoms have begun to subside (Diggs, 1967).  “The lesions consist of 
periosteal elevation, subperiosteal new-bone formation, and radiolucent areas 
intermingles with areas of increased density, giving a moth-eaten appearance” 
(Diggs, 1967:125). 
 
Avascular Necrosis in Long Bones 
 Acute infarcts of the diaphysis of the long bones involving pain and 
swelling are common in younger subjects prior to 8 to 10 years of age.  Bohrer 
(1970), in a retrospective study, examined 198 diaphyseal infarcts in 81 subjects 
from Nigeria.  He noted that 91% had occurred prior to 9 years of age, most often 
in the tibia and femur.  The lesions were bilateral and symmetrical in 23% of the 
subjects.  In older subjects, infarcts of the diaphysis of the long bones are less 
likely to be acute and often are not recognized clinically due to a more gradual 
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Fig. 10. A 7-month-old boy with HbSS and dactylitis of the right hand.  The right 
palm and proximal phalanges were edematous and painful.  Photograph from:  
Diggs LW, Bell A.  Sickle cell disease:  photographs and photomicrographs from 
60 years of study 1932-1993. Division of Hematology/Oncology, Department of 
Medicine, College of Medicine, University of Tennessee Health Science Center, 
Memphis, Tennessee.  Health Sciences Historical Collection, 2003. CD-ROM.   
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Fig. 11. Permanent deformation of digits of subject resulting from recurrent 
dactylitis.  Note the enlarged interphalangeal joints and the shortening of some 
digits, notably ray 3 of the left hand.  Photograph from:  Diggs LW, Bell A.  Sickle 
cell disease:  photographs and photomicrographs from 60 years of study 1932-
1993. Division of Hematology/Oncology, Department of Medicine, College of 
Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.  
Health Sciences Historical Collection, 2003. CD-ROM.   
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Fig. 12. Bony lesions from infarcts in the phalanges in the hand of a 7- month-old 
boy with HbSS.  In particular, the proximal phalanges of rays 2, 4, and 5 possess 
large radiolucencies resulting from localized infarcts that appear to emanate near 
the bones’ nutrient canals.  Photograph from:  Diggs LW, Bell A.  Sickle cell 
disease:  photographs and photomicrographs from 60 years of study 1932-1993. 
Division of Hematology/Oncology, Department of Medicine, College of 
Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.  
Health Sciences Historical Collection, 2003. CD-ROM.   
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process of marrow ischemia and necrosis (Bohrer, 1970).  In concept, the more 
acute symptoms observed in children may occur because of less collateral 
circulation to the periosteum in children than in adults; however, in children, the 
infarcts are more likely to resolve and heal without permanent alteration of bone 
structure than in adults (Serjeant, 2001).  Diggs (1967) points out the exception to 
the rule is that young children do not seem to be susceptible to avascular necrosis 
of the femoral head, presumably due to the artery in the ligamentum teres, which 
is patent in young children and can provide collateral circulation to the femoral 
head.  Infarcts of long bones occur most often in children in “the intermediate 
segment between the diaphysis and metaphysis at a point furthest from the entry 
of the nutrient vessels” (Serjeant, 2001:255).   
In adults, infarcts of the diaphysis often are more commonly manifested 
as medullary and cortical changes (Serjeant, 2001).  In 19 of 61 adults with sickle 
cell disease from Jamaica, there was cortical thickening and medullary narrowing 
instead of expansion (Ennis et al., 1973).  Sometimes, the medullary narrowing is 
extensive enough to obliterate the marrow space along a section of the diaphysis, 
providing an osteosclerotic appearance (Legant and Ball, 1948).  A bone in bone 
appearance may manifest after cortical infarct due to mineralization of the 
marrow space during the inflammatory response to the infarct (Diggs, 1967; 
Williams et al., 2004). 
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 Special imaging techniques are available for the examination of infarcts.  
Kim and Miller (2002) examined 50 subjects between the ages of 8 months and 22 
years over an 11 year period to determine the nature of infarcts with HbSS 
disease.  Examinations of the whole skeleton (n=93) were performed with 99mTc-
sulfur colloid bone marrow scanning and 99mTc-disphosphonate bone scanning.  
Twenty-one of the 50 subjects were examined more than once.  Overall, 34% of 
infarcts healed completely.  In some cases, infarcts recurred in previously healed 
sites, but no determination could be made as to whether sites of prior infarcts 
were more susceptible to subsequent infarcts.  Kim and Miller (2002) found that 
the most common sites of infarcts were the long bones, including the femur, 
humerus, tibia, and the pelvis.  Kim and Miller (2002:899) speculated:  “It is 
possible that the increased length of the nutrient arteries supplying the marrow 
in the long bones makes them more susceptible to occlusion.”   
 The head of the femur may undergo avascular necrosis due to sickle cell 
disease.  According to Hammer et al. (2003:384) “Osteonecrosis of the femoral 
head classically develops at an early age.”  Milner et al. (1991) found the highest 
incidence of such an event is in the 24 to 34-year-old group in the United States 
in subjects with HbSS disease, but the problem also has been seen in five-year-
old subjects.  Milner et al. (1991) found that avascular necrosis of the femoral 
head occurs at a rate of 2 to 4.5 cases per 100 patient years and that subjects with 
a combination of sickle cell disease and alpha-thalassemia together have the 
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highest risk.  Avascular necrosis of the femoral head appears to be a common 
complication in Kuwaitis with sickle cell disease and was more common in males 
in a sample examined by Marouf et al. (2003).  There also has been an isolated, 
first of its kind, case report of a slipped capital femoral epiphysis in a child with 
sickle cell disease, indicating that the effects of sickle cell disease may at times be 
somewhat unpredictable (Segal and Wallach, 2004). 
Most subjects heal and recover relatively well from necrosis of the femoral 
head and are able to continue with normal function (Serjeant, 2001).  Many 
subjects are asymptomatic despite permanent morphological alteration of the 
joints.  In rare cases, the deterioration progresses to the point of destructive 
osteoarthritis and immobility of the joint (Serjeant, 2001).  In severe cases of 
avascular necrosis of the femoral head, prosthetic replacement of the joint is 
“now the most widely practiced therapy,” but the procedure is often wrought 
with complications of sickle cell disease, including high fracture rates of the 
diaphysis of the femur (Serjeant, 2001:270).  Also, the obliteration of the marrow 
space of the femur from previous necrotic events may create complications 
because the marrow space has to be bored out to seat the prosthesis on the femur 
(Serjeant, 2001).   
 Diggs (1967:126) offers the following description of avascular necrosis of 
the femur:   
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Infarcts may occur in any part of the neck or the femoral head.  
Avascular necrosis of juxta-articular bone is associated with 
degenerative changes in the cartilage and the synovial membrane.  
Dead bone and granulation tissue grind against the acetabulum.  
Fragments of necrotic bone, shreds of cartilage and synovial 
membrane escape into the joint cavity.  The joint space is narrowed, 
the smooth contour of the synovial surface is replaced by jagged 
irregularities, and there are secondary hypertrophic arthritic 
changes.  The round head of the femur is squashed or acquires a 
mushroom shape.  In the end stage, the residual capital epiphysis is 
fused to the pelvis, and the joint is completely ankylosed.  
Secondary infection may be superimposed at any time, adding 
insult to injury. 
 
Avascular necrosis of the humeral head also occurs, but since the shoulder 
joint is not weight bearing, the incidence of collapse or remodeling of the joint is 
lower following necrosis than in the head of the femur (Serjeant, 2001).   
 Infarcts in the cranium may involve a number of clinical manifestations.  
Infarcts around the orbit will occasionally interfere with movement of the eye 
and result in pain and swelling.  Serjeant (2001:273) stated from observation of 
Jamaican subjects that “numbness or paraesthesia in the distribution of the 
mental nerve is not uncommon during the painful crisis, even in the absence of 
clinical mandibular involvement, and occasionally persists for months,“ but he 
did not offer statistics on the frequency of this condition.   
Infarcts causing avascular necrosis can be very painful.  Bone pain 
presumably results from the intramedullary pressure related to the inflammatory 
response in the non-compliant (rigid non-expandable compartment) marrow 
space of the bone (Serjeant, 2001).  Pain may arise from infarcts in the ribs, often 
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presenting similarly to acute pulmonary pain, but the lungs are clear while 
painful swellings can be found on the ribs and sternum.  Similarly, the spine and 
pelvis may undergo painful infarcts, which are painful to palpation and may 
result in localized swelling (Serjeant, 2001).   
 
Osteomyelitis and Bacterial Prophylaxis 
 Osteomyelitis is a concern for patients with sickle cell disease in locations 
of avascular necrosis.  Commonly, strains of salmonella and staphylococcus are 
responsible for the infection.  In areas of rapid bone destruction, osteomyelitis 
should be suspected, although it is difficult to diagnose (Serjeant, 2001).  
According to Golding et al. (1959), osteomyelitis is twice as common in African 
subjects with sickle cell disease compared to African American subjects.  Diggs 
(1967:139) stated:  “It is thought that ischemia and necrosis of bone furnish a 
favorable nidus for the growth of bacteria, but the reason for the predominance 
of Salmonella organisms as the most common etiologic agent is not obvious.” 
 General bacterial infections, in addition to the aforementioned 
osteomyelitis, are a “major cause of morbidity and mortality among young 
children with sickle cell disease” (Lepage et al., 2004:145).  Bacteremias occur at a 
rate of about 8 events per 100 patient years in HbSS subjects and about 5 events 
per 100 patient years in HbSC subjects.  
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Dental Development 
Conflicting results have come from studies on the effects of sickle cell 
disease on dental development.  Sears et al. (1981) examined 27 subjects, 13 males 
and 14 females, between 6 to 17 years old from records of the Sickle Cell 
Foundation of Western Pennsylvania.  They found that dental development in 
subjects with the sickle cell disease appeared to be normal despite alterations in 
the surrounding bone.  In the sample examined by Sears et al. (1981), the dental 
age corresponded to the chronological age.  In contrast, Harris and Harris (1994) 
examined 35 subjects by cephalometric and panoral radiographs.  They found 
that subjects with sickle cell disease exhibited approximately 1.2 years of dental 
developmental delay in both males and females.  Subjects with HbSC were 
delayed less, 0.4 years, than subjects with HbSS, 1.7 years (Harris and Harris, 
1994).  Also, “later forming teeth were more delayed because they were the 
elements actively undergoing mineralization” (Harris and Harris, 1994:273; 
Johnson-Nance et al., 1994).   
 
Cephalometrics and Sickle Cell Disease 
In rats, hypoxia has been shown to affect skeletal development.  In 
comparison to controls, hypoxia caused reduced body length and reduced tail 
length due to retardation of the growth of the experimental rats’ skeletons 
(Hunter and Clegg, 1973).  A finding of note from this study is that “the stress 
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did not affect the body uniformly, so that although tail and body length grew in 
proportion to body weight, the limbs grew longer in relation to this parameter 
than in litter mate control animals” (Hunter and Clegg, 1973:216).   
In hypoxic environments, morphological and physical changes have been 
documented to occur in humans, as well.  The Cholos, natives of high mountain 
altitudes of the Andes in Peru, have wide, deep chests and shorter stature than 
related groups near sea level, presumably as an adaptation to the low oxygen 
environment in which they live (Barcroft, 1925).  The question remains, however, 
how craniofacial growth of humans is affected by hypoxia or anemia and the 
associated physiological process of the specific anemia.   
There has been little research on the cephalometric analysis of subjects 
with sickle cell disease.  Harris’ research group (Robinson and Harris, 1992; 
Wasson and Harris, 1992; Harris and Harris, 1994; Hubrich and Harris, 1995; 
Johnson-Nance and Harris, 1995) found alterations of cranial morphology as 
measured from lateral cephalometric roentgenograms taken on a sample of 
subjects with sickle cell disease.  Cephalometrically, the mandibular plane angle 
was steeper in subjects with sickle cell disease, but otherwise angular 
measurements were reported to be similar to controls.  Linear measurements 
“were significantly small-for-age” in subjects with sickle cell disease.  Males and 
females were affected equally, and there was no difference between children 
with HbSS and HbSC genotypes. 
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Alhaija et al. (2002) examined lateral cephalometric roentgenograms of 54 
subjects with Beta thalassemia major.  While this study was not on subjects with 
sickle cell disease, it is notable because Beta thalassemia is another of the 
hemolytic anemias.  Subjects with Beta thalassemia major had large 
intermaxillary discrepancies, as measured by the ANB angle, and had short 
cranial bases and small mandibles that resulted in a Class II skeletal appearance.  
Also, the angle from the maxillary plane to the mandibular plane was increased 
for the thalassemic subjects compared to controls (Alhaija et al., 2002). 
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CHAPTER III 
 
METHODS AND MATERIALS 
 
Sample Composition 
 Somewhat in excess of half of the metropolitan population of Memphis, 
Tennessee is comprised of American Blacks, and this community was the source 
of the children with sickle cell disease studied in this report.  Families with 
children who were patients of record in the city’s hematology programs were 
contacted.  Diagnostic records were obtained in conjunction with dental health 
screening examinations that included dental and orthodontic examinations.  Data 
collection was preceded by written informed consent per this institution’s 
Internal Review Board.  There is, then, the slight chance that children in this 
sample (because of their medical histories) were more likely than the average 
individual to seek medical treatment than sickle cell disease children who were 
not patients of record.  On the other hand, sequelae of sickle cell disease are so 
common in SCD children, particularly episodic crises, that we feel comfortable 
that these children are representative of those in the community at large. 
A total of 75 children with sickle cell disease were studied for the present 
research.  Of these, 13 subjects were excluded due to incomplete records (Table 
1).  This left 62 subjects the final analysis:  16 HbSS males, 19 HbSS females, 14 
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Table 1.  Excluded subjects and reasons for exclusion. 
 
Subject  
Number Reason for Exclusion 
  
113 Non-diagnostic cephalometric radiograph 
115 No genotype indicated in record 
117 No cephalometric radiograph in record 
121 No cephalometric radiograph in record 
122 No genotype indicated in record 
125 No cephalometric radiograph in record 
127 Non-diagnostic cephalometric radiograph 
129 No genotype indicated in record 
131 No cephalometric radiograph in record 
137 No genotype indicated in record 
143 Non-diagnostic cephalometric radiograph 
146 No cephalometric radiograph in record 
147 No cephalometric radiograph in record 
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HbSC males, 7 HbSC females, 5 HbSB+ females, and 1 HbSB+ male.  For the 
purposes of this study, the HbSB+ children were pooled with the HbSC children. 
Ages of subjects ranged from 3 years of age to 18 years of age.  A graph of the 
distributions of age by sex is provided in Figure 13.  This graph shows that the 
distributions are comparable between boys and girls.  Likewise, Figure 14 shows 
that the age distributions are comparable across the genotypes.  That is, the 
patterns of age across genotypes and across sexes are similar, so results of the 
study are unlikely to be confounded by age or sex differences between the 
subgroups. 
 
Cephalometric Analysis 
The selection of the landmarks and the measurements used in this thesis 
resulted from a compromise between (1) an interest in being comprehensive 
(cephalometrically and anatomically) and (2) constraints imposed by the 
availability of values in the Richardson atlas from which we obtained our control 
values.  We attempted to compile our list of measured variables in groups that 
include broad aspects of the craniofacial complex, both skeletal and dental, with 
some redundancy of variables in close proximity to one another so as to allow 
comparison of results within the sample.  We compiled a list of 37 angular and 
millimetric variables for this thesis. 
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Fig. 13. Chronologial age distributions of the sample, by sex.
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Fig. 14.  Sequenced age distributions by sex and genotype.  For
example, there were 5 individuals with "other" genotypes (not SS or
SC), the youngest at 3.3 years of age, the second at 5.1, the third at
5.4, the fourth at 8.0, and the fifth at 15.6.
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Cephalometric Landmarks 
All of the cephalometric landmarks are defined when viewing the skull in 
norma lateralis.  Definitions of the cephalometric landmarks are listed and defined 
in Table 2 and illustrated in Figure 15. 
 
Cephalometric Measurements 
Cephalometric measurements were organized for presentation into six 
anatomical regional categories as described in Table 3:  (1) cranial base, (2) 
cranial base to face, (3) mandible, (4) facial divergence, (5) Tweed triangle, and 
(6) dental relationships.  Skeletal distances measured are illustrated are in Figure 
16.  Most of the skeletal angles measured are illustrated in Figures 17 and 18. 
Dental angular and millimetric measurements are illustrated in Figures 19, 20, 21, 
and 22.  
 
Cephalometric Tracing Method 
Each lateral cephalometric roentgenogram was traced by the author onto a 
sheet of 0.003 inch thick acetate tracing paper with a 0.5 mm mechanical pencil.  
In this study, double images of bilateral structures on the radiographs from left 
and right sides of the skull (i.e., right and left sides of the mandible) were 
averaged for the purposes of tracing.  The distance between the double images 
was split in the tracings, as recommended by Baumrind and Frantz (1971a,b). 
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Table 2.  Alphabetical listing of definitions of the cephalometric landmarks used 
in the present study. 
 
 
A Point A (Subspinale):  the most posterior point on the exterior ventral 
curve of the maxillae between the anterior nasal spine and superdentale. 
ANS Anterior Nasal Spine:  the spinous process of the maxilla forming the most 
anterior projection of the floor of the nasal cavity. 
Ar Articulare:  the intersection of the radiographic images of the inferior 
surface of the cranial base and the posterior surfaces of the collum of the 
condyle of the mandible. 
B Supramentale:  the most posterior point on the bony curvature of the 
mandible between infradentale and pogonion. 
Ba Basion:  the most inferior-posterior point in the midsagittal plane on the 
anterior margin of the foramen magnum at the base of the clivus. 
Cd Condylion:  the most superior and posterior point on the curvature of the 
capitulum of the condyle. 
DOP Downs’ Occlusal Plane:  the line that bisects incisal overbite vertically and 
the most anterior occlusal contact of the maxillary and mandibular first 
molars (Downs, 1948). 
Continued 
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Table 2. Continued. 
Gn Gnathion (anatomic):  the most anterior-inferior point of the mandibular 
symphysis. 
Go Gonion (anatomic):  the most posterior-inferior point on the gonial angle 
of the mandible. 
Ii Incision inferius:  the incisal tip of the most anterior mandibular central 
incisor. 
Is Incision superius:  the incisal tip of the most anterior maxillary central 
incisor. 
LIA Apex of mandibular central incisor:  the apical end of the same 
mandibular central incisor used to locate Ii. 
L6C L6 cusp:  the mesial cusp tip of the mandibular first molar. 
Me Menton:  the most inferior point on the symphysis of the mandible. 
Na Nasion:  the anterior point of the intersection between the nasal and 
frontal bones. 
Or Orbitale:  the most inferior point on the lower margin of the bony orbit. 
PNS Posterior Nasal Spine:  the most posterior point at the midsagittal plane on 
the bony hard palate. 
Continued 
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Table 2. Continued. 
Po Porion:  the midpoint on the superior aspect of the rim of the external 
auditory meatus. 
Pg Pogonion:  the most anterior point on the anterior contour of the bony 
chin below B point and above gnathion. 
Pt Pterygomaxillary fissure:  the most superior-posterior point on the 
radiographic outlines of the pterygomaxillary fissure. 
Se Sella turcica:  the center of the hypophyseal fossa determined by 
inspection. 
U1A Apex of the maxillary central incisor:  the apical end of the most anterior 
maxillary central incisor of the same tooth used to locate Is. 
U6C U6 cusp:  the mesial cusp tip of the maxillary first molar. 
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Fig. 15.  Cephalometric diagram showing locations of the skeletodental
landmarks used in this study.
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Table 3. Arrangement of the 37 cephalometric variables by anatomical region. 
 
 Variable Measurement Unit 
Cranial Base 
 Sella-Nasion Distance...............................................................millimeters 
 Sella-Basion Distance................................................................millimeters 
 Nasion-Basion Distance ...........................................................millimeters 
 Basion-Sella-Nasion Angle (Saddle Angle)...........................degrees 
Cranial Base to Face 
 Y-Axis Length............................................................................millimeters 
 Sella-Gonion Distance ..............................................................millimeters 
 SNA Angle .................................................................................degrees 
 SNB Angle..................................................................................degrees 
 ANB Angle.................................................................................degrees 
 Nasion-A-Pogonion Angle ......................................................degrees 
Mandible 
 Condylion-Gnathion Distance ................................................millimeters 
 Gonion-Gnathion Distance......................................................millimeters 
 Condylion-Gonion Distance....................................................millimeters 
 Gonion-Pogonion Distance .....................................................millimeters 
 Gonion-Menton Distance.........................................................millimeters 
 Articulare-Gonion-Gnathion Angle .......................................degrees 
Continued 
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Table 3. Continued. 
 
 Variable Measurement Unit 
Facial Divergence 
 Y-Axis Angle (SeGn-SeNa)......................................................degrees 
 Y-Axis Angle (Se-Gn-FH) ........................................................degrees 
 FH to Sella-Nasion Angle ........................................................degrees 
 Sella-Nasion to Palatal Plane Angle.......................................degrees 
 Occlusal Plane to Sella-Nasion Angle....................................degrees 
 Occlusal Plane to Frankfort Horizontal Angle .....................degrees 
 Palatal Plane to Mandibular Plane Angle .............................degrees 
 Nasion-Menton Height ............................................................millimeters 
 ANS-Menton Height ................................................................millimeters 
 Upper Face Height (UFH; Na-ANS) ......................................millimeters 
Tweed Triangle 
 FMA ............................................................................................degrees 
 FMIA...........................................................................................degrees 
 IMPA...........................................................................................degrees 
 
Continued 
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Table 3. Continued. 
 
 Variable Measurement Unit 
 
Dental Relationships 
 L1-Mandibular Plane Angle....................................................millimeters 
 Mandibular M1 to Mandibular Plane (L6 to MP) ................millimeters 
 Overbite…………………………………………………….…..millimeters 
 Overjet………………………………………………………….millimeters 
 Interincisal Angle (U1 to L1) ...................................................degrees 
 L1 to Nasion-B Point Angle.....................................................degrees 
 U1 to Nasion-A Point Angle ...................................................degrees 
 U1 to Sella-Nasion Angle.........................................................degrees 
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Fig. 16.  Cephalometric diagram showing distances measured in this study.
Distances shown here are (1) anterior face height (Na-Me), (2) upper face height
(Na-ANS), (3) lower face height (ANS-Me), (4) Y-axis length (Se-Gn), (5) posterior
face height (Se-Go), (6) ramus height (Cd-Go), (7) mandibular length (Cd-Gn), (8)
corpus length to Pogonion (Go-Pg), (10) corpus length to Gnathion (Go-Gn), and
(11) corpus length to Menton (Go-Me).
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Fig. 17.  Cephalometric diagram showing six of the angular measurements used
in this study. The six angles illustrated here are (1) Frankfort mandibular plane
angle, (2) the Se-Gn to Se-Na angle, (3) the Se-Gn to FH angle, (4) the NAP angle,
and (5) the angle between the Se-Na and Frankfort Horizontal planes, and (6) the
angle between the palatal and mandibular planes.
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Fig. 18.  Cephalometric diagram showing four of the angular measurements
used in this study. The four angles illustrated here are (1) the Gonion angle
(the angle between the ramus (Ar-Go) and corpus (Go-Me) axes), (2) the ANB
angle (the difference between SNA minus SNB), and (4) the Se-Na to Palatal
Plane (ANS-PNS) angle, and (4) the Palatal Plane to Mandibular Plane angle.
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B.
Fig. 19.  Schematic outlines of the lateral views of the maxillary and mandibular
central incisors.  Overjet (A) was the horizontal millimetric distance from
the labial surface to that of the mandibular incisor, measured parallel with
Down’s occlusal plane.  Overbite (B) was the vertical millimetric distance
fro the incisal edge of the maxillary incisor to the incisal edge of the mandibular
incisor, meaured perpendicular to Down’s occlusal plane.
A.
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Fig. 20.  Cephalometric diagram of a mandible showing measurement of
1L height and 6L height, both assessed perpendicular to the anatomic
mandibular plane.
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Fig. 21.  Cephalometric diagram showing incisor angular relationships
used in this study.  Illustrated here are (1) IMPA, (2) FMA, and (3)
interincisal angle.
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Fig. 22.  Cephalometric diagram showing maxillary incisor relationships
used in this study.  Illustrated here are (1) the U1-to-Nasion-A Point  line
angle and (2) the U1-to-Sella-Nasion angle.
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Data Entry 
Records obtained on the subjects for the present study included:  lateral 
cephalometric roentgenogram, health history, and clinical examination including 
genotyping from blood sample.  Records for subjects 001 to 028 were obtained in 
1991 by Robinson and Harris (1992), and records for subjects 101 to 147 were 
obtained in 1994 by Johnson-Nance and Harris (1995).  Examinations, along with 
dental charting, prophylaxis, and some restorative dental work were done in a 
pediatric dental department. 
The cephalometric tracings were scanned along with a 150 mm ruler for 
calibration using a Hewlett Packard psc 1210xi flatbed scanner and saved as 
JPEG files.  The tracings in JPEG format were imported into Dolphin Imaging® 
9.0 software (Dolphin Imaging, Chatsworth, CA) and traced using the digital 
cephalometric tracing function of the program.  Prints of the cephalometric 
tracings of the all subjects used in the present study can be found in Appendix A.  
A custom analysis was created with the “custom analysis builder” function of 
Dolphin Imaging 9.0 Beta® for measurement of the 37 skeletodental angular and 
millimetric variables used in the present study. 
The measurements were exported from Dolphin Imaging 9.0 Beta® into 
Microsoft Excel® 2000.  Age of each subject was rounded to the nearest year to 
match the format for data found in Richardson (1988).  Also, individuals younger 
than 6 were rounded up to 6 years of age, and individuals older than 16 were 
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rounded down to 16 years of age to match the data found in Richardson (1988).  
Cephalometric measurements for each subject in the present study can be found 
in Appendix B. 
 
Statistical Analysis 
Elisha Richardson’s (1988) cephalometric atlas of North American black 
children was used as the standard against which growth of the children with 
sickle cell disease was evaluated.  Richardson (1988) examined 82 African 
American subjects, 41 males and 41 females, from the metropolitan area of 
Nashville, Tennessee.  Richardson’s subjects were selected using a modified 
random sampling technique with socioeconomic stratification.  The subjects were 
6 years old or younger at the time of initial records and were followed serially for 
at least 11 years.  None of the subjects received orthodontic treatment during the 
period of data collection.  Richardson (1988) grouped subjects by sex and age.  
His descriptive data were reported as means and standard deviations for angular 
and millimetric cephalometric measurements.  The data were grouped separately 
for boys and girls and sequentially by age in one year increments from 6 through 
16 years of age for a total of 11 age groups.   
Each child in the present study was individually matched by sex and age 
to the group from the Richardson data that corresponded for sex and nearest age.  
Then, the variables from children in our sample were compared to the 
85
corresponding sex and age groups’ means and standard deviations from the 
Richardson data.  Richardson’s descriptive data served as the control values used 
to calculate the z-scores for this study.  Z-scores were calculated as 
sd
xXz −=  
where X is the value of the given variable from this study, x  is the age- and sex-
specific mean from Richardson (1988) for the given variable, sd is the 
corresponding age and sex specific standard deviation from Richardson (1988), 
and z is the z-score.  Converting the raw data to z-scores permits these children 
of various chronological ages (and different sexes) to be analyzed together (e.g., 
Garn and Shamir, 1958). 
Standard descriptive statistics and inferential tests were computed as 
described in Sokal and Rohlf (1995).  Statistics were calculated using StatView® 5 
(SAS Institute, Cary, NC).  Individual tests are described as they are encountered 
in the Results, but the analysis revolves primarily on three issues:  One, if the 
data (transformed to z-scores) for these children with sickle cell disease does not 
differ from the control group, then the mean z-score will not differ significantly 
from zero.  This is tested using a one-sample (two-tail) t-test.  Two, if the severity 
of the effect of sickle cell disease on growth differs by sex or among genotypes, 
this can be tested using unpaired t-tests (two groups) or factorial analysis of 
variance (multiple groups).  Three, if the effect of sickle cell disease on growth is 
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independent of chronological age, then linear regression analysis would show 
that the z-scores among children do not increase or decrease significantly with 
age.  That is, the regression coefficient will not differ to a statistically significant 
extent from zero. 
All tests were evaluated as conservative two-tailed alternative hypotheses 
with alpha set at the conventional level of 0.05. 
Graphs of the noteworthy findings here were generated using DeltaGraph 
5.0 (SPSS Inc., Chicago, IL). 
 
Measurement Error 
Any measurement made with a measuring device is approximate.  If you 
measure the same object two times, the two measurements may not be the same.  
According to Sokal and Rohlf (1995:13) this issue of repeatability concerns 
precision, which they define as the closeness of repeated measurements of the 
same quantity to each other.  The cephalometric method used in the present 
study consisted of (1) attaching an acetate sheet to a radiograph and tracing the 
key skeletodental structures as well as locating the required landmarks then (2) 
using Dolphin Imaging 9.0 Beta® to digitize the landmarks as Cartesian 
coordinates.  Consequently, random errors can affect the final measurements due 
to two major sources, namely (1) inconsistencies in landmark identification while 
tracing, (2) inconsistencies in digitizing landmarks (e.g., Baumrind and Frantz 
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1971a,b; Baumrind et al., 1976).  The purpose of this section is to estimate these 
sources of random measurement error. 
We explicitly do not deal here with issues of cephalometric distortion.  All 
of the radiographs were made using the same cephalometer, with a source to 
midline distance fixed at 7 feet.  The midline to film distance was variable 
depending on the size of the patient’s head and was not recorded.  This 
introduces variability in magnification, both random and systematic, among 
children in the study. 
Random measurement error was calculated using the familiar Dahlberg 
statistic (Dahlberg, 1940), namely 
( )
2n
XX
d 1i
2
2j1j∑
=
−
=  
where and 1jX 2jX  are the two independently repeated measurements of variable 
j, and n is the number of pairs of measurements.  The result, d, is the average 
measurement error of the cephalometric dimensions, either in millimeters for 
linear variables or degrees for angular variables.  These two sorts of variables 
(distance and angular) were analyzed separately. 
We also assessed two hierarchical sources of error, (1) the error due to 
digitization and (2) the error due to cephalometric landmark identification plus 
88
digitization.  One would, of course, expect this second, more inclusive error 
estimate to be larger than the first. 
 
Linear Dimensions 
Six patients’ cephalograms were selected at random and redigitized.   
Pooling across all of the linear distances used in this study, Dahlberg’s d was 0.28 
mm.  In other words, point identification using the computer’s mouse to select 
the landmarks that are viewed on a computer screen had a mean error of about a 
quarter of a millimeter. 
More telling is the random error due to tracing and digitization.  For the 
same subjects (78 repeated measures), mean error was 1.46 mm.  On average, 
then, the skeletodental dimensions (distances) differed by a millimeter-and-a-
half among replications, and most of this (81% on average) was due to variations 
in landmark identification during the tracing procedure (with the other 19% 
attributed to digitizing inconsistencies). 
 
Angular Variables 
Digitizing error due to intraobserver variability averaged 0.55 degrees for 
123 replicate angular measurements.  Again, retracing the skeletodental 
structures, which introduces variation in landmark identification, increases the 
error estimation.  This latter average was 1.48 degrees.  Typically then, 63% of the 
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error is attributable to tracing variabilities, with the other third (37%) is due to 
inconsistencies introduced during the digitization phase of data acquisition. 
 
Intraobserver Error Analysis 
These measures of intraobserver random error can also be expressed as 
percentages of the sizes of the variables measured,  
n
2
XX
XXn
1i 2j1j
2j1j∑
= ⎥⎥
⎥⎥
⎦
⎤
⎢⎢
⎢⎢
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⎛ +
−
 
where n, here, is the number of pairs of measurements.  The benefit is that this 
formula expresses the imprecision of the measurements as a function of trait size. 
 
Linear Dimensions 
 The digitization process alone introduces a mean error of just 0.53% of 
trait size.  In contrast, retracing and redigitizing the cephalograms yields a mean 
percentage of 2.53%.  While still small, these results again emphasize that 
landmark identification (Baumrind and Frantz, 1971a) is the greater source of 
variation compared to digitization of the tracings. 
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Angular Variables 
Mean percentage error for the angular variables was 2.08% due to 
digitizing alone and increased to 8.68% when tracing error was included.  These 
percentages somewhat overestimate the relative error because some of the angles 
(in the denominator term) are close to zero, so, percentage-wise, the minor errors 
are proportionately large. 
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CHAPTER IV 
 
RESULTS 
 
Sex Differences in Response to Sickle Cell Disease 
During preliminary analysis, it became evident that girls with sickle cell 
disease were affected to greater extents than boys.  One measure of this sex 
difference is shown in Table 4, which lists the mean z-scores, by sex, for the 37 
skeletodental variables.  Of these, the absolute mean z-scores are larger (more 
affected) in females than males for 26 of these 37 skeletodental variables.  Since 
the z-scores were calculated on a sex- and age-specific basis, a greater mean 
indicates a greater deviation of the cases from the age- and sex-matched norms.  
This predominance is statistically significant when tested against the null 
hypothesis of a uniform (1:1) distribution (X2 with 1 df = 6.1; 0.05 < P < 0.01).  
This departure is even more noteworthy given that the extreme deviations occur 
in the subset of females.  Furthermore, when the dental traits are excluded 
(bottom of Table 4), the remaining 29 skeletal variables show a clearer 
preponderance of more-severe conditions in the females (  = 7.8; P < 0.01).  
Consequently, we analyzed the data separately but in parallel by sex.  
2
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(Alternatively, these 29 skeletal variables probably are not statistically 
independent of one another.) 
 
Sickle Cell Disease: Tests for Severity by Genotype 
There were 27 HbSC and 35 HbSS children in the study.  Two-way 
factorial ANOVA was used to test whether there was any significant difference 
in the degree of response to SCD depending on genotype.  The two-way ANOVA 
simultaneously tested for genotype (SC vs. SS) and for sex differences as well as 
genotype-sex interactions.   Just 2 of the 37 variables exhibited a significant 
difference by genotype:  one, length of the posterior cranial base was shorter in 
the HbSS genotype (P = 0.023), and, two, the angle between the palatal plane and 
the mandibular plane (PP-MP) was larger in the HbSS genotype (P = 0.003).  
Other than these two significant variables, there was no trend among the other 
dimensions.   
We also separated the data by sex and compared the absolute mean z-
scores between the HbSC and HbSS genotypes, but there was no genotype 
difference within either sex.  These data are presented in Appendix C.  For sexes 
combined, the mean scores did not differ between genotypes.  The observed split 
of 40 versus 34 did not differ from chance (X2 with 1 df = 0.48; P > 0.90).  
Consequently, the data were not separated by genotype for analysis. 
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For completeness, we also calculated the ANCOVA statistics in Appendix 
D.  These show the results for each variable.  The model tested for genotype (SS 
or SC, with the few SB genotypes pooled with the SC) and for sex (boys, girls), 
with age at examination and the covariate.  No improvement in explained 
variance was gained by using a more complex covariate (e.g., age + age2) or by 
using a sex-specific covariance. 
 
Craniofacial Size 
The focus of this section is to evaluate the effects of SCD on dimensions of 
the skeletodental structures.  That is, if a trait were unaffected by SCD, then the 
sample’s mean z-score would be distributed around zero.  Alternatively, if the 
bulk of the sample systematically diverges above or below the mean, then the 
sex-specific tests will detect this.  There was, however, another important 
complicating factor that we noticed early on when the results were plotted 
against the children’s chronological ages, several variables exhibited an 
association with age, indicating that the variables worsened (became more 
deviant) as the person gets older.  Appendix E provides bivariate plots for all 
variables testing the presence of an association between ages at examination and 
magnitude of the z-score, on a sex-specific basis.  Inspection shows that most of 
the cases where a substantial association occurs are for the male subset of the 
sample.  Consequently, we used analysis of covariance (ANCOVA) with age as 
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the covariate to account for this occasionally-significant source of variation.  The 
covariate was for sexes combined.  The reader will, then, want to evaluate two 
statistical results at once, namely (1) whether the one-sample t-tests disclose a 
significant departure from normal growth and (2) whether there is a sex and/or 
age effect for the variables under scrutiny.  Results are listed in Table 5, and they 
are interpreted in the following sections.  
 
Cranial Base 
Both the anterior and posterior cranial base lengths are significantly 
undersize in these children with SCD (Table 5).  Lengths of the anterior cranial 
base (Se-Na) and the posterior cranial base (Se-Ba) are about equally affected, 
with an overall reduction in growth of about 0.8 standard deviations.  In a 12-
year-old, this corresponds to a deficit in the length of the cranial base of about 6 
mm for the two dimensions (Se-Na + Se-Ba).  Predictably, these smaller cranial 
segments cause the overall length of the cranial base (Nasion to Basion) to be 
significantly small for chronological age.  It also is of note that the saddle angle 
(Ba-Se-Na) is flatter (larger) than expected (P < 0.05) in both sexes, by about a 
half a standard deviation.  A larger saddle angle has the effect of compensating 
for the shorter cranial base lengths.  These dimensional and angular changes are 
statistically equivalent in the samples of boys and girls.  None of the standard 
deviation scores for the four cranial base variables were dependent on age. 
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Cranial Base to Face 
Facial relationships were more affected in females than males, though 
both sexes were significantly undersize (Table 5).  We evaluated six variables in 
this category, two linear and four angular dimensions.  In the males, two of the 
variables were significantly deviant.  One was a deficiency in length of posterior 
face height (Se-Go), and the other was the excessive size of the NAP angle.  It is 
of note that these two differences occurred in faces where SNA, SNB, and ANB 
were judged to be within normal limits statistically. 
In the sample of females, all six variables in this section were affected to 
statistically significant extents.  Sella-Gnathion distance was larger than 
anticipated, but posterior face height (Se-Go) was much smaller than expected, so 
the overall length of the mandible is long but with a short ascending ramus.  The 
assertion that the overall length of the mandible is larger than anticipated is 
supported by the measurement of Condylion-Gnathion which was about a half 
of a standard deviation longer in females with SCD (P = 0.0478).  The angular 
relationships were this:  SNA and SNB both were significantly smaller angles 
than expected, with SNB being affected more severely.  This latter effect (greater 
deficit in SNB than SNA) accounts for the highly significant disparities between 
the two jaws, namely the larger than expected ANB and NAP angles.  These 
angular differences create an obvious disharmony―the maxilla is deficient 
anteroposteriorly (negative score for SNA), but the mandible is still 
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proportionately retrognathic (deficient SNB combined with exaggerated ANB 
and NAP).  Again, these statistics show that the females are discernibly more 
affected than the males. 
 
Mandible 
Six measurements were made of the mandible (Table 5).  Five variables 
measure size of the mandible, one of the overall size (Cd-Gn), one of ascending 
ramus (Cd-Go), and three measures of corpus length that ought to produce fairly 
redundant measurements (Go-Gn, Go-Pg, and Go-Me).  Finally, the angle Ar-Go-
Gn is a measure of the gonial angle. 
The signs of all six z-scores are the same in males and females suggesting 
a similarity in the nature of deviance from controls across the sexes.  Condylion-
Gnathion, Gonion-Gnathion, and Condylion-Gonion show a statistically 
significant difference by sex in the severity of the growth-deficit.  Condylion-
Gnathion and Gonion-Gnathion are more deviant (have absolutely larger z-
scores) in girls than in boys, while Condylion-Gonion is more deviant in boys 
than in girls (Table 5).  Overall, for both sexes, the mean z-scores show that the 
ramus is small but that the corpus is particularly affected, with means of about -
1.5 standard deviations.  The ramus and corpus are small, but the gonial angle 
(Ar-Go-Gn) is excessively obtuse, which largely camouflages the short bony 
elements.  An excessive gonial angle helps offset the short ramus and corpus to 
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the degree that the mandibular symphysis, judged by SNA, SNB, and NAP, is 
significantly retrusive, but not nearly as much as if the gonial angle were smaller.  
For clarity it will be remembered that NAP is measured as the superior-
anterior angle (Fig. 17), so the larger NAP is, the more retrusive the chin point, so 
the significant, positive mean z-score (especially so in girls) indicates that the 
mandible is retrusive. Just one of these six variables has a statistical dependence 
with age:  The z-scores for the gonial angle increases with the children’s’ ages.  It 
is useful to understand this progressive relationship.  Consider two choices.  
One, if the gonial angle were proportionately large in children with sickle cell 
disease, then the mean z-score would be large (as noted), but it would be 
independent of age―all children with sickle cell disease would be at about +1.5 z-
scores.  Alternatively, if the gonial angle was excessive and it progressively 
increased with age vis-à-vis children without sickle cell disease, then the age 
covariate in Table 5 would be significant.  Of course, this latter alternative is the 
case.  The gonial angle is excessive and it increases with age out of proportion to 
the changes expected in “normal growers.” 
As was mentioned, the excessive gonial angle explains why the generally 
small linear dimensions in these SCD children were not evident in the measure 
of overall size of the mandible (Cd-Gn).  Instead, the small ramus and corpus are 
“camouflaged” because of an excessive gonial angle. 
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Examination of the millimetric size of the mandibular corpus (Go-Gn, Go-
Pg, Go-Me) confirms the diminutive size of this bone, at least its horizontal 
portion.  The three landmarks on the symphysis, namely Pogonion, Gnathion, 
and Menton, are fairly close together, so we have no explanation why the mean 
z-score for Go-Gn is only one-third as large as the other two (a finding consistent 
across the sexes). 
 
Facial Divergence 
Six angular measurements were examined to determine the degree of 
facial divergence.  All were significantly larger in SCD females compared to 
controls, and all but two, Sella-Nasion to Palatal Plane angle and the Occlusal 
Plane to Sella-Nasion angle, were significantly larger in SCD males compared to 
controls, which establishes a finding of facial hyperdivergence in these SCD 
children. 
One of these angles, FH to Sella-Nasion, differs in boys and girls with 
SCD, and the nature of the difference is distinctive.  The divergence between FH 
and the Sella-Nasion plane is smaller-than-normal in boys ( x  = -0.39) but larger-
than-normal in girls ( x  = +0.43).  Both the male and female samples are 
marginally significant (P ≈ 0.04) relative to the standards, but in different 
directions, so, compared to each other, the difference in mean z-scores is obvious 
(P = 0.01). 
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The other significant sex difference in this set (Occlusal Plane to Sella-
Nasion) occurs because the mean for boys is above zero ( x  = 0.32) but not 
significantly so.  The mean z-score for girls ( x  = 1.09) is significantly larger than 
that of the boys.  That is, the occlusal plane tips down more in the front in girls 
than boys (P = 0.001). 
Three of the six variables in this section also are age-dependent.  All of 
these three covariates are positive, meaning that the variables grew (increased) 
significantly faster than in children without SCD.  One of these significant 
covariates is the Y-axis (SeGn to SeNA angle).  The Y-axis is excessively large in 
these children with SCD, and it increases (steepened) with age at a 
disproportionate rate.  The angle between the Sella-Nasion plane and FH also 
shows a significant age effect, which is interesting because there are no major 
sutures between these planes to facilitate this change.  We suppose the increasing 
divergence between these two cephalometric planes is due to remodeling of at 
least some of the relevant landmarks (Sella, Nasion, Porion, Orbitale) so as to 
drift the planes apart. 
As an aside, it merits emphasis that the present data are cross-sectional.  It 
needs to be confirmed with serial data that these observed “changes” actually 
occur within individuals.  Alternatively―though it seems unlikely to us―these 
“changes” could be due to differential mortality in children with SCD and/or 
biased selection among the children who chose to be examined. 
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The other variable in this section whose z-score is age dependent is the 
angle between Sella-Nasion and the Occlusal Plane.  This angle too is excessive 
(hyperdivergent) in children with SCD, and it increases disproportionately with 
age.    
 
Anterior Face Height 
There is an interesting dichotomy in these data.  In the sample of males, 
the vertical dimensions are smaller than expected but the one angular variable 
(Palatal Plane to Mandibular Plane) is larger than expected.  The result is a 
convex facial profile.  It is of note, then, that all of the several planes of the face 
(Table 5) are hyperdivergent in these children with SCD.   
Anterior facial height is significantly underdeveloped in the males; 
however, this small size is primarily a consequence of undergrowth of the lower 
portion of the face (ANS to Menton).  The upper portion of the face(Na-ANS) 
also has a negative mean z-score suggesting undergrowth, but the extent is not 
significant statistically. 
These results for the boys are not shared altogether by the girls.  
Dimensionally, the three measures of size are not affected (all three means are 
close to zero), but the girls do share the boys’ hyperdivergence between the 
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Palatal Plane and Mandibular Plane.  Indeed, this mean ( x = 1.55) is larger than 
in the sample of boys but the sex difference is not significant statistically. 
One sees that most of the facial planes in these children are significantly 
more divergent than American black children without SCD (Richardson, 1988) 
and that divergence increases―grows more severe―with age.  The one angle in 
this section, Palatal Plane to Mandibular Plane, exemplifies this trend.  One 
might suppose that changes in the mandibular plane might contribute most to 
this because the mandible is free to autorotate down-and-back.  It can be seen, 
though, that both anterior measures of anterior height contribute to this age-
dependency.  Total anterior face height (Nasion-Menton) and lower anterior face 
height (ANS-Menton) both are age dependent. 
 
Tweed Triangle 
This set of three clinical relationships shows a mixture of results.  FMA is 
significantly steeper than expected in both sexes.  Results for FMA show that the 
hyperdivergence seen for PP-to-MP (above) is due more to steepness of the 
mandibular plane and less to the cant of the Palatal Plane.  The mandibular plane 
is significantly steeper than in the controls for both boys and girls (P < 0.0001).  
There is no difference between sexes in the steepness of FMA, nor does the 
severity of this hyperdivergence change across the ages. 
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The negative, significant departures of FMIA (Table 5) show that the 
mandibular incisor is more reclined in the subjects with SCD than in the controls 
(P = 0.0019 in boys and P = 0.0005 in girls).   In fact, as shown by the “normal” 
values for IMPA, the small angles seen for FMIA seem to be due to the steepness 
of the mandibular plane.  (See Figure 21 for an illustration of the variable FMIA).  
Downward-backward rotation of the mandible (i.e., steeper FMA) will reduce 
FMIA in the absence of dental compensations.  This seems to be the case because 
IMPA―orientation of the lower incisor to the mandibular plane―is slightly 
reclined in the SCD sample, but no significantly so.  Neither FMIA nor IMPA is 
sexually dimorphic, nor is either variable dependent on the age at observation. 
 
Dental Relationships 
The large battery of eight dental relationships occurs here because 
Richardson’s atlas contains many such variables for comparison.  We did not 
suppose that the dental (occlusal) variables would be targeted by SCD.  Instead, 
we interpret the occlusal problems as consequences of the affected growth of the 
supporting skeletal complexes in children with SCD.   
The millimetric dimension L1-to-Mandibular Plane is substantially shorter 
than expected; indeed, this variable has the largest t-test of any of the variables 
examined, and the mean score is on the order of –2.4 standard deviations in both 
sexes.  This undergrowth of the incisors is paralleled in the buccal segment 
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dimension L6-to-Mandibular Plane, though the extent of underdevelopment in 
the molar segment is not as extreme as for the incisors (mean z = -0.9 in boys and 
–0.5 in girls).  Both L1-to-MP and L6-to-MP are millimetric dimensions, and our 
speculation is that these dimensions are undersize predominately because corpus 
height is so undersize in these children.  We have no measurement to document 
this, but inspection of the cephalograms confirms that the tooth dimensions are 
within normal limits and that the teeth themselves are not incompletely erupted.  
Instead, the diminutive size of the corpus appears to be the source of the 
problem.  In other words, the “heights” of the teeth are not at fault; the problem 
is the underdevelopment of the bony base against which tooth height is 
measured. 
 
Regression of Z-Scores on Age 
We intentionally collected records of males and females of various 
chronological ages to study whether the craniofacial effects of SCD vary with 
age.  It will be recalled that the high concentrations of fetal hemoglobin are 
protective in utero and during infancy; it is not until childhood when fetal 
hemoglobin’s production wanes and is substituted by adult hemoglobin, that 
health problems related to the rapid lysis of erythrocytes arise (Serjeant, 2001).  
The question, here, is whether the debilitating problems affect growth in a 
progressive, cumulative manner. 
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This was tested, within each sex, using linear regression of the variable on 
age.  The raw data had been converted to z-scores with regard to the child’s sex 
and age, so a statistically significant regression coefficient would disclose that the 
SCD child’s growth differs progressively with age.  The two alternatives are (1) 
that the severity of the effects of SCD is independent of age or (2) that the effects 
are disproportionate.  To make this interpretation clearer, consider a 
conventional percentile chart for stature (Fig. 23).  It is well-documented that 
children with SCD have impaired linear growth that places them in the lower 
centiles (e.g., Lowry et al., 1978; Phebus et al., 1984; Barden et al., 2002).  Say, for 
example, their modal growth is along the 10th centile (the specifics are 
immaterial for this example).  Their z-scores would have some negative mean 
that is significantly less than zero.  If, however, their pattern of growth were 
normal, just depressed by some degree, then their z-score would not change with 
age.  Though short, the children would track along the same centiles as they grew 
(Tanner and Whitehouse, 1976).   
The alternative scenario is that the children do not track; instead, their 
tempos of growth cause them to cross centiles.  In concept, crossing centiles can be 
a good or a bad thing since it may mean either that their growth normalizes or 
that it worsens.  The health issue (and statistical question) is whether these 
children with SCD track along the same centiles (in which case there is no 
dependency between age and z-score) or systematically cross centiles (so there is 
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Fig. 23. A centile chart for stature.  In the absence of growth
perturbations, expectation is that a child will track along
approximately the same centile from birth to adulthood.
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an association between age and z-score).  Analysis was performed within each 
sex because of differences in severity.   
Statistical results are listed in Table 6.  Eleven of the 37 tests disclosed 
significant regression coefficients for the sample of boys, and 10 of these are 
localized to the categories of “mandible” and “facial divergence” with one 
measurement, SNB, in the category of “cranial base to face”.  The sample of girls, 
in contrast, showed virtually no trends with age.  Just one of the 37 variables 
(Occlusal Plane to Sella-Nasion; P = 0.02) changed significantly with age in the 
sample of girls. 
The SNB angle is marginally significant in males (P = 0.036) and the 
regression coefficient is negative (b = -0.09), which show that the boys become 
disproportionately more retrognathic as they get older.  On the other hand, there 
is no such suggestion among girls (P = 0.955), and, if the changes in SNB were 
real for the boys, the ANB angle for the boys should reflect this as well but it 
does not (P = 0.222).  In other words, if SNB angle in boys is becoming 
progressively smaller with age while SNA angle is not, then the ANB angle 
should show an increase, but the ANB angle does not show a significant increase 
with age.  Therefore, it is doubtful that there is a real change occurring in the 
SNB angle with age. 
Several of the measures of facial divergence are statistically associated 
with age, especially in males.  This stimulated our earlier comments about these 
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children becoming more hyperdivergent with age.  The angle between Sella-
Nasion and Frankfort Horizontal shows an interesting trend; the angle was 
smaller than expected in the young boys (Fig. 24) but increased 
disproportionately such that this angle is larger than expected in the adolescents. 
The occlusal plane (measured relative to Sella-Nasion) also depended on 
age in the boys (Fig 25).  Z-scores are near zero (i.e., age appropriate) in 
childhood, but increased over time.  Scores exceed 2 standard deviations in some 
of the adolescents.   
A third angle, Palatal Plane to Mandibular Plane, also depended on age, 
and, again, the angle becomes more divergent with age in males (Fig. 26). 
Just one of the variables in this category of “Facial Divergence” is 
significant among the girls, and this is the angle between Sella-Nasion and the 
Occlusal Plane (Fig. 27).  The relationship here parallels that for the boys:  z-
scores are normal (in the vicinity of zero) for the younger children, but increase 
with age.  Four of the adolescent girls have z-scores that exceed 2 SDs.   
In boys, all of the measurements of size in the category of “mandible” 
tended towards being relatively smaller than controls with age while the gonial 
angle (Ar-Go-Gn) became more obtuse with age (Table 6).  This trend was not 
seen in girls. 
None of the other cephalometric dimensions are dependent on age, and 
none of the dental variables were significantly dependent on age (Table 6).  In 
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Fig. 24.  Bivariate plot between chronological age and z-score of
the angle between Sella-Nasion and Frankfort Horizontal, in males.
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Fig. 25.  Bivariate plot between chronological age and z-score of
the angle between Sella-Nasion and the Occlusal Plane, in males.
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Fig. 26.  Bivariate plot between chronological age and z-score of the
angle between Palatal Plane and the Mandibular Plane, in males.
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Fig. 27.  Bivariate plot between chronological age and z-score of
the angle between Sella-Nasion and the Occlusal Plane, in females.
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sum, these children with SCD tend to be small in size relative to their peers, but 
none of the size dimensions, with the exception of the mandible in boys, get 
proportionately worse with age.  Facial relationships―the angular 
variables―tend to become disproportionately worse with age, notably so in the 
boys.  The faces become more overtly hyperdivergent.   
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CHAPTER V 
 
DISCUSSION 
 
Perspective 
According to the US Census, there were 281.4 million people in the United 
States, of which 36.4 million, or 12.9%, were African American (McKinnon, 2000).  
About 10% of African Americans are heterozygous for the sickle cell gene 
(Serjeant, 2001), and approximately 0.3% of African Americans in the US are 
homozygous for the sickle cell gene (Beers and Berkow, 1999).  A rough estimate 
is, then, that there are about 110,000 people in the United States with sickle cell 
disease and many more with the trait.  Sickle cell disease results collectively from 
several genetic abnormalities that produce aberrant hemoglobin molecules (e.g. 
Livingstone, 1967).  There has been extensive research on the treatment and the 
systemic growth and development of individuals with sickle cell disease; 
however, virtually no research has evaluated the craniofacial growth and 
development of children with this growth-inhibiting genetic disease. 
Sickle cell disease is the result of any of a number of genetic abnormalities 
that produce aberrant hemoglobin structures, such as hemoglobin S (HbS) and 
hemoglobin C (HbC).  Bunn and Forget (1986) group the manifestations of sickle 
cell disease into four main categories:  (1) chronic hemolytic anemia, (2) systemic 
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manifestations such as altered growth and development, (3) vaso-occlusive 
crises, and (4) organ damage resulting from chronic anemia and vaso-occlusive 
events. 
The chronic hypoxia and other pathophysiological processes experienced 
by individuals with sickle cell disease can be expected to affect their craniofacial 
growth.  Previous examinations have shown the deleterious and retarding effects 
of sickle cell disease on general growth (Barden et al., 2002; Lowry et al., 1978; 
Luban et al., 1982; Phebus et al., 1984).  Previous studies on subjects with another 
of the hemolytic anemias, β-thalassemia major, showed discernible differences in 
craniofacial structure as measured by lateral cephalometric radiographs (Alhaija 
et al., 2002).  Significant differences are expected in the craniofacial growth of 
children with SCD if trends from previous studies of general growth in SCD and 
trends from craniofacial growth in similar diseases hold true.   
In the present study, lateral cephalometric radiographs of 62 children with 
sickle cell disease (HbSS and HbSC) were examined to determine if craniofacial 
growth is altered compared to controls without sickle cell disease. 
 
Cohort Effect 
Treatment of SCD has undergone many advances over the last century.  
Transfusions, antibiotics, hydroxyurea, and pain medications now are common 
forms of treatment (Miller, 1994).  Combining hydroxyurea with other 
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medications such as butyrate to induce fetal hemoglobin production has shown 
promising therapeutic results “for complete amelioration of the clinical 
manifestations” (Atweh et al., 2003:14).  Transfusions have been successfully used 
as preventative treatment for the complications of sickle cell disease (Fullerton et 
al., 2004).  New approaches to finding a cure are being examined in vitro and in 
transgenic mouse models (Noguchi et al., 1993; Ballas, 2002; Atweh et al., 2003).  
Gene therapy is a promising treatment that would permanently correct defects in 
hematopoietic stem cells, but attainment of this goal is currently impeded by 
problems of vector instability (Puthenveetil and Malik, 2004).   
It is possible to screen blood from the umbilical cord of newborn infants to 
identify infants with SCD prior to clinical manifestations of the disease (O’Brien 
et al., 1976).  Subjects with sickle cell disease are living longer through the efforts 
of modern medicine (Quinn et al., 2004), so examination of the growth and 
development of children with sickle cell disease is now possible where 
historically it was impossible due to substantial early mortality tied the disease.  
As Quinn et al. (2004:4023) stated:  “Childhood mortality from sickle cell disease 
is decreasing, the mean age at death is increasing, and a smaller proportion of 
deaths are from infection.” 
With the improvements in treatment of SCD, the children in this sample 
are inherently different from the patients of years past (Quinn et al., 2004).  
Improvements in SCD treatment have changed the degree to which SCD affects 
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an individual’s growth.  The patients examined by Diggs the mid 1900’s (e.g., 
Diggs et al., 1934, 1937) were a cohort with problems reflective of the treatment 
modalities of that time.  The sample examined in this study should be considered 
a cohort representative of patients who received the standard of care in the 
1980’s and 90’s.  Further, children with SCD growing up and being treated in the 
future will be considered a separate cohort reflecting the future standard of care 
relying on medical advances yet to come.  Such advances are likely to include 
gene therapy (Puthenveetil and Malik, 2004).  The issue is this:  the subjects that 
we examined are probably less affected by SCD than older patients who grew up 
with less effective treatment.  Also, since this was a cross-sectional study, the 
possibility exists of a cohort effect within our sample such that the younger 
children in our sample may have received more advanced medical care than 
children who were only a few years older in our sample. 
 
Genotypes:  SS vs. SC 
Much previous literature has established that, between the HbS and HbC 
alleles, HbS produces the more severe form of the disease.  Subjects possessing 
the HbSS genotype tend to exhibit more severe symptoms than those with HbSC 
since the alleles involved are co-dominant and HbC by itself is not as serious 
(Levitan, 1977; Serjeant, 2001; Nagel et al., 2003).  In our results, however, we did 
not find that children with HbSS exhibited more deviance from controls than did 
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those with HbSC.  Only two of the 37 measured variables exhibited a significant 
difference by genotype:  one, length of the posterior cranial base, was shorter in 
the HbSS genotype (P = 0.023), and, two, the angle between the palatal plane and 
the mandibular plane (PP-MP) was larger in the HbSS genotype (P = 0.003).  
Other than these two significant variables, there was no trend among the other 
dimensions.  One possibility is that improved medical treatment has ameliorated 
the growth-inhibiting effects of SCD, making effects of the various genotypes 
indistinct. 
 
Growth Trends Independent of Age 
Overall, independent of age, certain trends are notable among the children 
with SCD:  short posterior facial height (Se-Go), short mandibular corpus length 
(Go-Gn, Go-Pg, Go-Me), large gonial angle (Ar-Go-Me), short cranial base 
lengths (Se-Na, Se-Ba, Na-Ba), increased saddle angle (Ba-Se-Na), large Nasion-
A-Pogion angle, and increased FMA.  Also, other angles contributed to the 
hyperdivergence:  (1) Y-axis angle as measured from both Sella-Nasion and from 
Frankfort Horizontal and (2) Occlusal Plane to Frankfort Plane were increased in 
both males and females.  Of note, all other measured angles of facial divergence 
(Frankfort-Sella angle, Occlusal Plane-Sella-Nasion angle, Sella-Nasion-Palatal 
Plane angle) were larger in the subsample of females compared to controls (Table 
5). Collectively, these alterations create a hyperdivergent, retrognathic facial 
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appearance, though the small dimensions of the corpus and ramus are partially 
camouflaged by the large gonial angle.   
It is quite obvious that the craniofacial growth and development of 
children with SCD has been altered by the disease.  The changes involve smaller 
linear dimensions and increased angular dimensions, leading to a 
hyperdivergent, convex, retrognathic appearance with an open bite tendency.  It 
previously has been shown that subjects with SCD are undersized skeletally 
(Lowry et al., 1978; Phebus et al., 1984; Barden et al., 2002).  Stature (and 
component limb and trunk dimensions) are inhibited by the disease.  Diminished 
oxygen supply, reduced nutrient transport (due to rapid hemolysis), and 
recurrent painful crises (Serjeant, 2001) are thought to be the major causes of the 
diminished growth.  The present study shows that – not surprisingly – reduced 
growth potentials also measurably affect the craniofacial complexes, probably 
due to the same causes.  Of more impact clinically, this study shows that it is not 
just size that is affected, but also shape.  SCD substantially impacts the patterns 
of craniofacial growth, notably increasing vertical growth that expresses itself as 
a dolichofacial, hyperdivergent form. 
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Similarity of Subjects with SCD to Chronic Mouthbreathers 
Subjects from other studies with nasal obstruction and chronic 
mouthbreathing typically exhibit high Frankfort Plane to Mandibular Plane 
angles (FMA), short mandibular body lengths, large gonial angles, and retrusive 
chins and faces (e.g., Yang et al., 2002).  The resemblance of subjects with SCD in 
this study to the hyperdivergent mouthbreathers with long face syndrome 
described by Yang et al. (2002) is striking.  Harvold et al. (1973) showed that 
hyperdivergence of facial planes occurred in monkeys that were forced to 
become mouthbreathers because of induced nasal airway obstruction.  In our 
study, all millimetric dimensions tended to be small compared to controls, but 
the palatal plane, occlusal plane, FMA, and Y-axis all were increased.  This 
parallels the hyperdivergence seen in obligatory mouth breathers.  It does not 
seem, however, that the cause of the hyperdivergence seen in these children with 
SCD is due to chronic mouthbreathing.  Review of the literature failed to disclose 
any risk of children with SCD exhibiting chronic mouthbreathing.  While the 
sickle cell disease patients may have chronic hypoxia and even commonly have 
acute chest syndrome (Delatte et al., 1999; Lombardo et al., 2003; Liem et al., 2004), 
these conditions do not seem to cause an upper airway obstruction or 
impediment, specifically of the nasopharnyx, which has been shown to be a 
cause of mouthbreathing.  Consequently, the similarity is striking, but currently 
remains unexplained. 
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Dental Relationships 
The mandibular incisors of these children were more proclined (higher 
FMIA) than controls.   However, the other measurements of incisor angulation 
did not disclose any significant proclination, so to assert from FMIA alone that 
the mandibular incisors were proclined probably is misleading.   Shnorhokian et 
al. (1984) examined 27 subjects with sickle cell disease and found that while both 
the maxillae and mandible were protrusive, the maxillary and mandibular 
incisors were reclined.  They speculated that increased lip pressure from the 
protrusive maxillae and mandible might have caused reclination of the incisors 
relative to the maxillae and mandible.  This could occur, though we found no 
evidence during the initial clinical examinations of hypertonic lips or dimpling of 
the orbicular musculature suggestive of muscle strain.  
The interincisal angle is not deviant in these children with SCD.  Also, as 
was previously established, FMIA had a significantly negative score meaning 
FMIA was smaller than in controls and the mandibular incisors were more 
proclined.  In females, the L1-Nasion B Point angle showed significant 
mandibular incisor proclination, but this measurement relies on B-point which 
may be more posterior than in controls as shown by significantly lower z-scores 
for SNB angle in females (Table 5).  Consequently, the mandibular incisors may 
be relatively proclined with reference to a retrusive mandible and a 
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hyperidivergent face.  Any perceived incisor proclination may be the result of a 
high FMA and a retrusive B Point.   
There was a noted lack of height of the mandibular teeth as measured by 
the distance from the lower border of the mandible to the incisal tip of the 
mandibular first molar and central incisor (L1-Mandibular Plane and L6-
Mandibular Plane).  L1-MP was over 2.5 times more affected than L6-MP (Table 
5).  This is further indication of the diminutive nature of the mandibles in 
subjects with SCD.  The mandibular teeth are fully erupted, but the overall size 
of the mandible is small as has been established by measurements of the corpus 
and ramus (Table 5). 
 
Findings Compared to Beta Thalassemia 
Cephalometric analyses of children with sickle cell disease have seldom 
been undertaken, probably due to the historically high early mortality of 
individuals with SCD (and because of the specialized equipment required).  As 
such, little research is available with which to compare the present findings.  In 
fact, we are aware of just one prior study, and this was of one of the other 
hemolytic anemias, Beta thalassemia. 
Our findings concurred with those of Alhaija et al. (2002) who examined 
subjects with Beta thalassemia major.  Subjects with Beta thalassemia major had 
large ANB angles, as did the females with sickle cell disease (Table 5).  The 
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subjects with Beta thalassemia had short cranial bases as did the children in our 
study (Table 5).   Also, both the sample with Beta thalassemia major observed by 
Alhaija et al. (2002) and our sample of SCD childre from the present study had 
small mandibles that resulted in a Class II skeletal relationship (Table 5).  Finally, 
the angle from the Palatal Plane to the Mandibular Plane was increased for the 
thalassemic subjects and also for the SCD children (Table 5) (Alhaija et al., 2002).  
Of note in our findings, is the increase in hyperdivergence with age, especially in 
boys.  Such a finding relative to age was not noted by Alhaija et al. (2002) among 
the Beta thalassemia subjects. 
The apparent similarity between individuals with SCD and Beta 
thalassemia major brings about questions as to whether some of the trends 
observed with these samples may apply to growth and development of 
individuals with other similar stressed conditions and diseases.  Research on 
craniofacial growth and development of children with congenital heart defects 
resulting in chronic hypoxia might offer a helpful sample of hypoxic individuals 
for comparison in this thesis, but such research is unavailable.  On a similar note, 
research on Andean highlanders who have morphologically adapted to a low 
oxygen environment (Barcroft, 1925) may offer insightful comparisons, but their 
craniofacial growth is currently undocumented. 
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Sex Dependence 
 Figures 28 and 29 plot the average z-scores for the boys and girls in this 
study.  Figure 28 plots the 17 linear variables, and Figure 29 plots the 20 angular 
variables.  For all the variables, but particularly the angular ones, the girls 
typically exhibited the larger z-score.  That is, the girls were more affected by 
SCD in regards to their craniofacial relationships than the boys.  Counting all 37 
variables, girls had the more severe z-score in 26 instances ( = 6.1; P < 0.05).  
What is not clear is why girls should characteristically be more affected than 
boys. 
2
1X
 In studies by Phebus et al. (1984), boys with SCD were shown to have a 
greater delay in somatic growth as measured by weight, height, and rate of 
increase in stature.  As noted, our data indicate that girls are more affected, 
which is contrary to the Phebus et al. (1984) study. 
 
Age Dependence 
An intriguing question in this study was whether the debilitating 
problems affect growth in a progressive, cumulative manner.  This was tested, 
within each sex, using linear regression on age.  The raw data had been 
converted to z-scores with regard to the child’s sex and age, so a statistically 
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significant regression coefficient would disclose that the SCD child’s growth 
changed progressively with age.   
Consider, as previously discussed, the standard percentile chart for 
stature in Figure 23.  It is known that children with SCD have impaired growth 
that places them in the lower centiles.  If their pattern of growth were normal, 
just depressed by some degree, then their z-score would not change with age as 
they grew (Tanner and Whitehouse, 1976).  Alternatively, if their growth rates 
changed relative to controls, the children would cross centiles.  The health issue 
(and statistical question) is whether these children with SCD track along the 
same centiles (in which case there is no association between age and z-score) or 
systematically cross centiles (so there is a dependency between age and z-score).   
Analysis was performed within each sex because of differences in severity 
by sex.  Statistical results are listed in Table 6.  Eleven of the 37 tests disclosed 
significant regression coefficients for the sample of boys.  Those features that 
worsen disproportionately with increasing age are, (1) SNB angle, (2) Condylion-
Gnathion length, (3) Gonion-Gnathion length, (4) Condylion-Gonion length, (5) 
Gonion Pogonion length, (6) Gonion-Menton length, (7) Gonial Angle (Ar-Go-
Gn), (8) Y-axis (SeGn-SeNa), (9) Frankfort Plane to Sella-Nasion plane, (10) 
Occlusal Plane (to Se-Na) and (11) the Palatal Plane to the Mandibular Plane 
angle.  These relationships are graphed in Appendix F.  Ten of these are localized 
to the categories of “mandible” and “facial divergence” with one measurement, 
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SNB, in the category of “cranial base to face.”  The sample of females, in contrast, 
showed virtually no trend with age.  Just one of the 37 variables (Occlusal Plane 
to Sella-Nasion plane; P = 0.02) changed significantly with age in the girls.  But in 
all of these cases, the coefficient of determination (r2) is substantial, ranging from 
13 to 24%.  We interpret these as large, clinically relevant increases in severity –
though the cause remains obscure. 
Inspection of the graphs in Appendix F shows that we plotted the 
regression line for males and females separately.  Again, the purpose of plotting 
the data for the boys was to document these age-dependencies.  Conversely, the 
data for females is provided to confirm the absence of any association with age.  
Since, for all of the 37 variables (Table 7) there is a preponderance of traits where 
the girls were more severely affected than boys, the argument could be 
marshaled that boys and girls follow distinctive patterns during growth to 
achieve their observed serverities of malformation by late adolescence.  Perhaps 
girls are more severely affected than boys during childhood and that boys 
“catch-up” to the girls by undergoing the age-progressive increases in severity 
during adolescence.  The data does not, however, support this scenario (Appendix 
F).  If this were the case, then the z-scores for girls would need to be appreciably 
larger than that of boys during childhood until late adolescence.  Inspection of 
the regression lines shows that this seldom is the case.  In fact, just two of the 11 
variables in Appendix F show this pattern, namely the Gonial Angle (Ar-Go-Gn) 
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and one measure of Y-axis (Se-Gn to Se-Na).  In these instances, the mean z-
score, assessed by the regression line, is higher in girls than boys until the oldest 
ages when the boys’ and girls’ converge.  Several other patterns are at least as 
common.  At present we are unable to explain the sex differences in the patterns 
of these craniofacial variables. 
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CHAPTER VI 
 
SUMMARY AND CONCLUSIONS 
 
There are about 110,000 people in the United States with sickle cell 
disease.  Sickle cell disease results collectively from several genetic abnormalities 
that produce aberrant hemoglobin molecules.  There has been extensive research 
on the treatment and the systemic growth and development of individuals with 
sickle cell disease; however, esentially no research has evaluated the craniofacial 
growth and development of children with this growth-inhibiting genetic disease.  
The present study is cross-sectional.  It is based on analysis of the lateral 
cephalograms of 62 subjects with sickle cell disease (HbSS and HbSC) who are 
between 3 and 16 years of age at examination: 
1. Craniofacial dimensions are reduced; subjects’ faces are small at all ages, 
probably as a result of chronic hypoxia due to hemolytic anemia. Subjects 
with SCD present with small mandible, short cranial base, and 
hyperdivergent facial planes.  The cumulative effect of the altered growth 
produces hyperdivergent, dolichofacial, retrognathic facies. 
2. No statistically significant difference in craniofacial growth was found 
between genotypes (HbSS vs. HbSC), which differs from previous 
findings of body habitus that found that children with HbSS are more 
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severely affected.  Absence of a genotypic difference in severity may be 
due to the improved management of this cohort of children versus the 
older literature and samples drawn from third-world localities. 
3. Females tended to be more affected than males overall.  This was 
particularly true of the angular relationships, though we have no 
explanations as to why. 
4. Males experienced disproportionately more deviant growth with age, 
particularly in adolescence.  They became more hyperdivergent with age 
but not to the point of being more deviant than females who do not 
exhibit this age effect.  The linear and angular deviations were greater in 
the early permanent dentitions when most subjects seek orthodontic 
treatment. 
5. Subjects with SCD exhibited hyperdivergence similar to subjects with Beta 
thalassemia major, another of the hemolytic anemias, examined by Alhaija 
et al. (2002).  
6. SCD causes the face to become hyperdivergent.  We do not know the 
process, but the planes of the face—palatal plane, occlusal plane, 
mandibular plane (including Y-axis, gonial angle, and FMA)—
progressively steepen with age, especially during adolescence.  This 
combination of small linear dimensions and progressive hyperdivergence 
creates several dental compensations.  
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7. Established trends of growth of the rest of the body, males being more 
delayed and affected than females, do not directly apply to the 
craniofacial growth of subjects with SCD. 
Importantly, subjects with SCD provide special challenges for the 
orthodontist.  More of these patients will be seeking care in such areas as 
orthodontics as advances are made in treating SCD that allow them to live 
longer, with higher quality lives.  Understanding the altered craniofacial growth 
in sickle cell disease will aid health care providers in the treatment of these 
children.  The topic of craniofacial growth in subjects with SCD is largely 
unexplored beyond case reports and notes of clinical observations.  Longitudinal 
examination of craniofacial growth of subjects with SCD would be helpful to 
verify the findings from our cross-sectional study.  Alterations in craniofacial 
growth will likely lessen as advances are made in the treatment of SCD are 
made, but, until such time, our findings may elucidate some of the unique 
characteristics of craniofacial growth in individuals with sickle cell disease.
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Appendix A 
 
Prints of the cephalometric tracings of the subjects used in the present study. 
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Figure A-1.  Print of cephalometric tracing of subject 001:  7.41-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-2.  Print of cephalometric tracing of subject 002:  12.96-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-3.  Print of cephalometric tracing of subject 003:  14.09-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-4.  Print of cephalometric tracing of subject 004:  9.57-year-old SC 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-5.  Print of cephalometric tracing of subject 005:  9.38-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-6.  Print of cephalometric tracing of subject 006:  7.04-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-7.  Print of cephalometric tracing of subject 007:  14.38-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-8.  Print of cephalometric tracing of subject 008:  11.32-year-old SC 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-9.  Print of cephalometric tracing of subject 009:  13.41-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  
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Figure A-10.  Print of cephalometric tracing of subject 010:  6.26-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The maxillary 
primary incisor was traced for this subject. 
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Figure A-11.  Print of cephalometric tracing of subject 011:  7-year-old SC female 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-12.  Print of cephalometric tracing of subject 012:  11.6-year-old SC 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-13.  Print of cephalometric tracing of subject 013:  11.72-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-14.  Print of cephalometric tracing of subject 014:  10.78-year-old SC 
male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-15.  Print of cephalometric tracing of subject 015:  13.29-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-16.  Print of cephalometric tracing of subject 016:  15.55-year-old SS 
male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-17.  Print of cephalometric tracing of subject 017:  6.23-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-18.  Print of cephalometric tracing of subject 018:  11.62-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-19.  Print of cephalometric tracing of subject 019:  10.08-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-20.  Print of cephalometric tracing of subject 020:  9.52-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-21.  Print of cephalometric tracing of subject 021:  9.52-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-22.  Print of cephalometric tracing of subject 022:  8.47-year-old SC 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
 
 
 
 
 185
  
 
Figure A-23.  Print of cephalometric tracing of subject 023:  11.01-year-old SC 
male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-24.  Print of cephalometric tracing of subject 024:  14.94-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-25.  Print of cephalometric tracing of subject 025:  14.82-year-old SS 
male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-26.  Print of cephalometric tracing of subject 026:  12.11-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-27.  Print of cephalometric tracing of subject 027:  9.91-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-28.  Print of cephalometric tracing of subject 028:  12.4-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-29.  Print of cephalometric tracing of subject 101:  3.86-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The primary 
molars and incisors were traced for this subject. 
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Figure A-30.  Print of cephalometric tracing of subject 102:  11.96-year-old SS 
male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-31.  Print of cephalometric tracing of subject 103:  16.61-year-old SC 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-32.  Print of cephalometric tracing of subject 104:  5.65-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The primary 
incisors were traced for this subject. 
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Figure A-33.  Print of cephalometric tracing of subject 105:  5.91-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The 
primary incisors were traced for this subject. 
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Figure A-34.  Print of cephalometric tracing of subject 106:  6.89-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The primary 
maxillary incisor was traced for this subject. 
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Figure A-35.  Print of cephalometric tracing of subject 107:  14.97-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-36.  Print of cephalometric tracing of subject 108:  7.4-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-37.  Print of cephalometric tracing of subject 109:  17.41-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-38.  Print of cephalometric tracing of subject 110:  9.96-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-39.  Print of cephalometric tracing of subject 111:  14.41-year-old SC 
male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-40.  Print of cephalometric tracing of subject 112:  5.8-year-old SC 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The 
primary maxillary incisor was traced for this subject. 
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Figure A-41.  Print of cephalometric tracing of subject 114:  5.31-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The primary 
incisors were traced for this subject. 
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Figure A-42.  Print of cephalometric tracing of subject 116:  5.08-year-old SB+ 
Thalassemia female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 
cm)  The primary incisors were traced for this subject. 
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Figure A-43.  Print of cephalometric tracing of subject 118:  15.64-year-old SB+ 
Thalassemia male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 
cm) 
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Figure A-44.  Print of cephalometric tracing of subject 119:  7.97-year-old SB+ 
Thalassemia female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 
cm) 
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Figure A-45.  Print of cephalometric tracing of subject 120:  8.97-year-old SC 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-46.  Print of cephalometric tracing of subject 123:  16.02-year-old SS 
male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-47.  Print of cephalometric tracing of subject 124:  6.25-year-old SC 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The 
primary incisors were traced for this subject. 
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Figure A-48.  Print of cephalometric tracing of subject 126:  15.38-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-49.  Print of cephalometric tracing of subject 128:  7.98-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-50.  Print of cephalometric tracing of subject 130:  8.51-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
 
 
 
 
 213
  
 
Figure A-51.  Print of cephalometric tracing of subject 132:  13.46-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-52.  Print of cephalometric tracing of subject 133:  5.39-year-old SB 
Thalassemia male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 
cm)  The primary incisors were traced for this subject. 
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Figure A-53.  Print of cephalometric tracing of subject 134:  16.76-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-54.  Print of cephalometric tracing of subject 135:  3.98-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The primary 
incisors were traced for this subject. 
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Figure A-55  Print of cephalometric tracing of subject 136:  17.86-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-56.  Print of cephalometric tracing of subject 138:  13.16-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-57.  Print of cephalometric tracing of subject 139:  7.02-year-old SS 
female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-58.  Print of cephalometric tracing of subject 140:  9.13-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-59.  Print of cephalometric tracing of subject 141:  6.09-year-old SS male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The primary 
incisors were traced for this subject. 
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Figure A-60.  Print of cephalometric tracing of subject 142:  3.26-year-old Beta 
Thalassemia female (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 
cm)  The primary molars and incisors were traced for this subject. 
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Figure A-61.  Print of cephalometric tracing of subject 144:  15.75-year-old SS 
male (tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm) 
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Figure A-62.  Print of cephalometric tracing of subject 145:  6.68-year-old SC male 
(tracing is 1:1 with original radiograph, border is 15.3 x 18.0 cm)  The primary 
incisors were traced for this subject. 
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Appendix B 
 
Cephalometric measurements for each subject in the sample.†
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
___________ 
†Not all measurements could be taken on all cephalograms because of patient 
orientation or film quality.  The marker “---“ denotes missing values. 
226
Table B-1.  Cephalometric measurement values for subject 
001:  7.41-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 67.5 
 Sella-Basion Length (mm) 46.5 
 Nasion-Basion Length (mm) 106.2 
 Basion-Sella-Nasion (º) 136.7 
 
Cranial Base to Face 
 Y-Axis Length (mm) 120.8 
 Sella-Gonion Length (mm) 71.2 
 Sella-Nasion-A Point (º) 80.6 
 Sella-Nasion-B Point (º) 75.0 
 A Pont-Nasion-B Point (º) 5.7 
 Nasion-A Point-Pogonion (º) 16.2 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) --- 
 Gonion-Nasion Distance (mm) 67.4 
 Condylion-Gonion Distance (mm) --- 
 Gonion-Pogonion Length (mm) 64.5 
 Gonion-Menton Length (mm) 60.2 
 Articulare-Gonion-Nasion (º) 134.8 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 75.9 
 Y-Axis (Se-Gn to FH) (º) 68.9 
 FH to Sella-Nasion (º) 11.4 
 Sella-Nasion to Palatal Plane (º) 11.4 
 Occlusal Plane to Sella-Nasion (º) 27.3 
 Occlusal Plane to FH (º) 15.9 
 Mand Plane to Occlusal Plane (º) 18.3 
 Palatal Plane to Mand Plane (º) 34.2 
Continued 
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Table B-1. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 120.0 
 ANS-Menton Height (mm) 69.7 
 Nasion-ANS Height (mm) 52.8 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.3 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 34.3 
 FMIA (L1 to FH) (º) 45.7 
 IMPA (L1-Mand Plane) (º) 100.0 
 
Dental Relationships 
 L1 to Mand Plane (mm) 32.1 
 L6 to Mand Plane Distance (mm) 32.5 
 Interincisal Angle (º) 112.0 
 L1 to Nasion-B Point (º) 40.6 
 U1 to Nasion-A Point (º) 21.8 
 U1 to Sella-Nasion (º) 102.4 
 U1 to Occlusal Plane (º) 129.7 
 Overbite (mm) -3.4 
 Overjet (mm) 1.6 
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Table B-2.  Cephalometric measurement values for subject 
002: 12.96-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 73.0 
 Sella-Basion Length (mm) 49.4 
 Nasion-Basion Length (mm) 108.0 
 Basion-Sella-Nasion (º) 122.6 
 
Cranial Base to Face 
 Y-Axis Length (mm) --- 
 Sella-Gonion Length (mm) 86.5 
 Sella-Nasion-A Point (º) 87.1 
 Sella-Nasion-B Point (º) 84.4 
 A Pont-Nasion-B Point (º) 2.7 
 Nasion-A Point-Pogonion (º) --- 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) --- 
 Gonion-Nasion Distance (mm) --- 
 Condylion-Gonion Distance (mm) --- 
 Gonion-Pogonion Length (mm) --- 
 Gonion-Menton Length (mm) --- 
 Articulare-Gonion-Nasion (º) --- 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) --- 
 Y-Axis (Se-Gn to FH) (º) --- 
 FH to Sella-Nasion (º) -0.4 
 Sella-Nasion to Palatal Plane (º) -1.2 
 Occlusal Plane to Sella-Nasion (º) 13.3 
 Occlusal Plane to FH (º) 13.7 
 Mand Plane to Occlusal Plane (º) --- 
 Palatal Plane to Mand Plane (º) --- 
Continued 
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Table B-2. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) --- 
 ANS-Menton Height (mm) --- 
 Nasion-ANS Height (mm) 47.3 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) --- 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) --- 
 FMIA (L1 to FH) (º) 40.5 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm) --- 
 L6 to Mand Plane Distance (mm) --- 
 Interincisal Angle (º) 110.3 
 L1 to Nasion-B Point (º) 43.5 
 U1 to Nasion-A Point (º) 23.5 
 U1 to Sella-Nasion (º) 110.6 
 U1 to Occlusal Plane (º) 123.9 
 Overbite (mm) -1.3 
 Overjet (mm) 1.4 
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Table B-3.  Cephalometric measurement values for subject 
003: 14.09-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 69.1 
 Sella-Basion Length (mm) 50.3 
 Nasion-Basion Length (mm) 112.3 
 Basion-Sella-Nasion (º) 139.9 
 
Cranial Base to Face 
 Y-Axis Length (mm) 127.7 
 Sella-Gonion Length (mm) 69.5 
 Sella-Nasion-A Point (º) 72.4 
 Sella-Nasion-B Point (º) 74.0 
 A Pont-Nasion-B Point (º) -1.6 
 Nasion-A Point-Pogonion (º) -1.4 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 120.3 
 Gonion-Nasion Distance (mm) 82.1 
 Condylion-Gonion Distance (mm) 51.2 
 Gonion-Pogonion Length (mm) 78.8 
 Gonion-Menton Length (mm) 74.9 
 Articulare-Gonion-Nasion (º) 129.2 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 75.7 
 Y-Axis (Se-Gn to FH) (º) 68.7 
 FH to Sella-Nasion (º) 11.8 
 Sella-Nasion to Palatal Plane (º) 8.8 
 Occlusal Plane to Sella-Nasion (º) 18.3 
 Occlusal Plane to FH (º) 6.5 
 Mand Plane to Occlusal Plane (º) 27.8 
 Palatal Plane to Mand Plane (º) 37.3 
Continued 
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Table B-3. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 126.0 
 ANS-Menton Height (mm) 74.1 
 Nasion-ANS Height (mm) 52.8 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.7 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 34.3 
 FMIA (L1 to FH) (º) 60.0 
 IMPA (L1-Mand Plane) (º) 85.8 
 
Dental Relationships 
 L1 to Mand Plane (mm) 37.0 
 L6 to Mand Plane Distance (mm) 27.0 
 Interincisal Angle (º) 125.5 
 L1 to Nasion-B Point (º) 25.8 
 U1 to Nasion-A Point (º) 30.3 
 U1 to Sella-Nasion (º) 102.7 
 U1 to Occlusal Plane (º) 121.0 
 Overbite (mm) -0.7 
 Overjet (mm) -0.5 
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Table B-4.  Cephalometric measurement values for subject 
004: 9.57-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 68.1 
 Sella-Basion Length (mm) 44.0 
 Nasion-Basion Length (mm) 106.4 
 Basion-Sella-Nasion (º) 142.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 125.6 
 Sella-Gonion Length (mm) 70.1 
 Sella-Nasion-A Point (º) 82.5 
 Sella-Nasion-B Point (º) 77.9 
 A Pont-Nasion-B Point (º) 4.7 
 Nasion-A Point-Pogonion (º) 14.2 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 118.1 
 Gonion-Nasion Distance (mm) 76.9 
 Condylion-Gonion Distance (mm) 53.6 
 Gonion-Pogonion Length (mm) 73.3 
 Gonion-Menton Length (mm) 64.7 
 Articulare-Gonion-Nasion (º) 130.8 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 72.7 
 Y-Axis (Se-Gn to FH) (º) 65.7 
 FH to Sella-Nasion (º) 14.5 
 Sella-Nasion to Palatal Plane (º) 10.1 
 Occlusal Plane to Sella-Nasion (º) 23.0 
 Occlusal Plane to FH (º) 8.6 
 Mand Plane to Occlusal Plane (º) 20.0 
 Palatal Plane to Mand Plane (º) 32.9 
Continued 
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Table B-4. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 118.5 
 ANS-Menton Height (mm) 69.7 
 Nasion-ANS Height (mm) 53.2 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.2 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 28.5 
 FMIA (L1 to FH) (º) 57.5 
 IMPA (L1-Mand Plane) (º) 94.0 
 
Dental Relationships 
 L1 to Mand Plane (mm) 31.8 
 L6 to Mand Plane Distance (mm) 30.7 
 Interincisal Angle (º) 124.6 
 L1 to Nasion-B Point (º) 34.8 
 U1 to Nasion-A Point (º) 15.9 
 U1 to Sella-Nasion (º) 98.5 
 U1 to Occlusal Plane (º) 121.5 
 Overbite (mm) -1.7 
 Overjet (mm) -0.9 
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Table B-5.  Cephalometric measurement values for subject 
005: 9.38-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.6 
 Sella-Basion Length (mm) 45.7 
 Nasion-Basion Length (mm) 108.4 
 Basion-Sella-Nasion (º) 136.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 131.0 
 Sella-Gonion Length (mm) 73.8 
 Sella-Nasion-A Point (º) 86.0 
 Sella-Nasion-B Point (º) 81.3 
 A Pont-Nasion-B Point (º) 4.7 
 Nasion-A Point-Pogonion (º) 11.5 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 121.7 
 Gonion-Nasion Distance (mm) 79.2 
 Condylion-Gonion Distance (mm) 54.9 
 Gonion-Pogonion Length (mm) 75.0 
 Gonion-Menton Length (mm) 66.9 
 Articulare-Gonion-Nasion (º) 130.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 67.7 
 Y-Axis (Se-Gn to FH) (º) 60.7 
 FH to Sella-Nasion (º) 5.9 
 Sella-Nasion to Palatal Plane (º) 4.2 
 Occlusal Plane to Sella-Nasion (º) 18.5 
 Occlusal Plane to FH (º) 12.6 
 Mand Plane to Occlusal Plane (º) 19.3 
 Palatal Plane to Mand Plane (º) 33.6 
Continued 
 235
Table B-5. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 117.7 
 ANS-Menton Height (mm) 69.5 
 Nasion-ANS Height (mm) 51.5 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 41.4 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 31.9 
 FMIA (L1 to FH) (º) 48.1 
 IMPA (L1-Mand Plane) (º) 100.0 
 
Dental Relationships 
 L1 to Mand Plane (mm) 36.3 
 L6 to Mand Plane Distance (mm) 31.6 
 Interincisal Angle (º) 113.8 
 L1 to Nasion-B Point (º) 39.1 
 U1 to Nasion-A Point (º) 22.4 
 U1 to Sella-Nasion (º) 108.4 
 U1 to Occlusal Plane (º) 126.9 
 Overbite (mm) 1.5 
 Overjet (mm) 3.0 
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Table B-6.  Cephalometric measurement values for subject 
006: 7.04-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 62.5 
 Sella-Basion Length (mm) 42.1 
 Nasion-Basion Length (mm) 94.6 
 Basion-Sella-Nasion (º) 128.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 118.1 
 Sella-Gonion Length (mm) 69.8 
 Sella-Nasion-A Point (º) 85.5 
 Sella-Nasion-B Point (º) 81.1 
 A Pont-Nasion-B Point (º) 4.3 
 Nasion-A Point-Pogonion (º) 11.3 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 103.9 
 Gonion-Nasion Distance (mm) 68.1 
 Condylion-Gonion Distance (mm) 47.4 
 Gonion-Pogonion Length (mm) 65.5 
 Gonion-Menton Length (mm) 61.2 
 Articulare-Gonion-Nasion (º) 127.1 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 69.0 
 Y-Axis (Se-Gn to FH) (º) 62.0 
 FH to Sella-Nasion (º) 4.8 
 Sella-Nasion to Palatal Plane (º) 2.1 
 Occlusal Plane to Sella-Nasion (º) 21.3 
 Occlusal Plane to FH (º) 16.5 
 Mand Plane to Occlusal Plane (º) 16.2 
 Palatal Plane to Mand Plane (º) 35.4 
Continued 
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Table B-6. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 109.1 
 ANS-Menton Height (mm) 65.0 
 Nasion-ANS Height (mm) 45.7 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.5 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 32.7 
 FMIA (L1 to FH) (º) 46.6 
 IMPA (L1-Mand Plane) (º) 100.7 
 
Dental Relationships 
 L1 to Mand Plane (mm) 30.9 
 L6 to Mand Plane Distance (mm) 30.2 
 Interincisal Angle (º) 116.6 
 L1 to Nasion-B Point (º) 39.3 
 U1 to Nasion-A Point (º) 19.7 
 U1 to Sella-Nasion (º) 105.2 
 U1 to Occlusal Plane (º) 126.5 
 Overbite (mm) -6.7 
 Overjet (mm) -1.9 
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Table B-7.  Cephalometric measurement values for subject 
007: 14.38-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 73.5 
 Sella-Basion Length (mm) 46.6 
 Nasion-Basion Length (mm) 110.0 
 Basion-Sella-Nasion (º) 131.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 134.6 
 Sella-Gonion Length (mm) 75.8 
 Sella-Nasion-A Point (º) 83.9 
 Sella-Nasion-B Point (º) 78.4 
 A Pont-Nasion-B Point (º) 5.5 
 Nasion-A Point-Pogonion (º) 14.1 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 125.2 
 Gonion-Nasion Distance (mm) 83.5 
 Condylion-Gonion Distance (mm) 54.4 
 Gonion-Pogonion Length (mm) 78.4 
 Gonion-Menton Length (mm) 71.5 
 Articulare-Gonion-Nasion (º) 128.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 70.8 
 Y-Axis (Se-Gn to FH) (º) 63.8 
 FH to Sella-Nasion (º) 6.0 
 Sella-Nasion to Palatal Plane (º) 4.0 
 Occlusal Plane to Sella-Nasion (º) 15.7 
 Occlusal Plane to FH (º) 9.6 
 Mand Plane to Occlusal Plane (º) 24.5 
 Palatal Plane to Mand Plane (º) 36.1 
Continued 
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Table B-7. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 125.4 
 ANS-Menton Height (mm) 77.0 
 Nasion-ANS Height (mm) 52.5 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.6 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 34.1 
 FMIA (L1 to FH) (º) 43.3 
 IMPA (L1-Mand Plane) (º) 102.6 
 
Dental Relationships 
 L1 to Mand Plane (mm) 38.5 
 L6 to Mand Plane Distance (mm) 36.6 
 Interincisal Angle (º) 103.9 
 L1 to Nasion-B Point (º) 41.1 
 U1 to Nasion-A Point (º) 29.5 
 U1 to Sella-Nasion (º) 113.4 
 U1 to Occlusal Plane (º) 129.0 
 Overbite (mm) -1.8 
 Overjet (mm) 3.4 
 240
Table B-8.  Cephalometric measurement values for subject 
008: 11.32-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 64.8 
 Sella-Basion Length (mm) 44.0 
 Nasion-Basion Length (mm) 102.1 
 Basion-Sella-Nasion (º) 138.8 
 
Cranial Base to Face 
 Y-Axis Length (mm) 129.0 
 Sella-Gonion Length (mm) 73.3 
 Sella-Nasion-A Point (º) 84.6 
 Sella-Nasion-B Point (º) 79.7 
 A Pont-Nasion-B Point (º) 4.9 
 Nasion-A Point-Pogonion (º) 10.7 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 119.3 
 Gonion-Nasion Distance (mm) 76.7 
 Condylion-Gonion Distance (mm) 52.0 
 Gonion-Pogonion Length (mm) 72.1 
 Gonion-Menton Length (mm) 65.8 
 Articulare-Gonion-Nasion (º) 135.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 70.9 
 Y-Axis (Se-Gn to FH) (º) 63.9 
 FH to Sella-Nasion (º) 14.4 
 Sella-Nasion to Palatal Plane (º) 12.2 
 Occlusal Plane to Sella-Nasion (º) 21.6 
 Occlusal Plane to FH (º) 7.2 
 Mand Plane to Occlusal Plane (º) 19.4 
 Palatal Plane to Mand Plane (º) 28.9 
Continued 
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Table B-8. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 118.8 
 ANS-Menton Height (mm) 68.0 
 Nasion-ANS Height (mm) 54.1 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 43.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 26.6 
 FMIA (L1 to FH) (º) 56.6 
 IMPA (L1-Mand Plane) (º) 96.8 
 
Dental Relationships 
 L1 to Mand Plane (mm) 36.6 
 L6 to Mand Plane Distance (mm) 31.8 
 Interincisal Angle (º) 108.6 
 L1 to Nasion-B Point (º) 37.6 
 U1 to Nasion-A Point (º) 28.9 
 U1 to Sella-Nasion (º) 113.5 
 U1 to Occlusal Plane (º) 135.1 
 Overbite (mm) 0.3 
 Overjet (mm) 3.3 
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Table B-9.  Cephalometric measurement values for subject 
009: 13.41-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 73.2 
 Sella-Basion Length (mm) 45.6 
 Nasion-Basion Length (mm) 109.0 
 Basion-Sella-Nasion (º) 131.8 
 
Cranial Base to Face 
 Y-Axis Length (mm) 137.3 
 Sella-Gonion Length (mm) 78.3 
 Sella-Nasion-A Point (º) 83.0 
 Sella-Nasion-B Point (º) 79.9 
 A Pont-Nasion-B Point (º) 3.1 
 Nasion-A Point-Pogonion (º) 8.6 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 121.1 
 Gonion-Nasion Distance (mm) 80.0 
 Condylion-Gonion Distance (mm) 53.5 
 Gonion-Pogonion Length (mm) 76.6 
 Gonion-Menton Length (mm) 72.1 
 Articulare-Gonion-Nasion (º) 128.8 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 69.8 
 Y-Axis (Se-Gn to FH) (º) 62.8 
 FH to Sella-Nasion (º) 8.0 
 Sella-Nasion to Palatal Plane (º) 7.5 
 Occlusal Plane to Sella-Nasion (º) 21.6 
 Occlusal Plane to FH (º) 13.6 
 Mand Plane to Occlusal Plane (º) 18.7 
 Palatal Plane to Mand Plane (º) 32.8 
Continued 
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Table B-9. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 127.7 
 ANS-Menton Height (mm) 74.4 
 Nasion-ANS Height (mm) 55.8 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 32.3 
 FMIA (L1 to FH) (º) 58.1 
 IMPA (L1-Mand Plane) (º) 89.6 
 
Dental Relationships 
 L1 to Mand Plane (mm) 39.2 
 L6 to Mand Plane Distance (mm) 33.6 
 Interincisal Angle (º) 122.2 
 L1 to Nasion-B Point (º) 29.8 
 U1 to Nasion-A Point (º) 25.0 
 U1 to Sella-Nasion (º) 108.0 
 U1 to Occlusal Plane (º) 129.6 
 Overbite (mm) -0.2 
 Overjet (mm) 2.5 
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Table B-10.  Cephalometric measurement values for subject 
010: 6.26-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.4 
 Sella-Basion Length (mm) 45.0 
 Nasion-Basion Length (mm) 105.6 
 Basion-Sella-Nasion (º) 131.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 128.9 
 Sella-Gonion Length (mm) 73.0 
 Sella-Nasion-A Point (º) 85.4 
 Sella-Nasion-B Point (º) 78.8 
 A Pont-Nasion-B Point (º) 6.5 
 Nasion-A Point-Pogonion (º) 13.8 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 117.1 
 Gonion-Nasion Distance (mm) 79.0 
 Condylion-Gonion Distance (mm) 51.5 
 Gonion-Pogonion Length (mm) 74.9 
 Gonion-Menton Length (mm) 68.2 
 Articulare-Gonion-Nasion (º) 126.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 69.3 
 Y-Axis (Se-Gn to FH) (º) 62.3 
 FH to Sella-Nasion (º) 7.2 
 Sella-Nasion to Palatal Plane (º) 5.6 
 Occlusal Plane to Sella-Nasion (º) 20.1 
 Occlusal Plane to FH (º) 13.0 
 Mand Plane to Occlusal Plane (º) 18.5 
 Palatal Plane to Mand Plane (º) 33.1 
Continued 
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Table B-10. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 118.6 
 ANS-Menton Height (mm) 72.4 
 Nasion-ANS Height (mm) 50.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 31.5 
 FMIA (L1 to FH) (º) 58.2 
 IMPA (L1-Mand Plane) (º) 90.2 
 
Dental Relationships 
 L1 to Mand Plane (mm) 37.5 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) 27.7 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -0.0 
 Overjet (mm) 2.2 
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Table B-11.  Cephalometric measurement values for subject 
011: 7-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 68.0 
 Sella-Basion Length (mm) 41.3 
 Nasion-Basion Length (mm) 99.3 
 Basion-Sella-Nasion (º) 128.8 
 
Cranial Base to Face 
 Y-Axis Length (mm) 116.7 
 Sella-Gonion Length (mm) 66.0 
 Sella-Nasion-A Point (º) 79.5 
 Sella-Nasion-B Point (º) 74.3 
 A Pont-Nasion-B Point (º) 5.2 
 Nasion-A Point-Pogonion (º) 11.3 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 105.7 
 Gonion-Nasion Distance (mm) 70.0 
 Condylion-Gonion Distance (mm) 45.6 
 Gonion-Pogonion Length (mm) 66.8 
 Gonion-Menton Length (mm) 60.2 
 Articulare-Gonion-Nasion (º) 130.9 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 71.9 
 Y-Axis (Se-Gn to FH) (º) 64.9 
 FH to Sella-Nasion (º) 7.4 
 Sella-Nasion to Palatal Plane (º) 9.2 
 Occlusal Plane to Sella-Nasion (º) 18.7 
 Occlusal Plane to FH (º) 11.3 
 Mand Plane to Occlusal Plane (º) 23.3 
 Palatal Plane to Mand Plane (º) 32.8 
Continued 
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Table B-11. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 111.5 
 ANS-Menton Height (mm) 64.8 
 Nasion-ANS Height (mm) 48.8 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 34.6 
 FMIA (L1 to FH) (º) 49.8 
 IMPA (L1-Mand Plane) (º) 95.6 
 
Dental Relationships 
 L1 to Mand Plane (mm) 33.0 
 L6 to Mand Plane Distance (mm) 29.2 
 Interincisal Angle (º) 119.7 
 L1 to Nasion-B Point (º) 32.0 
 U1 to Nasion-A Point (º) 23.1 
 U1 to Sella-Nasion (º) 102.6 
 U1 to Occlusal Plane (º) 121.4 
 Overbite (mm) -0.5 
 Overjet (mm) 1.3 
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Table B-12.  Cephalometric measurement values for subject 
012: 11.6-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 72.2 
 Sella-Basion Length (mm) 42.1 
 Nasion-Basion Length (mm) 106.6 
 Basion-Sella-Nasion (º) 136.3 
 
Cranial Base to Face 
 Y-Axis Length (mm) 123.3 
 Sella-Gonion Length (mm) 63.9 
 Sella-Nasion-A Point (º) 77.1 
 Sella-Nasion-B Point (º) 69.3 
 A Pont-Nasion-B Point (º) 7.8 
 Nasion-A Point-Pogonion (º) 17.1 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 115.9 
 Gonion-Nasion Distance (mm) 75.3 
 Condylion-Gonion Distance (mm) 47.3 
 Gonion-Pogonion Length (mm) 70.3 
 Gonion-Menton Length (mm) 63.7 
 Articulare-Gonion-Nasion (º) 141.0 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 79.5 
 Y-Axis (Se-Gn to FH) (º) 72.5 
 FH to Sella-Nasion (º) 12.5 
 Sella-Nasion to Palatal Plane (º) 5.5 
 Occlusal Plane to Sella-Nasion (º) 28.5 
 Occlusal Plane to FH (º) 16.1 
 Mand Plane to Occlusal Plane (º) 25.7 
 Palatal Plane to Mand Plane (º) 48.7 
Continued 
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Table B-12. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 125.3 
 ANS-Menton Height (mm) 81.6 
 Nasion-ANS Height (mm) 48.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 35.9 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 41.8 
 FMIA (L1 to FH) (º) 50.4 
 IMPA (L1-Mand Plane) (º) 87.8 
 
Dental Relationships 
 L1 to Mand Plane (mm) 35.7 
 L6 to Mand Plane Distance (mm) 36.6 
 Interincisal Angle (º) 125.5 
 L1 to Nasion-B Point (º) 31.3 
 U1 to Nasion-A Point (º) 15.4 
 U1 to Sella-Nasion (º) 92.5 
 U1 to Occlusal Plane (º) 121.0 
 Overbite (mm) 0.0 
 Overjet (mm) 4.2 
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Table B-13.  Cephalometric measurement values for subject 
013: 11.72-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.0 
 Sella-Basion Length (mm) 48.1 
 Nasion-Basion Length (mm) 108.7 
 Basion-Sella-Nasion (º) 133.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 124.6 
 Sella-Gonion Length (mm) 74.6 
 Sella-Nasion-A Point (º) 81.0 
 Sella-Nasion-B Point (º) 75.3 
 A Pont-Nasion-B Point (º) 5.7 
 Nasion-A Point-Pogonion (º) 12.4 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 113.4 
 Gonion-Nasion Distance (mm) 72.7 
 Condylion-Gonion Distance (mm) 50.4 
 Gonion-Pogonion Length (mm) 70.4 
 Gonion-Menton Length (mm) 64.2 
 Articulare-Gonion-Nasion (º) 135.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 72.4 
 Y-Axis (Se-Gn to FH) (º) 65.4 
 FH to Sella-Nasion (º) 8.5 
 Sella-Nasion to Palatal Plane (º) 5.7 
 Occlusal Plane to Sella-Nasion (º) 17.2 
 Occlusal Plane to FH (º) 8.7 
 Mand Plane to Occlusal Plane (º) 22.6 
 Palatal Plane to Mand Plane (º) 34.1 
Continued 
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Table B-13. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 119.9 
 ANS-Menton Height (mm) 70.1 
 Nasion-ANS Height (mm) 51.9 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 41.8 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 31.3 
 FMIA (L1 to FH) (º) 46.9 
 IMPA (L1-Mand Plane) (º) 101.8 
 
Dental Relationships 
 L1 to Mand Plane (mm) 35.6 
 L6 to Mand Plane Distance (mm) 31.7 
 Interincisal Angle (º) 111.3 
 L1 to Nasion-B Point (º) 36.9 
 U1 to Nasion-A Point (º) 26.1 
 U1 to Sella-Nasion (º) 107.1 
 U1 to Occlusal Plane (º) 124.3 
 Overbite (mm) -1.0 
 Overjet (mm) 6.4 
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Table B-14.  Cephalometric measurement values for subject 
014: 10.78-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 69.4 
 Sella-Basion Length (mm) 49.8 
 Nasion-Basion Length (mm) 106.7 
 Basion-Sella-Nasion (º) 126.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 137.0 
 Sella-Gonion Length (mm) 75.8 
 Sella-Nasion-A Point (º) 84.5 
 Sella-Nasion-B Point (º) 80.5 
 A Pont-Nasion-B Point (º) 4.0 
 Nasion-A Point-Pogonion (º) 7.0 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 123.0 
 Gonion-Nasion Distance (mm) 84.3 
 Condylion-Gonion Distance (mm) 51.4 
 Gonion-Pogonion Length (mm) 80.5 
 Gonion-Menton Length (mm) 76.2 
 Articulare-Gonion-Nasion (º) 129.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 69.2 
 Y-Axis (Se-Gn to FH) (º) 62.2 
 FH to Sella-Nasion (º) 7.3 
 Sella-Nasion to Palatal Plane (º) 4.7 
 Occlusal Plane to Sella-Nasion (º) 18.4 
 Occlusal Plane to FH (º) 11.1 
 Mand Plane to Occlusal Plane (º) 21.4 
 Palatal Plane to Mand Plane (º) 35.1 
Continued 
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Table B-14. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 125.8 
 ANS-Menton Height (mm) 74.8 
 Nasion-ANS Height (mm) 52.9 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.5 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 32.6 
 FMIA (L1 to FH) (º) 59.8 
 IMPA (L1-Mand Plane) (º) 87.7 
 
Dental Relationships 
 L1 to Mand Plane (mm) 40.5 
 L6 to Mand Plane Distance (mm) 30.3 
 Interincisal Angle (º) 130.5 
 L1 to Nasion-B Point (º) 28.0 
 U1 to Nasion-A Point (º) 17.5 
 U1 to Sella-Nasion (º) 102.0 
 U1 to Occlusal Plane (º) 120.3 
 Overbite (mm) -0.6 
 Overjet (mm) 0.3 
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Table B-15.  Cephalometric measurement values for subject 
015: 13.29-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 74.6 
 Sella-Basion Length (mm) 44.5 
 Nasion-Basion Length (mm) 112.0 
 Basion-Sella-Nasion (º) 139.0 
 
Cranial Base to Face 
 Y-Axis Length (mm) 119.5 
 Sella-Gonion Length (mm) 65.5 
 Sella-Nasion-A Point (º) 84.0 
 Sella-Nasion-B Point (º) 78.9 
 A Pont-Nasion-B Point (º) 5.1 
 Nasion-A Point-Pogonion (º) 16.8 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 115.2 
 Gonion-Nasion Distance (mm) 82.0 
 Condylion-Gonion Distance (mm) 48.0 
 Gonion-Pogonion Length (mm) 78.9 
 Gonion-Menton Length (mm) 70.7 
 Articulare-Gonion-Nasion (º) 122.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 66.0 
 Y-Axis (Se-Gn to FH) (º) 59.0 
 FH to Sella-Nasion (º) 8.0 
 Sella-Nasion to Palatal Plane (º) 5.9 
 Occlusal Plane to Sella-Nasion (º) 20.2 
 Occlusal Plane to FH (º) 12.1 
 Mand Plane to Occlusal Plane (º) 14.4 
 Palatal Plane to Mand Plane (º) 28.6 
Continued 
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Table B-15. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 108.7 
 ANS-Menton Height (mm) 62.0 
 Nasion-ANS Height (mm) 50.7 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 44.5 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 26.5 
 FMIA (L1 to FH) (º) 34.7 
 IMPA (L1-Mand Plane) (º) 118.8 
 
Dental Relationships 
 L1 to Mand Plane (mm) 28.9 
 L6 to Mand Plane Distance (mm) 29.3 
 Interincisal Angle (º) 94.7 
 L1 to Nasion-B Point (º) 52.2 
 U1 to Nasion-A Point (º) 28.0 
 U1 to Sella-Nasion (º) 112.0 
 U1 to Occlusal Plane (º) 132.2 
 Overbite (mm) 0.3 
 Overjet (mm) 2.5 
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Table B-16.  Cephalometric measurement values for subject 
016: 15.55-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 74.2 
 Sella-Basion Length (mm) 46.0 
 Nasion-Basion Length (mm) 103.2 
 Basion-Sella-Nasion (º) 116.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 148.1 
 Sella-Gonion Length (mm) 82.7 
 Sella-Nasion-A Point (º) 89.7 
 Sella-Nasion-B Point (º) 85.6 
 A Pont-Nasion-B Point (º) 4.1 
 Nasion-A Point-Pogonion (º) 7.5 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 129.9 
 Gonion-Nasion Distance (mm) 85.4 
 Condylion-Gonion Distance (mm) 53.8 
 Gonion-Pogonion Length (mm) 79.2 
 Gonion-Menton Length (mm) 73.6 
 Articulare-Gonion-Nasion (º) 136.5 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 63.8 
 Y-Axis (Se-Gn to FH) (º) 56.8 
 FH to Sella-Nasion (º) 3.3 
 Sella-Nasion to Palatal Plane (º) 5.8 
 Occlusal Plane to Sella-Nasion (º) 19.1 
 Occlusal Plane to FH (º) 15.8 
 Mand Plane to Occlusal Plane (º) 17.0 
 Palatal Plane to Mand Plane (º) 30.2 
Continued 
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Table B-16. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 127.3 
 ANS-Menton Height (mm) 74.1 
 Nasion-ANS Height (mm) 55.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 41.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 32.8 
 FMIA (L1 to FH) (º) 63.1 
 IMPA (L1-Mand Plane) (º) 84.2 
 
Dental Relationships 
 L1 to Mand Plane (mm) 43.8 
 L6 to Mand Plane Distance (mm) 35.5 
 Interincisal Angle (º) 125.3 
 L1 to Nasion-B Point (º) 25.8 
 U1 to Nasion-A Point (º) 24.9 
 U1 to Sella-Nasion (º) 114.6 
 U1 to Occlusal Plane (º) 133.6 
 Overbite (mm) 2.6 
 Overjet (mm) 5.0 
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Table B-17.  Cephalometric measurement values for subject 
017: 6.23-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 68.7 
 Sella-Basion Length (mm) 42.3 
 Nasion-Basion Length (mm) 106.8 
 Basion-Sella-Nasion (º) 147.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 119.6 
 Sella-Gonion Length (mm) 58.8 
 Sella-Nasion-A Point (º) 71.4 
 Sella-Nasion-B Point (º) 68.5 
 A Pont-Nasion-B Point (º) 3.0 
 Nasion-A Point-Pogonion (º) 7.7 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 117.9 
 Gonion-Nasion Distance (mm) 80.0 
 Condylion-Gonion Distance (mm) 45.6 
 Gonion-Pogonion Length (mm) 75.8 
 Gonion-Menton Length (mm) 71.1 
 Articulare-Gonion-Nasion (º) 138.2 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 80.6 
 Y-Axis (Se-Gn to FH) (º) 73.6 
 FH to Sella-Nasion (º) 17.3 
 Sella-Nasion to Palatal Plane (º) 7.2 
 Occlusal Plane to Sella-Nasion (º) 27.9 
 Occlusal Plane to FH (º) 10.5 
 Mand Plane to Occlusal Plane (º) 27.1 
 Palatal Plane to Mand Plane (º) 47.8 
Continued 
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Table B-17. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 123.4 
 ANS-Menton Height (mm) 75.8 
 Nasion-ANS Height (mm) 48.8 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 38.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 37.7 
 FMIA (L1 to FH) (º) 51.3 
 IMPA (L1-Mand Plane) (º) 91.0 
 
Dental Relationships 
 L1 to Mand Plane (mm) 34.7 
 L6 to Mand Plane Distance (mm) 31.0 
 Interincisal Angle (º) 117.1 
 L1 to Nasion-B Point (º) 34.5 
 U1 to Nasion-A Point (º) 25.4 
 U1 to Sella-Nasion (º) 96.9 
 U1 to Occlusal Plane (º) 124.7 
 Overbite (mm) 0.9 
 Overjet (mm) 2.8 
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Table B-18.  Cephalometric measurement values for subject 
018: 11.62-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 69.1 
 Sella-Basion Length (mm) 42.0 
 Nasion-Basion Length (mm) 106.8 
 Basion-Sella-Nasion (º) 147.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 120.0 
 Sella-Gonion Length (mm) 59.0 
 Sella-Nasion-A Point (º) 71.2 
 Sella-Nasion-B Point (º) 68.1 
 A Pont-Nasion-B Point (º) 3.1 
 Nasion-A Point-Pogonion (º) 7.1 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 118.2 
 Gonion-Nasion Distance (mm) 80.1 
 Condylion-Gonion Distance (mm) 45.8 
 Gonion-Pogonion Length (mm) 76.1 
 Gonion-Menton Length (mm) 71.0 
 Articulare-Gonion-Nasion (º) 138.0 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 80.6 
 Y-Axis (Se-Gn to FH) (º) 73.6 
 FH to Sella-Nasion (º) 17.4 
 Sella-Nasion to Palatal Plane (º) 7.5 
 Occlusal Plane to Sella-Nasion (º) 27.4 
 Occlusal Plane to FH (º) 10.0 
 Mand Plane to Occlusal Plane (º) 27.5 
 Palatal Plane to Mand Plane (º) 47.4 
Continued 
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Table B-18. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 123.6 
 ANS-Menton Height (mm) 75.9 
 Nasion-ANS Height (mm) 48.9 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 38.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 37.5 
 FMIA (L1 to FH) (º) 51.4 
 IMPA (L1-Mand Plane) (º) 91.1 
 
Dental Relationships 
 L1 to Mand Plane (mm) 34.9 
 L6 to Mand Plane Distance (mm) 31.2 
 Interincisal Angle (º) 116.6 
 L1 to Nasion-B Point (º) 34.1 
 U1 to Nasion-A Point (º) 26.3 
 U1 to Sella-Nasion (º) 97.5 
 U1 to Occlusal Plane (º) 124.9 
 Overbite (mm) 1.0 
 Overjet (mm) 2.9 
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Table B-19.  Cephalometric measurement values for subject 
019: 10.08-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 67.4 
 Sella-Basion Length (mm) 46.0 
 Nasion-Basion Length (mm) 104.2 
 Basion-Sella-Nasion (º) 132.6 
 
Cranial Base to Face 
 Y-Axis Length (mm) 126.6 
 Sella-Gonion Length (mm) 66.5 
 Sella-Nasion-A Point (º) 83.8 
 Sella-Nasion-B Point (º) 77.0 
 A Pont-Nasion-B Point (º) 6.8 
 Nasion-A Point-Pogonion (º) 18.6 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 121.0 
 Gonion-Nasion Distance (mm) 81.6 
 Condylion-Gonion Distance (mm) 49.0 
 Gonion-Pogonion Length (mm) 76.6 
 Gonion-Menton Length (mm) 68.9 
 Articulare-Gonion-Nasion (º) 130.7 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 75.1 
 Y-Axis (Se-Gn to FH) (º) 68.1 
 FH to Sella-Nasion (º) 11.7 
 Sella-Nasion to Palatal Plane (º) 7.6 
 Occlusal Plane to Sella-Nasion (º) 24.0 
 Occlusal Plane to FH (º) 12.3 
 Mand Plane to Occlusal Plane (º) 23.3 
 Palatal Plane to Mand Plane (º) 39.7 
Continued 
 263
Table B-19. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 121.1 
 ANS-Menton Height (mm) 75.8 
 Nasion-ANS Height (mm) 50.4 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 38.8 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 35.6 
 FMIA (L1 to FH) (º) 43.0 
 IMPA (L1-Mand Plane) (º) 101.3 
 
Dental Relationships 
 L1 to Mand Plane (mm) 34.3 
 L6 to Mand Plane Distance (mm) 34.9 
 Interincisal Angle (º) 103.6 
 L1 to Nasion-B Point (º) 45.6 
 U1 to Nasion-A Point (º) 23.9 
 U1 to Sella-Nasion (º) 107.7 
 U1 to Occlusal Plane (º) 131.7 
 Overbite (mm) 0.5 
 Overjet (mm) 3.5 
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Table B-20.  Cephalometric measurement values for subject 
020: 9.52-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 66.4 
 Sella-Basion Length (mm) 45.7 
 Nasion-Basion Length (mm) 104.1 
 Basion-Sella-Nasion (º) 135.7 
 
Cranial Base to Face 
 Y-Axis Length (mm) 114.8 
 Sella-Gonion Length (mm) 66.9 
 Sella-Nasion-A Point (º) 81.9 
 Sella-Nasion-B Point (º) 75.0 
 A Pont-Nasion-B Point (º) 6.9 
 Nasion-A Point-Pogonion (º) 17.3 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 108.7 
 Gonion-Nasion Distance (mm) 70.1 
 Condylion-Gonion Distance (mm) 48.5 
 Gonion-Pogonion Length (mm) 67.1 
 Gonion-Menton Length (mm) 60.7 
 Articulare-Gonion-Nasion (º) 133.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 73.3 
 Y-Axis (Se-Gn to FH) (º) 66.3 
 FH to Sella-Nasion (º) 10.7 
 Sella-Nasion to Palatal Plane (º) 5.2 
 Occlusal Plane to Sella-Nasion (º) 18.2 
 Occlusal Plane to FH (º) 7.5 
 Mand Plane to Occlusal Plane (º) 22.9 
 Palatal Plane to Mand Plane (º) 35.9 
Continued 
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Table B-20. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 111.5 
 ANS-Menton Height (mm) 68.4 
 Nasion-ANS Height (mm) 47.1 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.2 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 30.4 
 FMIA (L1 to FH) (º) 52.5 
 IMPA (L1-Mand Plane) (º) 97.1 
 
Dental Relationships 
 L1 to Mand Plane (mm) 32.5 
 L6 to Mand Plane Distance (mm) 29.5 
 Interincisal Angle (º) 107.9 
 L1 to Nasion-B Point (º) 33.2 
 U1 to Nasion-A Point (º) 32.0 
 U1 to Sella-Nasion (º) 113.9 
 U1 to Occlusal Plane (º) 132.2 
 Overbite (mm) -1.5 
 Overjet (mm) 5.9 
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Table B-21.  Cephalometric measurement values for subject 
021: 9.52-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 68.4 
 Sella-Basion Length (mm) 48.6 
 Nasion-Basion Length (mm) 107.1 
 Basion-Sella-Nasion (º) 131.7 
 
Cranial Base to Face 
 Y-Axis Length (mm) 117.2 
 Sella-Gonion Length (mm) 75.6 
 Sella-Nasion-A Point (º) 84.8 
 Sella-Nasion-B Point (º) 75.1 
 A Pont-Nasion-B Point (º) 9.7 
 Nasion-A Point-Pogonion (º) 23.4 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 108.8 
 Gonion-Nasion Distance (mm) 70.1 
 Condylion-Gonion Distance (mm) 52.7 
 Gonion-Pogonion Length (mm) 68.6 
 Gonion-Menton Length (mm) 62.8 
 Articulare-Gonion-Nasion (º) 124.7 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 72.8 
 Y-Axis (Se-Gn to FH) (º) 65.8 
 FH to Sella-Nasion (º) 7.9 
 Sella-Nasion to Palatal Plane (º) 2.9 
 Occlusal Plane to Sella-Nasion (º) 17.0 
 Occlusal Plane to FH (º) 9.1 
 Mand Plane to Occlusal Plane (º) 17.7 
 Palatal Plane to Mand Plane (º) 31.8 
Continued 
 267
Table B-21. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 114.9 
 ANS-Menton Height (mm) 68.3 
 Nasion-ANS Height (mm) 51.1 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.6 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 26.8 
 FMIA (L1 to FH) (º) 45.5 
 IMPA (L1-Mand Plane) (º) 107.6 
 
Dental Relationships 
 L1 to Mand Plane (mm) 34.3 
 L6 to Mand Plane Distance (mm) 32.7 
 Interincisal Angle (º) 103.3 
 L1 to Nasion-B Point (º) 37.5 
 U1 to Nasion-A Point (º) 29.6 
 U1 to Sella-Nasion (º) 114.4 
 U1 to Occlusal Plane (º) 131.4 
 Overbite (mm) -1.2 
 Overjet (mm) 8.8 
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Table B-22.  Cephalometric measurement values for subject 
022: 8.47-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.9 
 Sella-Basion Length (mm) 41.3 
 Nasion-Basion Length (mm) 105.0 
 Basion-Sella-Nasion (º) 137.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 120.7 
 Sella-Gonion Length (mm) 72.2 
 Sella-Nasion-A Point (º) 85.2 
 Sella-Nasion-B Point (º) 80.2 
 A Pont-Nasion-B Point (º) 5.0 
 Nasion-A Point-Pogonion (º) 12.6 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 109.4 
 Gonion-Nasion Distance (mm) 74.5 
 Condylion-Gonion Distance (mm) 48.6 
 Gonion-Pogonion Length (mm) 72.5 
 Gonion-Menton Length (mm) 66.0 
 Articulare-Gonion-Nasion (º) 125.0 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 65.7 
 Y-Axis (Se-Gn to FH) (º) 58.7 
 FH to Sella-Nasion (º) 4.1 
 Sella-Nasion to Palatal Plane (º) 8.6 
 Occlusal Plane to Sella-Nasion (º) 18.6 
 Occlusal Plane to FH (º) 14.5 
 Mand Plane to Occlusal Plane (º) 13.1 
 Palatal Plane to Mand Plane (º) 23.1 
Continued 
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Table B-22. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 109.3 
 ANS-Menton Height (mm) 61.4 
 Nasion-ANS Height (mm) 50.4 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 44.5 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 27.6 
 FMIA (L1 to FH) (º) 45.9 
 IMPA (L1-Mand Plane) (º) 106.5 
 
Dental Relationships 
 L1 to Mand Plane (mm) 33.2 
 L6 to Mand Plane Distance (mm) 30.4 
 Interincisal Angle (º) 104.4 
 L1 to Nasion-B Point (º) 38.4 
 U1 to Nasion-A Point (º) 32.3 
 U1 to Sella-Nasion (º) 117.5 
 U1 to Occlusal Plane (º) 136.1 
 Overbite (mm) 0.4 
 Overjet (mm) 4.4 
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Table B-23.  Cephalometric measurement values for subject 
023: 11.01-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 72.9 
 Sella-Basion Length (mm) 49.8 
 Nasion-Basion Length (mm) 115.7 
 Basion-Sella-Nasion (º) 140.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 134.5 
 Sella-Gonion Length (mm) 77.6 
 Sella-Nasion-A Point (º) 82.6 
 Sella-Nasion-B Point (º) 75.7 
 A Pont-Nasion-B Point (º) 6.9 
 Nasion-A Point-Pogonion (º) 16.2 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 128.0 
 Gonion-Nasion Distance (mm) 85.0 
 Condylion-Gonion Distance (mm) 55.7 
 Gonion-Pogonion Length (mm) 81.7 
 Gonion-Menton Length (mm) 76.7 
 Articulare-Gonion-Nasion (º) 130.6 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 73.6 
 Y-Axis (Se-Gn to FH) (º) 66.6 
 FH to Sella-Nasion (º) 8.4 
 Sella-Nasion to Palatal Plane (º) 10.5 
 Occlusal Plane to Sella-Nasion (º) 20.8 
 Occlusal Plane to FH (º) 12.4 
 Mand Plane to Occlusal Plane (º) 20.4 
 Palatal Plane to Mand Plane (º) 30.7 
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Table B-23. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 130.4 
 ANS-Menton Height (mm) 76.5 
 Nasion-ANS Height (mm) 58.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.5 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 32.8 
 FMIA (L1 to FH) (º) 43.8 
 IMPA (L1-Mand Plane) (º) 103.4 
 
Dental Relationships 
 L1 to Mand Plane (mm) 37.2 
 L6 to Mand Plane Distance (mm) 34.4 
 Interincisal Angle (º) 108.3 
 L1 to Nasion-B Point (º) 40.3 
 U1 to Nasion-A Point (º) 24.5 
 U1 to Sella-Nasion (º) 107.1 
 U1 to Occlusal Plane (º) 128.0 
 Overbite (mm) -2.0 
 Overjet (mm) 3.8 
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Table B-24.  Cephalometric measurement values for subject 
024: 14.94-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 73.3 
 Sella-Basion Length (mm) 45.5 
 Nasion-Basion Length (mm) 111.4 
 Basion-Sella-Nasion (º) 138.0 
 
Cranial Base to Face 
 Y-Axis Length (mm) 135.1 
 Sella-Gonion Length (mm) 77.7 
 Sella-Nasion-A Point (º) 83.7 
 Sella-Nasion-B Point (º) 79.1 
 A Pont-Nasion-B Point (º) 4.6 
 Nasion-A Point-Pogonion (º) 14.2 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 129.6 
 Gonion-Nasion Distance (mm) 82.4 
 Condylion-Gonion Distance (mm) 59.5 
 Gonion-Pogonion Length (mm) 79.3 
 Gonion-Menton Length (mm) 73.6 
 Articulare-Gonion-Nasion (º) 131.8 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 71.6 
 Y-Axis (Se-Gn to FH) (º) 64.6 
 FH to Sella-Nasion (º) 10.2 
 Sella-Nasion to Palatal Plane (º) 8.3 
 Occlusal Plane to Sella-Nasion (º) 19.5 
 Occlusal Plane to FH (º) 9.3 
 Mand Plane to Occlusal Plane (º) 20.7 
 Palatal Plane to Mand Plane (º) 31.9 
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Table B-24. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 128.1 
 ANS-Menton Height (mm) 73.8 
 Nasion-ANS Height (mm) 58.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 43.3 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 30.0 
 FMIA (L1 to FH) (º) 47.0 
 IMPA (L1-Mand Plane) (º) 103.0 
 
Dental Relationships 
 L1 to Mand Plane (mm) 36.5 
 L6 to Mand Plane Distance (mm) 34.7 
 Interincisal Angle (º) 108.1 
 L1 to Nasion-B Point (º) 42.3 
 U1 to Nasion-A Point (º) 24.9 
 U1 to Sella-Nasion (º) 108.6 
 U1 to Occlusal Plane (º) 128.1 
 Overbite (mm) -0.6 
 Overjet (mm) 1.4 
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Table B-25.  Cephalometric measurement values for subject 
025: 14.82-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 76.2 
 Sella-Basion Length (mm) 45.5 
 Nasion-Basion Length (mm) 114.7 
 Basion-Sella-Nasion (º) 139.5 
 
Cranial Base to Face 
 Y-Axis Length (mm) 132.2 
 Sella-Gonion Length (mm) 76.7 
 Sella-Nasion-A Point (º) 82.0 
 Sella-Nasion-B Point (º) 74.7 
 A Pont-Nasion-B Point (º) 7.3 
 Nasion-A Point-Pogonion (º) 14.7 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 126.1 
 Gonion-Nasion Distance (mm) 83.1 
 Condylion-Gonion Distance (mm) 58.6 
 Gonion-Pogonion Length (mm) 79.9 
 Gonion-Menton Length (mm) 72.4 
 Articulare-Gonion-Nasion (º) 127.9 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 71.5 
 Y-Axis (Se-Gn to FH) (º) 64.5 
 FH to Sella-Nasion (º) 13.1 
 Sella-Nasion to Palatal Plane (º) 9.9 
 Occlusal Plane to Sella-Nasion (º) 25.2 
 Occlusal Plane to FH (º) 12.1 
 Mand Plane to Occlusal Plane (º) 13.6 
 Palatal Plane to Mand Plane (º) 28.9 
Continued 
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Table B-25. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 126.0 
 ANS-Menton Height (mm) 74.4 
 Nasion-ANS Height (mm) 55.6 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 25.7 
 FMIA (L1 to FH) (º) 46.3 
 IMPA (L1-Mand Plane) (º) 108.0 
 
Dental Relationships 
 L1 to Mand Plane (mm) 35.2 
 L6 to Mand Plane Distance (mm) 35.2 
 Interincisal Angle (º) 121.6 
 L1 to Nasion-B Point (º) 41.5 
 U1 to Nasion-A Point (º) 9.6 
 U1 to Sella-Nasion (º) 91.6 
 U1 to Occlusal Plane (º) 116.8 
 Overbite (mm) -0.5 
 Overjet (mm) 0.6 
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Table B-26.  Cephalometric measurement values for subject 
026: 12.11-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.9 
 Sella-Basion Length (mm) 41.4 
 Nasion-Basion Length (mm) 106.4 
 Basion-Sella-Nasion (º) 141.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 133.0 
 Sella-Gonion Length (mm) 73.2 
 Sella-Nasion-A Point (º) 82.1 
 Sella-Nasion-B Point (º) 78.5 
 A Pont-Nasion-B Point (º) 3.5 
 Nasion-A Point-Pogonion (º) 9.1 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 129.6 
 Gonion-Nasion Distance (mm) 81.5 
 Condylion-Gonion Distance (mm) 58.3 
 Gonion-Pogonion Length (mm) 77.7 
 Gonion-Menton Length (mm) 71.6 
 Articulare-Gonion-Nasion (º) 135.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 71.0 
 Y-Axis (Se-Gn to FH) (º) 64.0 
 FH to Sella-Nasion (º) 10.0 
 Sella-Nasion to Palatal Plane (º) 8.2 
 Occlusal Plane to Sella-Nasion (º) 19.9 
 Occlusal Plane to FH (º) 9.9 
 Mand Plane to Occlusal Plane (º) 22.1 
 Palatal Plane to Mand Plane (º) 33.8 
Continued 
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Table B-26. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 124.1 
 ANS-Menton Height (mm) 69.8 
 Nasion-ANS Height (mm) 55.6 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 43.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 32.0 
 FMIA (L1 to FH) (º) 48.6 
 IMPA (L1-Mand Plane) (º) 99.4 
 
Dental Relationships 
 L1 to Mand Plane (mm) 36.8 
 L6 to Mand Plane Distance (mm) 30.4 
 Interincisal Angle (º) 112.0 
 L1 to Nasion-B Point (º) 40.0 
 U1 to Nasion-A Point (º) 24.5 
 U1 to Sella-Nasion (º) 106.6 
 U1 to Occlusal Plane (º) 126.5 
 Overbite (mm) 1.3 
 Overjet (mm) 2.9 
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Table B-27.  Cephalometric measurement values for subject 
027: 9.91-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.5 
 Sella-Basion Length (mm) 41.0 
 Nasion-Basion Length (mm) 104.2 
 Basion-Sella-Nasion (º) 136.6 
 
Cranial Base to Face 
 Y-Axis Length (mm) 123.9 
 Sella-Gonion Length (mm) 70.8 
 Sella-Nasion-A Point (º) 81.3 
 Sella-Nasion-B Point (º) 75.2 
 A Pont-Nasion-B Point (º) 6.1 
 Nasion-A Point-Pogonion (º) 13.9 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 119.2 
 Gonion-Nasion Distance (mm) 76.5 
 Condylion-Gonion Distance (mm) 55.9 
 Gonion-Pogonion Length (mm) 73.2 
 Gonion-Menton Length (mm) 67.0 
 Articulare-Gonion-Nasion (º) 126.1 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 72.7 
 Y-Axis (Se-Gn to FH) (º) 65.7 
 FH to Sella-Nasion (º) 10.8 
 Sella-Nasion to Palatal Plane (º) 3.5 
 Occlusal Plane to Sella-Nasion (º) 21.0 
 Occlusal Plane to FH (º) 10.2 
 Mand Plane to Occlusal Plane (º) 20.3 
 Palatal Plane to Mand Plane (º) 37.8 
Continued 
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Table B-27. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 119.2 
 ANS-Menton Height (mm) 72.7 
 Nasion-ANS Height (mm) 49.6 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.8 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 30.5 
 FMIA (L1 to FH) (º) 44.7 
 IMPA (L1-Mand Plane) (º) 104.8 
 
Dental Relationships 
 L1 to Mand Plane (mm) 34.2 
 L6 to Mand Plane Distance (mm) 31.6 
 Interincisal Angle (º) 115.2 
 L1 to Nasion-B Point (º) 41.4 
 U1 to Nasion-A Point (º) 17.3 
 U1 to Sella-Nasion (º) 98.6 
 U1 to Occlusal Plane (º) 119.6 
 Overbite (mm) 0.3 
 Overjet (mm) 1.7 
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Table B-28.  Cephalometric measurement values for subject 
028: 12.4-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.4 
 Sella-Basion Length (mm) 45.5 
 Nasion-Basion Length (mm) 108.9 
 Basion-Sella-Nasion (º) 138.9 
 
Cranial Base to Face 
 Y-Axis Length (mm) 133.3 
 Sella-Gonion Length (mm) 72.3 
 Sella-Nasion-A Point (º) 78.7 
 Sella-Nasion-B Point (º) 71.8 
 A Pont-Nasion-B Point (º) 6.9 
 Nasion-A Point-Pogonion (º) 15.1 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 125.3 
 Gonion-Nasion Distance (mm) 84.7 
 Condylion-Gonion Distance (mm) 52.2 
 Gonion-Pogonion Length (mm) 80.3 
 Gonion-Menton Length (mm) 76.5 
 Articulare-Gonion-Nasion (º) 132.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 79.3 
 Y-Axis (Se-Gn to FH) (º) 72.3 
 FH to Sella-Nasion (º) 14.6 
 Sella-Nasion to Palatal Plane (º) 9.5 
 Occlusal Plane to Sella-Nasion (º) 23.7 
 Occlusal Plane to FH (º) 9.1 
 Mand Plane to Occlusal Plane (º) 26.5 
 Palatal Plane to Mand Plane (º) 40.6 
Continued 
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Table B-28. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 134.7 
 ANS-Menton Height (mm) 81.9 
 Nasion-ANS Height (mm) 56.2 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.9 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 35.5 
 FMIA (L1 to FH) (º) 42.5 
 IMPA (L1-Mand Plane) (º) 102.0 
 
Dental Relationships 
 L1 to Mand Plane (mm) 38.2 
 L6 to Mand Plane Distance (mm) 33.3 
 Interincisal Angle (º) 97.3 
 L1 to Nasion-B Point (º) 43.9 
 U1 to Nasion-A Point (º) 31.9 
 U1 to Sella-Nasion (º) 110.6 
 U1 to Occlusal Plane (º) 134.2 
 Overbite (mm) -1.8 
 Overjet (mm) 6.5 
 282
Table B-29.  Cephalometric measurement values for subject 
101: 3.86-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 71.8 
 Sella-Basion Length (mm) 40.6 
 Nasion-Basion Length (mm) 100.8 
 Basion-Sella-Nasion (º) 125.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) --- 
 Sella-Gonion Length (mm) --- 
 Sella-Nasion-A Point (º) 88.5 
 Sella-Nasion-B Point (º) 81.7 
 A Pont-Nasion-B Point (º) 6.8 
 Nasion-A Point-Pogonion (º) 18.2 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) --- 
 Gonion-Nasion Distance (mm) --- 
 Condylion-Gonion Distance (mm) --- 
 Gonion-Pogonion Length (mm) --- 
 Gonion-Menton Length (mm) --- 
 Articulare-Gonion-Nasion (º) --- 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) --- 
 Y-Axis (Se-Gn to FH) (º) --- 
 FH to Sella-Nasion (º) 10.9 
 Sella-Nasion to Palatal Plane (º) -0.8 
 Occlusal Plane to Sella-Nasion (º) 20.9 
 Occlusal Plane to FH (º) 10.0 
 Mand Plane to Occlusal Plane (º) --- 
 Palatal Plane to Mand Plane (º) --- 
Continued 
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Table B-29. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 100.8 
 ANS-Menton Height (mm) 64.9 
 Nasion-ANS Height (mm) 38.8 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) --- 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) --- 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm) --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -0.9 
 Overjet (mm) 2.0 
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Table B-30.  Cephalometric measurement values for subject 
102: 11.96-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 74.3 
 Sella-Basion Length (mm) 45.2 
 Nasion-Basion Length (mm) 107.3 
 Basion-Sella-Nasion (º) 126.0 
 
Cranial Base to Face 
 Y-Axis Length (mm) 125.1 
 Sella-Gonion Length (mm) 68.5 
 Sella-Nasion-A Point (º) 88.6 
 Sella-Nasion-B Point (º) 79.3 
 A Pont-Nasion-B Point (º) 9.4 
 Nasion-A Point-Pogonion (º) 25.3 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 114.5 
 Gonion-Nasion Distance (mm) 68.7 
 Condylion-Gonion Distance (mm) 51.9 
 Gonion-Pogonion Length (mm) 64.6 
 Gonion-Menton Length (mm) 57.3 
 Articulare-Gonion-Nasion (º) 143.1 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 69.2 
 Y-Axis (Se-Gn to FH) (º) 62.2 
 FH to Sella-Nasion (º) 12.1 
 Sella-Nasion to Palatal Plane (º) 4.2 
 Occlusal Plane to Sella-Nasion (º) 29.4 
 Occlusal Plane to FH (º) 17.3 
 Mand Plane to Occlusal Plane (º) 15.6 
 Palatal Plane to Mand Plane (º) 40.8 
Continued 
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Table B-30. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 115.3 
 ANS-Menton Height (mm) 72.6 
 Nasion-ANS Height (mm) 49.2 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.5 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 32.9 
 FMIA (L1 to FH) (º) 40.6 
 IMPA (L1-Mand Plane) (º) 106.5 
 
Dental Relationships 
 L1 to Mand Plane (mm) 31.0 
 L6 to Mand Plane Distance (mm) 34.4 
 Interincisal Angle (º) 107.3 
 L1 to Nasion-B Point (º) 50.8 
 U1 to Nasion-A Point (º) 12.5 
 U1 to Sella-Nasion (º) 101.2 
 U1 to Occlusal Plane (º) 130.6 
 Overbite (mm) -0.6 
 Overjet (mm) 0.7 
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Table B-31.  Cephalometric measurement values for subject 
103: 16.61-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 71.3 
 Sella-Basion Length (mm) 48.6 
 Nasion-Basion Length (mm) 112.2 
 Basion-Sella-Nasion (º) 138.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 132.7 
 Sella-Gonion Length (mm) 80.9 
 Sella-Nasion-A Point (º) 88.9 
 Sella-Nasion-B Point (º) 80.7 
 A Pont-Nasion-B Point (º) 8.3 
 Nasion-A Point-Pogonion (º) 18.4 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 128.4 
 Gonion-Nasion Distance (mm) 86.9 
 Condylion-Gonion Distance (mm) 60.6 
 Gonion-Pogonion Length (mm) 84.7 
 Gonion-Menton Length (mm) 77.4 
 Articulare-Gonion-Nasion (º) 121.8 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 68.6 
 Y-Axis (Se-Gn to FH) (º) 61.6 
 FH to Sella-Nasion (º) 11.8 
 Sella-Nasion to Palatal Plane (º) 4.0 
 Occlusal Plane to Sella-Nasion (º) 17.4 
 Occlusal Plane to FH (º) 5.6 
 Mand Plane to Occlusal Plane (º) 15.0 
 Palatal Plane to Mand Plane (º) 28.4 
Continued 
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Table B-31. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 122.4 
 ANS-Menton Height (mm) 77.5 
 Nasion-ANS Height (mm) 50.9 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.3 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 20.6 
 FMIA (L1 to FH) (º) 51.8 
 IMPA (L1-Mand Plane) (º) 107.5 
 
Dental Relationships 
 L1 to Mand Plane (mm) 38.1 
 L6 to Mand Plane Distance (mm) 35.0 
 Interincisal Angle (º) 112.7 
 L1 to Nasion-B Point (º) 40.6 
 U1 to Nasion-A Point (º) 18.4 
 U1 to Sella-Nasion (º) 107.3 
 U1 to Occlusal Plane (º) 124.8 
 Overbite (mm) 1.5 
 Overjet (mm) 3.7 
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Table B-32.  Cephalometric measurement values for subject 
104: 5.65-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 67.7 
 Sella-Basion Length (mm) 37.0 
 Nasion-Basion Length (mm) 97.6 
 Basion-Sella-Nasion (º) 135.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 119.3 
 Sella-Gonion Length (mm) 66.8 
 Sella-Nasion-A Point (º) 80.3 
 Sella-Nasion-B Point (º) 77.2 
 A Pont-Nasion-B Point (º) 3.1 
 Nasion-A Point-Pogonion (º) 10.6 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 115.6 
 Gonion-Nasion Distance (mm) 72.5 
 Condylion-Gonion Distance (mm) 53.4 
 Gonion-Pogonion Length (mm) 68.9 
 Gonion-Menton Length (mm) 60.6 
 Articulare-Gonion-Nasion (º) 133.1 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 72.1 
 Y-Axis (Se-Gn to FH) (º) 65.1 
 FH to Sella-Nasion (º) 7.1 
 Sella-Nasion to Palatal Plane (º) 7.9 
 Occlusal Plane to Sella-Nasion (º) 20.0 
 Occlusal Plane to FH (º) 13.0 
 Mand Plane to Occlusal Plane (º) 22.4 
 Palatal Plane to Mand Plane (º) 34.5 
Continued 
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Table B-32. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 112.8 
 ANS-Menton Height (mm) 68.7 
 Nasion-ANS Height (mm) 46.3 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 35.4 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) 0.2 
 Overjet (mm) 3.0 
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Table B-33.  Cephalometric measurement values for subject 
105: 5.91-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 63.8 
 Sella-Basion Length (mm) 39.5 
 Nasion-Basion Length (mm) 95.6 
 Basion-Sella-Nasion (º) 134.3 
 
Cranial Base to Face 
 Y-Axis Length (mm) 118.6 
 Sella-Gonion Length (mm) 66.0 
 Sella-Nasion-A Point (º) 81.8 
 Sella-Nasion-B Point (º) 75.8 
 A Pont-Nasion-B Point (º) 6.0 
 Nasion-A Point-Pogonion (º) 15.3 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 112.7 
 Gonion-Nasion Distance (mm) 69.8 
 Condylion-Gonion Distance (mm) 52.2 
 Gonion-Pogonion Length (mm) 65.5 
 Gonion-Menton Length (mm) 57.7 
 Articulare-Gonion-Nasion (º) 134.2 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 75.8 
 Y-Axis (Se-Gn to FH) (º) 68.8 
 FH to Sella-Nasion (º) 14.5 
 Sella-Nasion to Palatal Plane (º) 4.3 
 Occlusal Plane to Sella-Nasion (º) 24.8 
 Occlusal Plane to FH (º) 10.3 
 Mand Plane to Occlusal Plane (º) 22.7 
 Palatal Plane to Mand Plane (º) 43.2 
Continued 
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Table B-33. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 114.4 
 ANS-Menton Height (mm) 72.0 
 Nasion-ANS Height (mm) 46.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 37.7 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 33.0 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -2.4 
 Overjet (mm) 0.2 
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Table B-34.  Cephalometric measurement values for subject 
106: 6.89-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.8 
 Sella-Basion Length (mm) 44.7 
 Nasion-Basion Length (mm) 104.3 
 Basion-Sella-Nasion (º) 127.7 
 
Cranial Base to Face 
 Y-Axis Length (mm) 119.6 
 Sella-Gonion Length (mm) 70.1 
 Sella-Nasion-A Point (º) 85.8 
 Sella-Nasion-B Point (º) 78.5 
 A Pont-Nasion-B Point (º) 7.3 
 Nasion-A Point-Pogonion (º) 13.5 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 113.6 
 Gonion-Nasion Distance (mm) 72.5 
 Condylion-Gonion Distance (mm) 51.3 
 Gonion-Pogonion Length (mm) 70.1 
 Gonion-Menton Length (mm) 63.7 
 Articulare-Gonion-Nasion (º) 133.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 65.5 
 Y-Axis (Se-Gn to FH) (º) 58.5 
 FH to Sella-Nasion (º) 4.9 
 Sella-Nasion to Palatal Plane (º) 2.8 
 Occlusal Plane to Sella-Nasion (º) 20.2 
 Occlusal Plane to FH (º) 15.3 
 Mand Plane to Occlusal Plane (º) 12.8 
 Palatal Plane to Mand Plane (º) 30.2 
Continued 
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Table B-34. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 107.8 
 ANS-Menton Height (mm) 63.3 
 Nasion-ANS Height (mm) 47.3 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.2 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 28.1 
 FMIA (L1 to FH) (º) 44.0 
 IMPA (L1-Mand Plane) (º) 107.9 
 
Dental Relationships 
 L1 to Mand Plane (mm) 34.1 
 L6 to Mand Plane Distance (mm) 29.9 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) 39.5 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) 1.0 
 Overjet (mm) 3.3 
 294
Table B-35.  Cephalometric measurement values for subject 
107: 14.97-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.6 
 Sella-Basion Length (mm) 38.7 
 Nasion-Basion Length (mm) 105.8 
 Basion-Sella-Nasion (º) 150.0 
 
Cranial Base to Face 
 Y-Axis Length (mm) 126.5 
 Sella-Gonion Length (mm) 64.5 
 Sella-Nasion-A Point (º) 72.0 
 Sella-Nasion-B Point (º) 66.9 
 A Pont-Nasion-B Point (º) 5.2 
 Nasion-A Point-Pogonion (º) 9.2 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 127.1 
 Gonion-Nasion Distance (mm) 85.1 
 Condylion-Gonion Distance (mm) 53.1 
 Gonion-Pogonion Length (mm) 80.5 
 Gonion-Menton Length (mm) 73.9 
 Articulare-Gonion-Nasion (º) 134.8 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 81.8 
 Y-Axis (Se-Gn to FH) (º) 74.8 
 FH to Sella-Nasion (º) 19.2 
 Sella-Nasion to Palatal Plane (º) 12.9 
 Occlusal Plane to Sella-Nasion (º) 27.8 
 Occlusal Plane to FH (º) 8.6 
 Mand Plane to Occlusal Plane (º) 26.5 
 Palatal Plane to Mand Plane (º) 41.3 
Continued 
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Table B-35. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 130.3 
 ANS-Menton Height (mm) 77.6 
 Nasion-ANS Height (mm) 55.1 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.2 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 35.0 
 FMIA (L1 to FH) (º) 53.6 
 IMPA (L1-Mand Plane) (º) 91.4 
 
Dental Relationships 
 L1 to Mand Plane (mm) 35.9 
 L6 to Mand Plane Distance (mm) 34.2 
 Interincisal Angle (º) 116.9 
 L1 to Nasion-B Point (º) 32.5 
 U1 to Nasion-A Point (º) 25.4 
 U1 to Sella-Nasion (º) 97.5 
 U1 to Occlusal Plane (º) 125.3 
 Overbite (mm) 1.6 
 Overjet (mm) 4.1 
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Table B-36.  Cephalometric measurement values for subject 
108: 7.4-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 68.8 
 Sella-Basion Length (mm) 41.5 
 Nasion-Basion Length (mm) 102.7 
 Basion-Sella-Nasion (º) 135.8 
 
Cranial Base to Face 
 Y-Axis Length (mm) 120.8 
 Sella-Gonion Length (mm) 65.8 
 Sella-Nasion-A Point (º) 79.4 
 Sella-Nasion-B Point (º) 77.0 
 A Pont-Nasion-B Point (º) 2.3 
 Nasion-A Point-Pogonion (º) 6.3 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 116.2 
 Gonion-Nasion Distance (mm) 79.9 
 Condylion-Gonion Distance (mm) 49.8 
 Gonion-Pogonion Length (mm) 76.2 
 Gonion-Menton Length (mm) 68.2 
 Articulare-Gonion-Nasion (º) 127.5 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 70.3 
 Y-Axis (Se-Gn to FH) (º) 63.3 
 FH to Sella-Nasion (º) 10.7 
 Sella-Nasion to Palatal Plane (º) 6.2 
 Occlusal Plane to Sella-Nasion (º) 18.8 
 Occlusal Plane to FH (º) 8.1 
 Mand Plane to Occlusal Plane (º) 21.2 
 Palatal Plane to Mand Plane (º) 33.8 
Continued 
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Table B-36. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 112.5 
 ANS-Menton Height (mm) 68.1 
 Nasion-ANS Height (mm) 46.7 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.6 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 29.3 
 FMIA (L1 to FH) (º) 57.1 
 IMPA (L1-Mand Plane) (º) 93.6 
 
Dental Relationships 
 L1 to Mand Plane (mm) 32.7 
 L6 to Mand Plane Distance (mm) 29.1 
 Interincisal Angle (º) 123.4 
 L1 to Nasion-B Point (º) 30.6 
 U1 to Nasion-A Point (º) 23.6 
 U1 to Sella-Nasion (º) 103.0 
 U1 to Occlusal Plane (º) 121.7 
 Overbite (mm) -5.2 
 Overjet (mm) -0.8 
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Table B-37.  Cephalometric measurement values for subject 
109: 17.41-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 77.2 
 Sella-Basion Length (mm) 48.7 
 Nasion-Basion Length (mm) 115.2 
 Basion-Sella-Nasion (º) 131.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 145.8 
 Sella-Gonion Length (mm) 77.3 
 Sella-Nasion-A Point (º) 81.9 
 Sella-Nasion-B Point (º) 78.9 
 A Pont-Nasion-B Point (º) 3.0 
 Nasion-A Point-Pogonion (º) 8.5 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 132.6 
 Gonion-Nasion Distance (mm) 91.9 
 Condylion-Gonion Distance (mm) 54.4 
 Gonion-Pogonion Length (mm) 88.4 
 Gonion-Menton Length (mm) 80.8 
 Articulare-Gonion-Nasion (º) 130.0 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 71.3 
 Y-Axis (Se-Gn to FH) (º) 64.3 
 FH to Sella-Nasion (º) 4.2 
 Sella-Nasion to Palatal Plane (º) 6.1 
 Occlusal Plane to Sella-Nasion (º) 17.7 
 Occlusal Plane to FH (º) 13.5 
 Mand Plane to Occlusal Plane (º) 25.9 
 Palatal Plane to Mand Plane (º) 37.5 
Continued 
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Table B-37. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 136.0 
 ANS-Menton Height (mm) 84.1 
 Nasion-ANS Height (mm) 54.3 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 38.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 39.4 
 FMIA (L1 to FH) (º) 48.4 
 IMPA (L1-Mand Plane) (º) 92.1 
 
Dental Relationships 
 L1 to Mand Plane (mm) 40.5 
 L6 to Mand Plane Distance (mm) 36.2 
 Interincisal Angle (º) 111.6 
 L1 to Nasion-B Point (º) 34.7 
 U1 to Nasion-A Point (º) 30.8 
 U1 to Sella-Nasion (º) 112.7 
 U1 to Occlusal Plane (º) 130.4 
 Overbite (mm) -1.6 
 Overjet (mm) 2.5 
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Table B-38.  Cephalometric measurement values for subject 
110: 9.96-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 67.9 
 Sella-Basion Length (mm) 40.3 
 Nasion-Basion Length (mm) 100.5 
 Basion-Sella-Nasion (º) 135.0 
 
Cranial Base to Face 
 Y-Axis Length (mm) 109.8 
 Sella-Gonion Length (mm) 64.5 
 Sella-Nasion-A Point (º) 76.2 
 Sella-Nasion-B Point (º) 70.2 
 A Pont-Nasion-B Point (º) 6.0 
 Nasion-A Point-Pogonion (º) 14.8 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 100.5 
 Gonion-Nasion Distance (mm) 65.1 
 Condylion-Gonion Distance (mm) 47.3 
 Gonion-Pogonion Length (mm) 62.7 
 Gonion-Menton Length (mm) 55.0 
 Articulare-Gonion-Nasion (º) 127.0 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 75.6 
 Y-Axis (Se-Gn to FH) (º) 68.6 
 FH to Sella-Nasion (º) 15.3 
 Sella-Nasion to Palatal Plane (º) 7.3 
 Occlusal Plane to Sella-Nasion (º) 23.8 
 Occlusal Plane to FH (º) 8.5 
 Mand Plane to Occlusal Plane (º) 19.8 
 Palatal Plane to Mand Plane (º) 36.3 
Continued 
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Table B-38. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 110.3 
 ANS-Menton Height (mm) 64.0 
 Nasion-ANS Height (mm) 49.3 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.8 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 28.4 
 FMIA (L1 to FH) (º) 56.2 
 IMPA (L1-Mand Plane) (º) 95.4 
 
Dental Relationships 
 L1 to Mand Plane (mm) 31.4 
 L6 to Mand Plane Distance (mm) 29.6 
 Interincisal Angle (º) 117.6 
 L1 to Nasion-B Point (º) 29.2 
 U1 to Nasion-A Point (º) 27.2 
 U1 to Sella-Nasion (º) 103.4 
 U1 to Occlusal Plane (º) 127.2 
 Overbite (mm) 2.2 
 Overjet (mm) 5.6 
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Table B-39.  Cephalometric measurement values for subject 
111: 14.41-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.1 
 Sella-Basion Length (mm) 46.8 
 Nasion-Basion Length (mm) 107.5 
 Basion-Sella-Nasion (º) 132.9 
 
Cranial Base to Face 
 Y-Axis Length (mm) 132.6 
 Sella-Gonion Length (mm) 88.4 
 Sella-Nasion-A Point (º) 76.8 
 Sella-Nasion-B Point (º) 73.2 
 A Pont-Nasion-B Point (º) 3.6 
 Nasion-A Point-Pogonion (º) 8.1 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 121.4 
 Gonion-Nasion Distance (mm) 78.6 
 Condylion-Gonion Distance (mm) 64.4 
 Gonion-Pogonion Length (mm) 76.5 
 Gonion-Menton Length (mm) 71.0 
 Articulare-Gonion-Nasion (º) 115.2 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 76.7 
 Y-Axis (Se-Gn to FH) (º) 69.7 
 FH to Sella-Nasion (º) 11.6 
 Sella-Nasion to Palatal Plane (º) 8.7 
 Occlusal Plane to Sella-Nasion (º) 28.4 
 Occlusal Plane to FH (º) 16.9 
 Mand Plane to Occlusal Plane (º) 8.1 
 Palatal Plane to Mand Plane (º) 27.8 
Continued 
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Table B-39. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 132.5 
 ANS-Menton Height (mm) 73.4 
 Nasion-ANS Height (mm) 61.3 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 45.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 25.0 
 FMIA (L1 to FH) (º) 53.6 
 IMPA (L1-Mand Plane) (º) 101.4 
 
Dental Relationships 
 L1 to Mand Plane (mm) 34.3 
 L6 to Mand Plane Distance (mm) 35.9 
 Interincisal Angle (º) 128.1 
 L1 to Nasion-B Point (º) 31.1 
 U1 to Nasion-A Point (º) 17.2 
 U1 to Sella-Nasion (º) 93.9 
 U1 to Occlusal Plane (º) 122.4 
 Overbite (mm) 0.7 
 Overjet (mm) 2.6 
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Table B-40.  Cephalometric measurement values for subject 
112: 5.8-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 67.6 
 Sella-Basion Length (mm) 40.3 
 Nasion-Basion Length (mm) 99.0 
 Basion-Sella-Nasion (º) 131.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 114.1 
 Sella-Gonion Length (mm) 60.4 
 Sella-Nasion-A Point (º) 83.8 
 Sella-Nasion-B Point (º) 77.0 
 A Pont-Nasion-B Point (º) 6.9 
 Nasion-A Point-Pogonion (º) 16.5 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 105.5 
 Gonion-Nasion Distance (mm) 69.9 
 Condylion-Gonion Distance (mm) 45.6 
 Gonion-Pogonion Length (mm) 66.0 
 Gonion-Menton Length (mm) 59.2 
 Articulare-Gonion-Nasion (º) 132.6 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 69.8 
 Y-Axis (Se-Gn to FH) (º) 62.8 
 FH to Sella-Nasion (º) 9.4 
 Sella-Nasion to Palatal Plane (º) 7.6 
 Occlusal Plane to Sella-Nasion (º) 24.2 
 Occlusal Plane to FH (º) 14.9 
 Mand Plane to Occlusal Plane (º) 18.9 
 Palatal Plane to Mand Plane (º) 35.6 
Continued 
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Table B-40. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 106.1 
 ANS-Menton Height (mm) 65.3 
 Nasion-ANS Height (mm) 45.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.8 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 33.8 
 FMIA (L1 to FH) (º) 51.5 
 IMPA (L1-Mand Plane) (º) 94.7 
 
Dental Relationships 
 L1 to Mand Plane (mm) 29.4 
 L6 to Mand Plane Distance (mm) 26.7 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) 34.8 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -3.2 
 Overjet (mm) 2.4 
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Table B-41.  Cephalometric measurement values for subject 
114: 5.31-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 75.9 
 Sella-Basion Length (mm) 42.4 
 Nasion-Basion Length (mm) 111.8 
 Basion-Sella-Nasion (º) 140.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 109.9 
 Sella-Gonion Length (mm) 63.4 
 Sella-Nasion-A Point (º) 76.9 
 Sella-Nasion-B Point (º) 73.3 
 A Pont-Nasion-B Point (º) 3.6 
 Nasion-A Point-Pogonion (º) 10.3 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 106.6 
 Gonion-Nasion Distance (mm) 70.3 
 Condylion-Gonion Distance (mm) 50.5 
 Gonion-Pogonion Length (mm) 68.6 
 Gonion-Menton Length (mm) 62.6 
 Articulare-Gonion-Nasion (º) 126.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 66.9 
 Y-Axis (Se-Gn to FH) (º) 59.9 
 FH to Sella-Nasion (º) 9.7 
 Sella-Nasion to Palatal Plane (º) 6.5 
 Occlusal Plane to Sella-Nasion (º) 25.1 
 Occlusal Plane to FH (º) 15.4 
 Mand Plane to Occlusal Plane (º) 9.2 
 Palatal Plane to Mand Plane (º) 27.7 
Continued 
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Table B-41. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 104.4 
 ANS-Menton Height (mm) 60.1 
 Nasion-ANS Height (mm) 46.1 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 43.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 24.6 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm) 27.4 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) 2.7 
 Overjet (mm) 4.3 
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Table B-42.  Cephalometric measurement values for subject 
116: 5.08-year-old SB+ Thalassemia female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 67.1 
 Sella-Basion Length (mm) 47.7 
 Nasion-Basion Length (mm) 108.2 
 Basion-Sella-Nasion (º) 140.7 
 
Cranial Base to Face 
 Y-Axis Length (mm) 113.0 
 Sella-Gonion Length (mm) 68.7 
 Sella-Nasion-A Point (º) 83.9 
 Sella-Nasion-B Point (º) 78.6 
 A Pont-Nasion-B Point (º) 5.3 
 Nasion-A Point-Pogonion (º) 15.4 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 109.5 
 Gonion-Nasion Distance (mm) 72.5 
 Condylion-Gonion Distance (mm) 51.2 
 Gonion-Pogonion Length (mm) 70.6 
 Gonion-Menton Length (mm) 64.3 
 Articulare-Gonion-Nasion (º) 124.1 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 68.4 
 Y-Axis (Se-Gn to FH) (º) 61.4 
 FH to Sella-Nasion (º) 8.6 
 Sella-Nasion to Palatal Plane (º) 5.2 
 Occlusal Plane to Sella-Nasion (º) 16.4 
 Occlusal Plane to FH (º) 7.8 
 Mand Plane to Occlusal Plane (º) 16.3 
 Palatal Plane to Mand Plane (º) 27.5 
Continued 
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Table B-42. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 105.8 
 ANS-Menton Height (mm) 62.7 
 Nasion-ANS Height (mm) 46.1 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 24.1 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) 1.8.0 
 Overjet (mm) 3.0.5 
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Table B-43.  Cephalometric measurement values for subject 
118: 15.64-year-old SB+ Thalassemia male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 75.5 
 Sella-Basion Length (mm) 47.5 
 Nasion-Basion Length (mm) 115.7 
 Basion-Sella-Nasion (º) 139.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 126.2 
 Sella-Gonion Length (mm) 71.8 
 Sella-Nasion-A Point (º) 77.4 
 Sella-Nasion-B Point (º) 71.1 
 A Pont-Nasion-B Point (º) 6.3 
 Nasion-A Point-Pogonion (º) 14.8 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 120.5 
 Gonion-Nasion Distance (mm) 77.4 
 Condylion-Gonion Distance (mm) 54.8 
 Gonion-Pogonion Length (mm) 73.7 
 Gonion-Menton Length (mm) 67.1 
 Articulare-Gonion-Nasion (º) 130.1 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 75.5 
 Y-Axis (Se-Gn to FH) (º) 68.5 
 FH to Sella-Nasion (º) 10.4 
 Sella-Nasion to Palatal Plane (º) 9.4 
 Occlusal Plane to Sella-Nasion (º) 19.4 
 Occlusal Plane to FH (º) 8.9 
 Mand Plane to Occlusal Plane (º) 25.3 
 Palatal Plane to Mand Plane (º) 35.2 
Continued 
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Table B-43. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 125.9 
 ANS-Menton Height (mm) 74.1 
 Nasion-ANS Height (mm) 55.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 41.8 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 34.2 
 FMIA (L1 to FH) (º) 46.7 
 IMPA (L1-Mand Plane) (º) 99.2 
 
Dental Relationships 
 L1 to Mand Plane (mm) 37.6 
 L6 to Mand Plane Distance (mm) 32.7 
 Interincisal Angle (º) 114.6 
 L1 to Nasion-B Point (º) 34.9 
 U1 to Nasion-A Point (º) 24.2 
 U1 to Sella-Nasion (º) 101.6 
 U1 to Occlusal Plane (º) 121.0 
 Overbite (mm) 4.2 
 Overjet (mm) 5.2 
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Table B-44.  Cephalometric measurement values for subject 
119: 7.97-year-old SB+ Thalassemia female. 
 
 Variable Value 
 
 
Cranial Base 
 Sella-Nasion (mm) 66.9 
 Sella-Basion Length (mm) 42.2 
 Nasion-Basion Length (mm) 101.4 
 Basion-Sella-Nasion (º) 135.5 
 
Cranial Base to Face 
 Y-Axis Length (mm) 119.3 
 Sella-Gonion Length (mm) 63.5 
 Sella-Nasion-A Point (º) 85.3 
 Sella-Nasion-B Point (º) 75.6 
 A Pont-Nasion-B Point (º) 9.7 
 Nasion-A Point-Pogonion (º) 21.4 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 114.6 
 Gonion-Nasion Distance (mm) 75.8 
 Condylion-Gonion Distance (mm) 47.8 
 Gonion-Pogonion Length (mm) 71.7 
 Gonion-Menton Length (mm) 66.5 
 Articulare-Gonion-Nasion (º) 136.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 72.7 
 Y-Axis (Se-Gn to FH) (º) 65.7 
 FH to Sella-Nasion (º) 11.5 
 Sella-Nasion to Palatal Plane (º) 4.8 
 Occlusal Plane to Sella-Nasion (º) 26.6 
 Occlusal Plane to FH (º) 15.0 
 Mand Plane to Occlusal Plane (º) 18.0 
 Palatal Plane to Mand Plane (º) 39.8 
Continued 
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Table B-44. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 113.9 
 ANS-Menton Height (mm) 70.5 
 Nasion-ANS Height (mm) 48.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.7 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 33.0 
 FMIA (L1 to FH) (º) 48.9 
 IMPA (L1-Mand Plane) (º) 98.1 
 
Dental Relationships 
 L1 to Mand Plane (mm) 33.1 
 L6 to Mand Plane Distance (mm) 31.2 
 Interincisal Angle (º) 119.0 
 L1 to Nasion-B Point (º) 38.3 
 U1 to Nasion-A Point (º) 13.1 
 U1 to Sella-Nasion (º) 98.4 
 U1 to Occlusal Plane (º) 125.0 
 Overbite (mm) -0.2 
 Overjet (mm) 2.6 
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Table B-45.  Cephalometric measurement values for subject 
120: 8.97-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 68.6 
 Sella-Basion Length (mm) 43.2 
 Nasion-Basion Length (mm) 103.7 
 Basion-Sella-Nasion (º) 134.8 
 
Cranial Base to Face 
 Y-Axis Length (mm) 120.5 
 Sella-Gonion Length (mm) 69.1 
 Sella-Nasion-A Point (º) 78.7 
 Sella-Nasion-B Point (º) 75.8 
 A Pont-Nasion-B Point (º) 2.9 
 Nasion-A Point-Pogonion (º) 9.9 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) --- 
 Gonion-Nasion Distance (mm) 71.9 
 Condylion-Gonion Distance (mm) --- 
 Gonion-Pogonion Length (mm) 68.6 
 Gonion-Menton Length (mm) 62.9 
 Articulare-Gonion-Nasion (º) --- 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 73.1 
 Y-Axis (Se-Gn to FH) (º) 66.1 
 FH to Sella-Nasion (º) 7.6 
 Sella-Nasion to Palatal Plane (º) 5.5 
 Occlusal Plane to Sella-Nasion (º) 25.0 
 Occlusal Plane to FH (º) 17.4 
 Mand Plane to Occlusal Plane (º) 17.5 
 Palatal Plane to Mand Plane (º) 37.0 
Continued 
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Table B-45. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 116.4 
 ANS-Menton Height (mm) 69.8 
 Nasion-ANS Height (mm) 48.5 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 34.9 
 FMIA (L1 to FH) (º) 49.8 
 IMPA (L1-Mand Plane) (º) 95.3 
 
Dental Relationships 
 L1 to Mand Plane (mm) 32.2 
 L6 to Mand Plane Distance (mm) 29.6 
 Interincisal Angle (º) 121.6 
 L1 to Nasion-B Point (º) 33.6 
 U1 to Nasion-A Point (º) 21.8 
 U1 to Sella-Nasion (º) 100.5 
 U1 to Occlusal Plane (º) 125.5 
 Overbite (mm) -0.4 
 Overjet (mm) 1.0 
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Table B-46.  Cephalometric measurement values for subject 
123: 16.02-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 72.2 
 Sella-Basion Length (mm) 43.8 
 Nasion-Basion Length (mm) 110.3 
 Basion-Sella-Nasion (º) 142.9 
 
Cranial Base to Face 
 Y-Axis Length (mm) 129.7 
 Sella-Gonion Length (mm) 74.0 
 Sella-Nasion-A Point (º) 85.6 
 Sella-Nasion-B Point (º) 70.4 
 A Pont-Nasion-B Point (º) 15.3 
 Nasion-A Point-Pogonion (º) 33.0 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 121.4 
 Gonion-Nasion Distance (mm) 73.5 
 Condylion-Gonion Distance (mm) 58.5 
 Gonion-Pogonion Length (mm) 69.7 
 Gonion-Menton Length (mm) 61.9 
 Articulare-Gonion-Nasion (º) 134.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 80.2 
 Y-Axis (Se-Gn to FH) (º) 73.2 
 FH to Sella-Nasion (º) 13.4 
 Sella-Nasion to Palatal Plane (º) 4.7 
 Occlusal Plane to Sella-Nasion (º) 22.2 
 Occlusal Plane to FH (º) 8.9 
 Mand Plane to Occlusal Plane (º) 29.4 
 Palatal Plane to Mand Plane (º) 47.0 
Continued 
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Table B-46. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 131.9 
 ANS-Menton Height (mm) 86.9 
 Nasion-ANS Height (mm) 52.8 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 37.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 38.3 
 FMIA (L1 to FH) (º) 32.9 
 IMPA (L1-Mand Plane) (º) 108.8 
 
Dental Relationships 
 L1 to Mand Plane (mm) 31.9 
 L6 to Mand Plane Distance (mm) 37.6 
 Interincisal Angle (º) 74.2 
 L1 to Nasion-B Point (º) 50.8 
 U1 to Nasion-A Point (º) 39.7 
 U1 to Sella-Nasion (º) 125.3 
 U1 to Occlusal Plane (º) 147.6 
 Overbite (mm) -5.7 
 Overjet (mm) 15.5 
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Table B-47.  Cephalometric measurement values for subject 
124: 6.25-year-old SC female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 68.0 
 Sella-Basion Length (mm) 47.7 
 Nasion-Basion Length (mm) 104.8 
 Basion-Sella-Nasion (º) 129.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 119.8 
 Sella-Gonion Length (mm) 69.7 
 Sella-Nasion-A Point (º) 83.8 
 Sella-Nasion-B Point (º) 77.9 
 A Pont-Nasion-B Point (º) 5.9 
 Nasion-A Point-Pogonion (º) 16.3 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 112.6 
 Gonion-Nasion Distance (mm) 65.6 
 Condylion-Gonion Distance (mm) 55.9 
 Gonion-Pogonion Length (mm) 61.5 
 Gonion-Menton Length (mm) 53.5 
 Articulare-Gonion-Nasion (º) 138.0 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 70.6 
 Y-Axis (Se-Gn to FH) (º) 63.6 
 FH to Sella-Nasion (º) 11.9 
 Sella-Nasion to Palatal Plane (º) 6.3 
 Occlusal Plane to Sella-Nasion (º) 20.5 
 Occlusal Plane to FH (º) 8.6 
 Mand Plane to Occlusal Plane (º) 21.5 
 Palatal Plane to Mand Plane (º) 35.7 
Continued 
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Table B-47. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 111.3 
 ANS-Menton Height (mm) 68.5 
 Nasion-ANS Height (mm) 48.4 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.5 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 30.1 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm) 28.1 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -1.3 
 Overjet (mm) 2.7 
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Table B-48.  Cephalometric measurement values for subject 
126: 15.38-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 67.6 
 Sella-Basion Length (mm) 41.9 
 Nasion-Basion Length (mm) 104.2 
 Basion-Sella-Nasion (º) 143.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 133.9 
 Sella-Gonion Length (mm) 82.3 
 Sella-Nasion-A Point (º) 82.0 
 Sella-Nasion-B Point (º) 76.1 
 A Pont-Nasion-B Point (º) 5.9 
 Nasion-A Point-Pogonion (º) 11.7 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 128.1 
 Gonion-Nasion Distance (mm) 79.4 
 Condylion-Gonion Distance (mm) 64.9 
 Gonion-Pogonion Length (mm) 75.9 
 Gonion-Menton Length (mm) 71.5 
 Articulare-Gonion-Nasion (º) 125.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 74.5 
 Y-Axis (Se-Gn to FH) (º) 67.5 
 FH to Sella-Nasion (º) 12.6 
 Sella-Nasion to Palatal Plane (º) 6.2 
 Occlusal Plane to Sella-Nasion (º) 18.2 
 Occlusal Plane to FH (º) 5.6 
 Mand Plane to Occlusal Plane (º) 21.5 
 Palatal Plane to Mand Plane (º) 33.5 
Continued 
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Table B-48. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 129.7 
 ANS-Menton Height (mm) 77.3 
 Nasion-ANS Height (mm) 55.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.9 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 27.1 
 FMIA (L1 to FH) (º) 58.0 
 IMPA (L1-Mand Plane) (º) 94.8 
 
Dental Relationships 
 L1 to Mand Plane (mm) 42.3 
 L6 to Mand Plane Distance (mm) 34.3 
 Interincisal Angle (º) 125.0 
 L1 to Nasion-B Point (º) 30.6 
 U1 to Nasion-A Point (º) 18.5 
 U1 to Sella-Nasion (º) 100.4 
 U1 to Occlusal Plane (º) 118.7 
 Overbite (mm) 0.5 
 Overjet (mm) 1.2 
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Table B-49.  Cephalometric measurement values for subject 
128: 7.98-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.2 
 Sella-Basion Length (mm) 40.4 
 Nasion-Basion Length (mm) 101.2 
 Basion-Sella-Nasion (º) 130.6 
 
Cranial Base to Face 
 Y-Axis Length (mm) 128.0 
 Sella-Gonion Length (mm) 75.5 
 Sella-Nasion-A Point (º) 83.8 
 Sella-Nasion-B Point (º) 79.1 
 A Pont-Nasion-B Point (º) 4.7 
 Nasion-A Point-Pogonion (º) 11.7 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 123.0 
 Gonion-Nasion Distance (mm) 76.0 
 Condylion-Gonion Distance (mm) 57.8 
 Gonion-Pogonion Length (mm) 72.6 
 Gonion-Menton Length (mm) 64.7 
 Articulare-Gonion-Nasion (º) 133.2 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 69.4 
 Y-Axis (Se-Gn to FH) (º) 62.4 
 FH to Sella-Nasion (º) 6.2 
 Sella-Nasion to Palatal Plane (º) -1.0 
 Occlusal Plane to Sella-Nasion (º) 18.9 
 Occlusal Plane to FH (º) 12.7 
 Mand Plane to Occlusal Plane (º) 18.3 
 Palatal Plane to Mand Plane (º) 38.2 
Continued 
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Table B-49. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 118.1 
 ANS-Menton Height (mm) 71.3 
 Nasion-ANS Height (mm) 48.9 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.7 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 31.0 
 FMIA (L1 to FH) (º) 55.1 
 IMPA (L1-Mand Plane) (º) 93.9 
 
Dental Relationships 
 L1 to Mand Plane (mm) 35.7 
 L6 to Mand Plane Distance (mm) 30.5 
 Interincisal Angle (º) 125.9 
 L1 to Nasion-B Point (º) 30.3 
 U1 to Nasion-A Point (º) 19.1 
 U1 to Sella-Nasion (º) 102.9 
 U1 to Occlusal Plane (º) 121.8 
 Overbite (mm) 1.1 
 Overjet (mm) 1.4 
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Table B-50.  Cephalometric measurement values for subject 
130: 8.51-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 66.6 
 Sella-Basion Length (mm) 36.4 
 Nasion-Basion Length (mm) 96.6 
 Basion-Sella-Nasion (º) 137.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 117.3 
 Sella-Gonion Length (mm) 67.5 
 Sella-Nasion-A Point (º) 82.4 
 Sella-Nasion-B Point (º) 74.2 
 A Pont-Nasion-B Point (º) 8.2 
 Nasion-A Point-Pogonion (º) 22.7 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 113.2 
 Gonion-Nasion Distance (mm) 68.9 
 Condylion-Gonion Distance (mm) 53.7 
 Gonion-Pogonion Length (mm) 66.0 
 Gonion-Menton Length (mm) 59.8 
 Articulare-Gonion-Nasion (º) 132.6 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 76.9 
 Y-Axis (Se-Gn to FH) (º) 69.9 
 FH to Sella-Nasion (º) 10.8 
 Sella-Nasion to Palatal Plane (º) 3.4 
 Occlusal Plane to Sella-Nasion (º) 26.5 
 Occlusal Plane to FH (º) 15.7 
 Mand Plane to Occlusal Plane (º) 20.0 
 Palatal Plane to Mand Plane (º) 43.1 
Continued 
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Table B-50. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 117.2 
 ANS-Menton Height (mm) 72.8 
 Nasion-ANS Height (mm) 48.5 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.3 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 35.8 
 FMIA (L1 to FH) (º) 53.3 
 IMPA (L1-Mand Plane) (º) 90.9 
 
Dental Relationships 
 L1 to Mand Plane (mm) 35.0 
 L6 to Mand Plane Distance (mm) 33.5 
 Interincisal Angle (º) 121.1 
 L1 to Nasion-B Point (º) 31.7 
 U1 to Nasion-A Point (º) 19.1 
 U1 to Sella-Nasion (º) 101.5 
 U1 to Occlusal Plane (º) 128.0 
 Overbite (mm) 0.9 
 Overjet (mm) 4.9 
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Table B-51.  Cephalometric measurement values for subject 
132: 13.46-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.3 
 Sella-Basion Length (mm) 41.6 
 Nasion-Basion Length (mm) 105.0 
 Basion-Sella-Nasion (º) 138.1 
 
Cranial Base to Face 
 Y-Axis Length (mm) 128.7 
 Sella-Gonion Length (mm) 79.6 
 Sella-Nasion-A Point (º) 83.5 
 Sella-Nasion-B Point (º) 80.3 
 A Pont-Nasion-B Point (º) 3.2 
 Nasion-A Point-Pogonion (º) 9.8 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 123.0 
 Gonion-Nasion Distance (mm) 82.2 
 Condylion-Gonion Distance (mm) 58.3 
 Gonion-Pogonion Length (mm) 79.4 
 Gonion-Menton Length (mm) 71.3 
 Articulare-Gonion-Nasion (º) 121.6 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 68.7 
 Y-Axis (Se-Gn to FH) (º) 61.7 
 FH to Sella-Nasion (º) 12.3 
 Sella-Nasion to Palatal Plane (º) 4.9 
 Occlusal Plane to Sella-Nasion (º) 19.5 
 Occlusal Plane to FH (º) 7.3 
 Mand Plane to Occlusal Plane (º) 12.6 
 Palatal Plane to Mand Plane (º) 27.3 
Continued 
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Table B-51. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 118.8 
 ANS-Menton Height (mm) 68.3 
 Nasion-ANS Height (mm) 52.5 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 42.7 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 19.9 
 FMIA (L1 to FH) (º) 54.6 
 IMPA (L1-Mand Plane) (º) 105.5 
 
Dental Relationships 
 L1 to Mand Plane (mm) 35.6 
 L6 to Mand Plane Distance (mm) 32.9 
 Interincisal Angle (º) 112.9 
 L1 to Nasion-B Point (º) 38.0 
 U1 to Nasion-A Point (º) 25.9 
 U1 to Sella-Nasion (º) 109.4 
 U1 to Occlusal Plane (º) 128.9 
 Overbite (mm) 0.7 
 Overjet (mm) 3.2 
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Table B-52.  Cephalometric measurement values for subject 
133: 5.39-year-old SB Thalassemia male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 70.2 
 Sella-Basion Length (mm) 40.4 
 Nasion-Basion Length (mm) 103.2 
 Basion-Sella-Nasion (º) 136.3 
 
Cranial Base to Face 
 Y-Axis Length (mm) 118.4 
 Sella-Gonion Length (mm) 63.1 
 Sella-Nasion-A Point (º) 79.1 
 Sella-Nasion-B Point (º) 71.4 
 A Pont-Nasion-B Point (º) 7.7 
 Nasion-A Point-Pogonion (º) 18.0 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 106.2 
 Gonion-Nasion Distance (mm) 69.9 
 Condylion-Gonion Distance (mm) 46.5 
 Gonion-Pogonion Length (mm) 64.6 
 Gonion-Menton Length (mm) 59.9 
 Articulare-Gonion-Nasion (º) 130.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 75.5 
 Y-Axis (Se-Gn to FH) (º) 68.5 
 FH to Sella-Nasion (º) 9.7 
 Sella-Nasion to Palatal Plane (º) 5.5 
 Occlusal Plane to Sella-Nasion (º) 22.5 
 Occlusal Plane to FH (º) 12.8 
 Mand Plane to Occlusal Plane (º) 27.4 
 Palatal Plane to Mand Plane (º) 44.4 
Continued 
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Table B-52. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 116.9 
 ANS-Menton Height (mm) 69.0 
 Nasion-ANS Height (mm) 50.6 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 41.2 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 40.2 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -0.4 
 Overjet (mm) 3.1 
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Table B-53.  Cephalometric measurement values for subject 
134: 16.76-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 75.8 
 Sella-Basion Length (mm) 46.6 
 Nasion-Basion Length (mm) 111.9 
 Basion-Sella-Nasion (º) 130.6 
 
Cranial Base to Face 
 Y-Axis Length (mm) 144.1 
 Sella-Gonion Length (mm) 82.3 
 Sella-Nasion-A Point (º) 85.8 
 Sella-Nasion-B Point (º) 82.7 
 A Pont-Nasion-B Point (º) 3.1 
 Nasion-A Point-Pogonion (º) 8.1 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 134.5 
 Gonion-Nasion Distance (mm) 86.9 
 Condylion-Gonion Distance (mm) 63.4 
 Gonion-Pogonion Length (mm) 82.6 
 Gonion-Menton Length (mm) 75.7 
 Articulare-Gonion-Nasion (º) 126.1 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 66.8 
 Y-Axis (Se-Gn to FH) (º) 59.8 
 FH to Sella-Nasion (º) 4.7 
 Sella-Nasion to Palatal Plane (º) 6.2 
 Occlusal Plane to Sella-Nasion (º) 16.1 
 Occlusal Plane to FH (º) 11.3 
 Mand Plane to Occlusal Plane (º) 20.1 
 Palatal Plane to Mand Plane (º) 30.0 
Continued 
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Table B-53. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 128.9 
 ANS-Menton Height (mm) 75.4 
 Nasion-ANS Height (mm) 56.0 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 41.5 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 31.4 
 FMIA (L1 to FH) (º) 56.0 
 IMPA (L1-Mand Plane) (º) 92.6 
 
Dental Relationships 
 L1 to Mand Plane (mm) 42.3 
 L6 to Mand Plane Distance (mm) 35.2 
 Interincisal Angle (º) 115.6 
 L1 to Nasion-B Point (º) 31.4 
 U1 to Nasion-A Point (º) 30.0 
 U1 to Sella-Nasion (º) 115.7 
 U1 to Occlusal Plane (º) 131.8 
 Overbite (mm) 2.6 
 Overjet (mm) 3.6 
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Table B-54.  Cephalometric measurement values for subject 
135: 3.98-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 68.0 
 Sella-Basion Length (mm) 37.8 
 Nasion-Basion Length (mm) 98.6 
 Basion-Sella-Nasion (º) 135.6 
 
Cranial Base to Face 
 Y-Axis Length (mm) 110.0 
 Sella-Gonion Length (mm) 61.3 
 Sella-Nasion-A Point (º) 87.0 
 Sella-Nasion-B Point (º) 81.6 
 A Pont-Nasion-B Point (º) 5.4 
 Nasion-A Point-Pogonion (º) 19.4 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 102.4 
 Gonion-Nasion Distance (mm) 68.0 
 Condylion-Gonion Distance (mm) 44.3 
 Gonion-Pogonion Length (mm) 66.0 
 Gonion-Menton Length (mm) 58.8 
 Articulare-Gonion-Nasion (º) 132.5 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 65.6 
 Y-Axis (Se-Gn to FH) (º) 58.6 
 FH to Sella-Nasion (º) 7.3 
 Sella-Nasion to Palatal Plane (º) 4.7 
 Occlusal Plane to Sella-Nasion (º) 18.2 
 Occlusal Plane to FH (º) 11.0 
 Mand Plane to Occlusal Plane (º) 17.4 
 Palatal Plane to Mand Plane (º) 30.9 
Continued 
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Table B-54. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 99.4 
 ANS-Menton Height (mm) 61.7 
 Nasion-ANS Height (mm) 42.3 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 28.3 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -0.2 
 Overjet (mm) 1.0 
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Table B-55.  Cephalometric measurement values for subject 
136: 17.86-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 78.3 
 Sella-Basion Length (mm) 49.8 
 Nasion-Basion Length (mm) 120.2 
 Basion-Sella-Nasion (º) 138.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 139.0 
 Sella-Gonion Length (mm) 77.2 
 Sella-Nasion-A Point (º) 83.5 
 Sella-Nasion-B Point (º) 73.8 
 A Pont-Nasion-B Point (º) 9.7 
 Nasion-A Point-Pogonion (º) 24.4 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 130.8 
 Gonion-Nasion Distance (mm) 83.5 
 Condylion-Gonion Distance (mm) 57.3 
 Gonion-Pogonion Length (mm) 78.2 
 Gonion-Menton Length (mm) 69.9 
 Articulare-Gonion-Nasion (º) 135.3 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 76.1 
 Y-Axis (Se-Gn to FH) (º) 69.1 
 FH to Sella-Nasion (º) 10.2 
 Sella-Nasion to Palatal Plane (º) 6.9 
 Occlusal Plane to Sella-Nasion (º) 15.3 
 Occlusal Plane to FH (º) 5.0 
 Mand Plane to Occlusal Plane (º) 32.0 
 Palatal Plane to Mand Plane (º) 40.3 
Continued 
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Table B-55. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 136.2 
 ANS-Menton Height (mm) 82.2 
 Nasion-ANS Height (mm) 57.8 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 40.1 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 37.0 
 FMIA (L1 to FH) (º) 42.8 
 IMPA (L1-Mand Plane) (º) 100.2 
 
Dental Relationships 
 L1 to Mand Plane (mm) 40.9 
 L6 to Mand Plane Distance (mm) 37.6 
 Interincisal Angle (º) 107.6 
 L1 to Nasion-B Point (º) 41.2 
 U1 to Nasion-A Point (º) 21.5 
 U1 to Sella-Nasion (º) 104.9 
 U1 to Occlusal Plane (º) 120.2 
 Overbite (mm) 4.2 
 Overjet (mm) 6.6 
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Table B-56.  Cephalometric measurement values for subject 
138: 13.16-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 74.1 
 Sella-Basion Length (mm) 46.6 
 Nasion-Basion Length (mm) 111.8 
 Basion-Sella-Nasion (º) 134.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 138.6 
 Sella-Gonion Length (mm) 73.0 
 Sella-Nasion-A Point (º) 81.7 
 Sella-Nasion-B Point (º) 72.5 
 A Pont-Nasion-B Point (º) 9.2 
 Nasion-A Point-Pogonion (º) 20.6 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 130.5 
 Gonion-Nasion Distance (mm) 85.6 
 Condylion-Gonion Distance (mm) 54.5 
 Gonion-Pogonion Length (mm) 79.3 
 Gonion-Menton Length (mm) 69.8 
 Articulare-Gonion-Nasion (º) 136.1 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 77.6 
 Y-Axis (Se-Gn to FH) (º) 70.6 
 FH to Sella-Nasion (º) 9.4 
 Sella-Nasion to Palatal Plane (º) 6.8 
 Occlusal Plane to Sella-Nasion (º) 26.1 
 Occlusal Plane to FH (º) 16.6 
 Mand Plane to Occlusal Plane (º) 25.0 
 Palatal Plane to Mand Plane (º) 44.2 
Continued 
 337
Table B-56. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 134.6 
 ANS-Menton Height (mm) 81.6 
 Nasion-ANS Height (mm) 57.7 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.9 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 41.6 
 FMIA (L1 to FH) (º) 27.7 
 IMPA (L1-Mand Plane) (º) 110.6 
 
Dental Relationships 
 L1 to Mand Plane (mm) 34.5 
 L6 to Mand Plane Distance (mm) 37.0 
 Interincisal Angle (º) 94.3 
 L1 to Nasion-B Point (º) 54.2 
 U1 to Nasion-A Point (º) 22.2 
 U1 to Sella-Nasion (º) 104.0 
 U1 to Occlusal Plane (º) 130.0 
 Overbite (mm) -1.6 
 Overjet (mm) 5.1 
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Table B-57.  Cephalometric measurement values for subject 
139: 7.02-year-old SS female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 65.4 
 Sella-Basion Length (mm) 41.8 
 Nasion-Basion Length (mm) 98.3 
 Basion-Sella-Nasion (º) 131.9 
 
Cranial Base to Face 
 Y-Axis Length (mm) 126.7 
 Sella-Gonion Length (mm) 72.5 
 Sella-Nasion-A Point (º) 87.6 
 Sella-Nasion-B Point (º) 78.9 
 A Pont-Nasion-B Point (º) 8.8 
 Nasion-A Point-Pogonion (º) 21.6 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 115.7 
 Gonion-Nasion Distance (mm) 74.5 
 Condylion-Gonion Distance (mm) 51.3 
 Gonion-Pogonion Length (mm) 70.4 
 Gonion-Menton Length (mm) 59.3 
 Articulare-Gonion-Nasion (º) 132.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 72.6 
 Y-Axis (Se-Gn to FH) (º) 65.6 
 FH to Sella-Nasion (º) 6.6 
 Sella-Nasion to Palatal Plane (º) 7.4 
 Occlusal Plane to Sella-Nasion (º) 23.0 
 Occlusal Plane to FH (º) 16.4 
 Mand Plane to Occlusal Plane (º) 19.6 
 Palatal Plane to Mand Plane (º) 35.2 
Continued 
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Table B-57. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 117.2 
 ANS-Menton Height (mm) 70.5 
 Nasion-ANS Height (mm) 53.1 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 41.8 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 36.0 
 FMIA (L1 to FH) (º) 35.0 
 IMPA (L1-Mand Plane) (º) 109.0 
 
Dental Relationships 
 L1 to Mand Plane (mm) 29.9 
 L6 to Mand Plane Distance (mm) 35.4 
 Interincisal Angle (º) 91.2 
 L1 to Nasion-B Point (º) 50.5 
 U1 to Nasion-A Point (º) 29.6 
 U1 to Sella-Nasion (º) 117.2 
 U1 to Occlusal Plane (º) 140.3 
 Overbite (mm) -3.7 
 Overjet (mm) 2.3 
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Table B-58.  Cephalometric measurement values for subject 
140: 9.13-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 73.9 
 Sella-Basion Length (mm) 39.3 
 Nasion-Basion Length (mm) 104.9 
 Basion-Sella-Nasion (º) 133.4 
 
Cranial Base to Face 
 Y-Axis Length (mm) 129.8 
 Sella-Gonion Length (mm) 73.4 
 Sella-Nasion-A Point (º) 82.8 
 Sella-Nasion-B Point (º) 78.2 
 A Pont-Nasion-B Point (º) 4.5 
 Nasion-A Point-Pogonion (º) 12.7 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 122.2 
 Gonion-Nasion Distance (mm) 78.4 
 Condylion-Gonion Distance (mm) 53.8 
 Gonion-Pogonion Length (mm) 75.1 
 Gonion-Menton Length (mm) 66.7 
 Articulare-Gonion-Nasion (º) 133.9 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 70.0 
 Y-Axis (Se-Gn to FH) (º) 63.0 
 FH to Sella-Nasion (º) 6.6 
 Sella-Nasion to Palatal Plane (º) 3.7 
 Occlusal Plane to Sella-Nasion (º) 20.6 
 Occlusal Plane to FH (º) 14.0 
 Mand Plane to Occlusal Plane (º) 19.2 
 Palatal Plane to Mand Plane (º) 36.1 
Continued 
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Table B-58. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 120.7 
 ANS-Menton Height (mm) 73.6 
 Nasion-ANS Height (mm) 49.5 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.2 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 33.1 
 FMIA (L1 to FH) (º) 47.4 
 IMPA (L1-Mand Plane) (º) 99.5 
 
Dental Relationships 
 L1 to Mand Plane (mm) 36.8 
 L6 to Mand Plane Distance (mm) 32.5 
 Interincisal Angle (º) 113.4 
 L1 to Nasion-B Point (º) 37.5 
 U1 to Nasion-A Point (º) 24.6 
 U1 to Sella-Nasion (º) 107.4 
 U1 to Occlusal Plane (º) 128.0 
 Overbite (mm) 1.9 
 Overjet (mm) 2.7 
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Table B-59.  Cephalometric measurement values for subject 
141: 6.09-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 65.7 
 Sella-Basion Length (mm) 41.4 
 Nasion-Basion Length (mm) 93.5 
 Basion-Sella-Nasion (º) 119.8 
 
Cranial Base to Face 
 Y-Axis Length (mm) 121.7 
 Sella-Gonion Length (mm) 72.1 
 Sella-Nasion-A Point (º) 89.1 
 Sella-Nasion-B Point (º) 86.8 
 A Pont-Nasion-B Point (º) 2.3 
 Nasion-A Point-Pogonion (º) 6.9 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 113.1 
 Gonion-Nasion Distance (mm) 71.8 
 Condylion-Gonion Distance (mm) 50.0 
 Gonion-Pogonion Length (mm) 68.4 
 Gonion-Menton Length (mm) 61.3 
 Articulare-Gonion-Nasion (º) 134.5 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 61.6 
 Y-Axis (Se-Gn to FH) (º) 54.6 
 FH to Sella-Nasion (º) -0.3 
 Sella-Nasion to Palatal Plane (º) -5.0 
 Occlusal Plane to Sella-Nasion (º) 12.3 
 Occlusal Plane to FH (º) 12.6 
 Mand Plane to Occlusal Plane (º) 17.0 
 Palatal Plane to Mand Plane (º) 34.3 
Continued 
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Table B-59. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 103.3 
 ANS-Menton Height (mm) 62.5 
 Nasion-ANS Height (mm) 42.2 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.2 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 29.6 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -0.5 
 Overjet (mm) 2.0 
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Table B-60.  Cephalometric measurement values for subject 
142: 3.26-year-old Beta Thalassemia female. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 62.5 
 Sella-Basion Length (mm) 35.0 
 Nasion-Basion Length (mm) 90.9 
 Basion-Sella-Nasion (º) 135.9 
 
Cranial Base to Face 
 Y-Axis Length (mm) 109.2 
 Sella-Gonion Length (mm) 58.0 
 Sella-Nasion-A Point (º) 80.7 
 Sella-Nasion-B Point (º) 71.3 
 A Pont-Nasion-B Point (º) 9.4 
 Nasion-A Point-Pogonion (º) 22.5 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 104.5 
 Gonion-Nasion Distance (mm) 62.8 
 Condylion-Gonion Distance (mm) 46.6 
 Gonion-Pogonion Length (mm) 58.8 
 Gonion-Menton Length (mm) 52.3 
 Articulare-Gonion-Nasion (º) 144.7 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 79.1 
 Y-Axis (Se-Gn to FH) (º) 72.1 
 FH to Sella-Nasion (º) 9.6 
 Sella-Nasion to Palatal Plane (º) 2.2 
 Occlusal Plane to Sella-Nasion (º) 23.3 
 Occlusal Plane to FH (º) 13.7 
 Mand Plane to Occlusal Plane (º) 31.6 
 Palatal Plane to Mand Plane (º) 52.8 
Continued 
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Table B-60. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 109.7 
 ANS-Menton Height (mm) 71.0 
 Nasion-ANS Height (mm) 42.2 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 36.0 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 45.4 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -2.0 
 Overjet (mm) 3.3 
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Table B-61.  Cephalometric measurement values for subject 
144: 15.75-year-old SS male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 76.2 
 Sella-Basion Length (mm) 44.5 
 Nasion-Basion Length (mm) 114.6 
 Basion-Sella-Nasion (º) 142.2 
 
Cranial Base to Face 
 Y-Axis Length (mm) 139.2 
 Sella-Gonion Length (mm) 84.4 
 Sella-Nasion-A Point (º) 85.1 
 Sella-Nasion-B Point (º) 82.5 
 A Pont-Nasion-B Point (º) 2.6 
 Nasion-A Point-Pogonion (º) 4.2 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 133.2 
 Gonion-Nasion Distance (mm) 79.5 
 Condylion-Gonion Distance (mm) 66.7 
 Gonion-Pogonion Length (mm) 75.5 
 Gonion-Menton Length (mm) 69.8 
 Articulare-Gonion-Nasion (º) 131.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 64.0 
 Y-Axis (Se-Gn to FH) (º) 57.0 
 FH to Sella-Nasion (º) 11.7 
 Sella-Nasion to Palatal Plane (º) 0.8 
 Occlusal Plane to Sella-Nasion (º) 12.0 
 Occlusal Plane to FH (º) 0.4 
 Mand Plane to Occlusal Plane (º) 19.0 
 Palatal Plane to Mand Plane (º) 30.2 
Continued 
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Table B-61. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 122.4 
 ANS-Menton Height (mm) 70.7 
 Nasion-ANS Height (mm) 52.6 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 41.7 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 19.4 
 FMIA (L1 to FH) (º) 62.2 
 IMPA (L1-Mand Plane) (º) 98.5 
 
Dental Relationships 
 L1 to Mand Plane (mm) 41.6 
 L6 to Mand Plane Distance (mm) 32.1 
 Interincisal Angle (º) 113.3 
 L1 to Nasion-B Point (º) 32.0 
 U1 to Nasion-A Point (º) 32.1 
 U1 to Sella-Nasion (º) 117.1 
 U1 to Occlusal Plane (º) 129.2 
 Overbite (mm) 2.4 
 Overjet (mm) 4.5 
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Table B-62.  Cephalometric measurement values for subject 
145: 6.68-year-old SC male. 
 
 Variable Value 
 
Cranial Base 
 Sella-Nasion (mm) 69.1 
 Sella-Basion Length (mm) 38.2 
 Nasion-Basion Length (mm) 100.5 
 Basion-Sella-Nasion (º) 136.9 
 
Cranial Base to Face 
 Y-Axis Length (mm) 114.2 
 Sella-Gonion Length (mm) 64.9 
 Sella-Nasion-A Point (º) 83.8 
 Sella-Nasion-B Point (º) 76.0 
 A Pont-Nasion-B Point (º) 7.8 
 Nasion-A Point-Pogonion (º) 17.0 
 
Mandibular Relationships 
 Condylion-Gnathion Distance (mm) 109.2 
 Gonion-Nasion Distance (mm) 69.9 
 Condylion-Gonion Distance (mm) 49.8 
 Gonion-Pogonion Length (mm) 66.8 
 Gonion-Menton Length (mm) 59.8 
 Articulare-Gonion-Nasion (º) 130.4 
 
Facial Divergence 
 Y-Axis (Se-Gn to Se-Na) (º) 68.7 
 Y-Axis (Se-Gn to FH) (º) 61.7 
 FH to Sella-Nasion (º) 6.4 
 Sella-Nasion to Palatal Plane (º) 9.3 
 Occlusal Plane to Sella-Nasion (º) 14.0 
 Occlusal Plane to FH (º) 7.6 
 Mand Plane to Occlusal Plane (º) 24.0 
 Palatal Plane to Mand Plane (º) 28.7 
Continued 
 349
Table B-62. Continued 
 
 Variable Value 
 
Face Heights 
 Nasion-Menton Height (mm) 106.4 
 ANS-Menton Height (mm) 65.2 
 Nasion-ANS Height (mm) 44.4 
 Face Ht Ratio (Na-ANS/Na-Gn) (%) 39.8 
 
Tweed Triangle 
 FMA (Mand Plane to FH) (º) 31.6 
 FMIA (L1 to FH) (º) --- 
 IMPA (L1-Mand Plane) (º) --- 
 
Dental Relationships 
 L1 to Mand Plane (mm)  --- 
 L6 to Mand Plane Distance (mm)  --- 
 Interincisal Angle (º) --- 
 L1 to Nasion-B Point (º) --- 
 U1 to Nasion-A Point (º) --- 
 U1 to Sella-Nasion (º) --- 
 U1 to Occlusal Plane (º) --- 
 Overbite (mm) -5.2 
 Overjet (mm) 6.5 
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APPENDIX C 
Descriptive statistics of the z-transformed data, 
presented by genotype and by sex. 
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APPENDIX D 
Results of two-way analysis of covariance testing for genotype and for 
sex differences in trait expression with examination age as the covariate. 
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Table D-1.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  Sella-Nasion (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.1539950 0.1871 0.6676 
Sex 1 0.4501305 0.5469 0.4638 
Age 1 2.9922569 3.6353 0.0636 
 
Table D-2.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  Sella-Basion (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 3.2996729 2.7083 0.1075 
Sex 1 0.0184145 0.0151 0.9028 
Age 1 0.1343279 0.1103 0.7415 
 
Table D-3.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  Nasion-Basion (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.4342934 0.5425 0.4656 
Sex 1 0.0086361 0.0108 0.9178 
Age 1 1.5339021 1.9163 0.1738 
 
Table D-4.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  Basion-Sella-Nasion (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.03879919 0.0315 0.8599 
Sex 1 0.00104167 0.0008 0.9769 
Age 1 0.13461079 0.1094 0.7425 
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Table D-5.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  Sella-Gnathion Length (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.2781222 0.2344 0.6309 
Sex 1 2.4393428 2.0557 0.1592 
Age 1 0.3387222 0.2855 0.5960 
 
 
Table D-6.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  Sella-Gonion (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.9770072 1.0065 0.3216 
Sex 1 0.0592088 0.0610 0.8062 
Age 1 1.1033138 1.1366 0.2926 
 
Table D-7.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  SNA Angle (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.6753975 0.3607 0.5514 
Sex 1 1.8752394 1.0014 0.3228 
Age 1 0.1258528 0.0672 0.7967 
 
Table D-8.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  SNB Angle (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.93992340 0.8415 0.3643 
Sex 1 0.94753383 0.8483 0.3624 
Age 1 0.20409896 0.1827 0.6713 
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Table D-9.  Results of two-way analysis of covariance testing for genotype 
and for sex differences in trait expression with examination age as the 
covariate.  Variable:  ANB Angle (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.09417109 0.0579 0.8110 
Sex 1 0.01172431 0.0072 0.9327 
Age 1 0.39455921 0.2427 0.6249 
 
Table D-10.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Nasion-A-Pogonion (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.68757086 0.5242 0.4732 
Sex 1 0.00830734 0.0063 0.9370 
Age 1 0.03505635 0.0267 0.8709 
 
Table D-11.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Condylion-Gnathion (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.0588084 0.0454 0.8323 
Sex 1 1.8295897 1.4123 0.2415 
Age 1 1.4625658 1.1290 0.2942 
 
Table D-12.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Gonion-Gnathion (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 1.4443553 1.0516 0.3111 
Sex 1 3.1750222 2.3117 0.1361 
Age 1 3.0992800 2.2566 0.1407 
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Table D-13.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Condylion-Gonion (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.00344482 0.0036 0.9522 
Sex 1 0.02443842 0.0258 0.8733 
Age 1 0.29129306 0.3071 0.5825 
 
Table D-14.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Gonion-Pogonion (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.8693697 0.7315 0.3974 
Sex 1 2.2598087 1.9013 0.1754 
Age 1 0.9734031 0.8190 0.3708 
 
Table D-15.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Gonion-Menton (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 1.5330120 1.2391 0.2721 
Sex 1 3.3130760 2.6778 0.1094 
Age 1 0.1668014 0.1348 0.7154 
 
 
Table D-16.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Art-Gonion-Gnathion (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 1.8872627 2.3114 0.1361 
Sex 1 1.9860519 2.4324 0.1265 
Age 1 0.6179372 0.7568 0.3894 
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Table D-17.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  PP to Mandibular Plane (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 5.0491787 4.2105 0.0466 
Sex 1 2.8354250 2.3644 0.1318 
Age 1 0.0002753 0.0002 0.9880 
 
Table D-18.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Nasion-Menton Ht (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.0570315 0.0814 0.7768 
Sex 1 2.7521091 3.9293 0.0542 
Age 1 0.0030090 0.0043 0.9481 
 
Table D-19.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  ANS-Menton Ht (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.3027355 0.4690 0.4973 
Sex 1 3.0108462 4.6643 0.0367 
Age 1 0.0100592 0.0156 0.9013 
 
Table D-20.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  UFH (Na-ANS) (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.2450886 0.3897 0.5359 
Sex 1 1.0024782 1.5939 0.2139 
Age 1 0.0910046 0.1447 0.7056 
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Table D-21.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  FMA (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.78963133 0.8798 0.3538 
Sex 1 0.93358124 1.0402 0.3138 
Age 1 0.41215475 0.4592 0.5018 
 
Table D-22.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  FMIA (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.5574362 0.5520 0.4617 
Sex 1 0.2085148 0.2065 0.6519 
Age 1 1.2627805 1.2505 0.2700 
 
Table D-23.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  IMPA (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.0563117 0.0464 0.8305 
Sex 1 0.0084648 0.0070 0.9339 
Age 1 1.2387603 1.0203 0.3184 
 
Table D-24.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  L1-Mand Plane (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.05133131 0.0912 0.7642 
Sex 1 0.71954262 1.2780 0.2648 
Age 1 0.53020577 0.9417 0.3375 
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Table D-25.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  L6_MP (LPDH) (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.0112567 0.0221 0.8826 
Sex 1 2.4334625 4.7773 0.0346 
Age 1 1.3533446 2.6568 0.1108 
 
Table D-26.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Interincisal Angle (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 2.2141647 2.1777 0.1477 
Sex 1 0.4511085 0.4437 0.5091 
Age 1 0.0148520 0.0146 0.9044 
 
Table D-27.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  L1 to Nasion-B Pt (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.58800633 0.4677 0.4979 
Sex 1 0.90617539 0.7208 0.4008 
Age 1 0.61420205 0.4885 0.4885 
 
Table D-28.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  U1 to Nasion-A Pt (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 2.7912188 2.4308 0.1267 
Sex 1 0.0582383 0.0507 0.8229 
Age 1 0.5099416 0.4441 0.5089 
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Table D-29.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  U1 to Sella-Nasion (º) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 1.2545460 0.7270 0.3988 
Sex 1 0.3436939 0.1992 0.6577 
Age 1 0.0380387 0.0220 0.8827 
 
Table D-30.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Overbite (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 0.3792992 0.3239 0.5724 
Sex 1 0.4125427 0.3523 0.5561 
Age 1 5.1164392 4.3694 0.0428 
 
Table D-31.  Results of two-way analysis of covariance testing for 
genotype and for sex differences in trait expression with examination age 
as the covariate.  Variable:  Overjet (mm) 
 
 Source df Sum of Squares F Ratio Prob > F 
Genotype 1 2.7125527 2.2182 0.144 
Sex 1 0.5063025 0.4140 0.5235 
Age 1 2.7608486 2.2577 0.1406 
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APPENDIX E 
Bivariate plot for each of the variables studied assessing the 
dependence of the z-score on age of examination by sex. 
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Fig. E-1.  Bivariate plot between chronological age and z-score of
the Sella-Nasion distance in males and in females.  Age explains
9.1% of the variation in the dependent variable in males, and 1.6%
in females.  Solid square symbols denote males.
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Fig. E-2  Bivariate plot between chronological age and z-score of the
Sella-Basion distance in males and in females.  Age explains 0.9% of
the variation in the dependent variable in males, but 5.6% in
females.  Solid square symbols denote males.
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Fig. E-3.  Bivariate plot between chronological age and z-score of
the Nasion-Basion distance in males and in females.  Age explains
0.2% of the variation in the dependent variable in males, and 0.1%
in females.  Solid square symbols denote males.
368
BB
B
B
B
B
B
B
B
B
B
B
B
B B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
E
E
E
E
E
E
E
E E
E
E E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
-3
-2
-1
0
1
2
3
4
3 5 7 9 11 13 15 17
Z
 S
co
re
Age in Years
Fig. E-4.  Bivariate plot between chronological age and z-score of
the Saddle Angle (Ba-Se-Na) in males and in females.  Age explains
0.8% of the variation in the dependent variable in males, and 0.8%
in females.  Solid square symbols denote males.
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Fig. E-5.  Bivariate plot between chronological age and z-score of
the Sella-Gnathion distance in males and in females.  Age explains
7.4% of the variation in the dependent variable in males, but 0.0%
in females.  Solid square symbols denote males.
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Fig. E-6.  Bivariate plot between chronological age and z-score of
the Sella-Gonion distance in males and in females.  Age explains
1.8% of the variation in the dependent variable in males, but 11.3%
in females.  Solid square symbols denote males.
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Fig. E-7.  Bivariate plot between chronological age and z-score of
the SNA angle in males and in females.  Age explains 0.6% of the
variation in the dependent variable in males, and 0.4% in females.
Solid square symbols denote males.
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Fig. E-8.  Bivariate plot between chronological age and z-score of
the SNB angle in males and in females.  Age explains 14.0% of the
variation in the dependent variable in males, but 0.0% in females.
Solid square symbols denote males.
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Fig. E-9.  Bivariate plot between chronological age and z-score of
the ANB angle in males and in females.  Age explains 5.0% of the
variation in the dependent variable in males, but 0.2% in females.
Solid square symbols denote males.
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Fig. E-10.  Bivariate plot between chronological age and z-score of
the NAP angle in males and in females.  Age explains 3.0% of the
variation in the dependent variable in males, and 0.9% in females.
Solid square symbols denote males.
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Fig. E-11.  Bivariate plot between chronological age and z-score of
the Condylion-Gnathion distance in males and in females.  Age
explains 16.2% of the variation in the dependent variable in males,
and 1.7% in females.  Solid square symbols denote males.
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Fig. E-12.  Bivariate plot between chronological age and z-score of
the Condylion-Gonion distance in males and in females.  Age
explains 23.2% of the variation in the dependent variable in males,
but 3.7% in females.  Solid square symbols denote males.
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Fig. E-13.  Bivariate plot between chronological age and z-score of
Gonion-Pogonion distance in males and in females.  Age explains
19.1% of the variation in the dependent variable in males, but 3.9%
in females.  Solid square symbols denote males.
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Fig. E-14.  Bivariate plot between chronological age and z-score of
Gonion-Menton distance in males and in females.  Age explains
18.0% of the variation in the dependent variable in males, but 8.9%
in females.  Solid square symbols denote males.
379
BB
B
B
B
B
B
B
B
B
B B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
-1
0
1
2
3
4
3 5 7 9 11 13 15 17
Z
 S
co
re
Age in Years
Fig. E-15.  Bivariate plot between chronological age and z-score of
the Gonial Angle (Ar-Go-Gn) angle in males and in females.  Age
explains 16.5% of the variation in the dependent variable in males,
but 0.2% in females.  Solid square symbols denote males.
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Fig. E-16.  Bivariate plot between chronological age and z-score of
the Y-Axis (SeGn to SeNa) angle in males and in females.  Age
explains 12.7% of the variation in the dependent variable in males,
but 0.8% in females.  Solid square symbols denote males.
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Fig. E-17.  Bivariate plot between chronological age and z-score of
the Y-Axis (SeGn to FH) in males and in females.  Age explains
0.3% of the variation in the dependent variable in males, but 5.0%
in females.  Solid square symbols denote males.
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Fig. E-18.  Bivariate plot between chronological age and z-score of
the FH to SeNa angle in males and in females.  Age explains 23.7%
of the variation in the dependent variable in males, but 2.7% in
females.  Solid square symbols denote males.
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Fig. E-19.  Bivariate plot between chronological age and z-score of
the Palatal Plane to SeNa angle in males and in females.  Age
explains 0.8% of the variation in the dependent variable in males,
and 2.9% in females.  Solid square symbols denote males.
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Fig. E-20.  Bivariate plot between chronological age and z-score of
the Occlusal Plane to SeNa angle in males and in females.  Age
explains 15.9% of the variation in the dependent variable in males,
but 17.7% in females.  Solid square symbols denote males.
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Fig. E-21.  Bivariate plot between chronological age and z-score of
the Occlusal Plane to FH angle in males and in females.  Age
explains 0.0% of the variation in the dependent variable in males,
but 8.5% in females.  Solid square symbols denote males.
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Fig. E-22.  Bivariate plot between chronological age and z-score of
the Palatal Plane to Mandibular Plane angle in males and in
females.  Age explains 21.2% of the variation in the dependent
variable in males, but 0.2% in females.  Solid square symbols
denote males.
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Fig. E-23.  Bivariate plot between chronological age and z-score of
the Nasion-Menton distance in males and in females.  Age explains
2.7% of the variation in the dependent variable in males, and 0.0%
in females.  Solid square symbols denote males.
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Fig. E-24.  Bivariate plot between chronological age and z-score of
the ANS-Menton distance in males and in females.  Age explains
6.0% of the variation in the dependent variable in males, but 0.0%
in females.  Solid square symbols denote males.
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Fig. E-25.  Bivariate plot between chronological age and z-score of
the Nasion-ANS distance in males and in females.  Age explains
0.3% of the variation in the dependent variable in males, but 0.0%
in females.  Solid square symbols denote males.
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Fig. E-26.  Bivariate plot between chronological age and z-score of
FMA in males and in females.  Age explains 0.0% of the variation in
the dependent variable in males, but 0.2% in females.  Solid square
symbols denote males.
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Fig. E-27.  Bivariate plot between chronological age and z-score of
FMIA in males and in females.  Age explains 0.6% of the variation
in the dependent variable in males, and 3.9% in females.  Solid
square symbols denote males.
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Fig. E-28.  Bivariate plot between chronological age and z-score of
IMPA in males and in females.  Age explains 2.5% of the variation
in the dependent variable in males, and 3.4% in females.  Solid
square symbols denote males.
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Fig. E-29.  Bivariate plot between chronological age and z-score of
the L1 to Mandibular Plane distance in males and in females.  Age
explains 1.6% of the variation in the dependent variable in males,
and 1.6% in females.  Solid square symbols denote males.
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Fig. E-30.  Bivariate plot between chronological age and z-score of
the L6 to Mandibular Plane distance in males and in females.  Age
explains 11.2% of the variation in the dependent variable in males,
but 5.5% in females.  Solid square symbols denote males.
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Fig. E-31.  Bivariate plot between chronological age and z-score of
Interincisal Angle in males and in females.  Age explains 2.7% of
the variation in the dependent variable in males, and 0.0% in
females.  Solid square symbols denote males.
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Fig. E-32.  Bivariate plot between chronological age and z-score of
the L1 to Nasion-B Point angle in males and in females.  Age
explains 0.1% of the variation in the dependent variable in males,
and 2.7% in females.  Solid square symbols denote males.
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Fig. E-33.  Bivariate plot between chronological age and z-score of
the U1 to Nasion-A Point angle in males and in females.  Age
explains 5.7% of the variation in the dependent variable in males,
and 1.2% in females.  Solid square symbols denote males.
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Fig. E-34.  Bivariate plot between chronological age and z-score of
the U1 to SeNa angle in males and in females.  Age explains 1.8% of
the variation in the dependent variable in males, and 0.2% in
females.  Solid square symbols denote males.
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Fig. E-35.  Bivariate plot between chronological age and z-score of
overbite in males and in females.  Age explains 6.3% of the
variation in the dependent variable in males, but 20.5% in females.
Solid square symbols denote males.
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Fig. E-36.  Bivariate plot between chronological age and z-score of
overjet in males and in females.  Age explains 10.3% of the
variation in the dependent variable in males, but 0.4% in females.
Solid square symbols denote males.
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Fig. E-37.  Bivariate plot between chronological age and z-score of
the Gonion-Gnathion distance in males and in females.  Age
explains 23.7% of the variation in the dependent variable in males,
but 0.0% in females.  Solid square symbols denote males.
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APPENDIX F 
Bivariate plots of the cases in males where the age at examination 
had a significant association with the variable’s z-score. 
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Fig. F-1.  Bivariate plot between chronological age and z-score of
the SNB angle in males and in females.  Age explains 14.0% of the
variation in the dependent variable in males, but 0.0% in females.
Solid square symbols denote males.
404
BB
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
-3
-2
-1
0
1
2
3
3 5 7 9 11 13 15 17
Z
 S
co
re
Age in Years
Fig. F-2.  Bivariate plot between chronological age and z-score of
mandibular length (Cd-Gn) in males and in females.  Age explains
16.4% of the variation in the dependent variable in males, but 1.7%
in females.  Solid square symbols denote males.
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Fig. F-3.  Bivariate plot between chronological age and z-score of
mandibular length (Go-Gn) in males and in females.  Age explains
23.7% of the variation in the dependent variable in males, but 0.0%
in females.  Solid square symbols denote males.
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Fig. F-4.  Bivariate plot between chronological age and z-score of
mandibular length (Cd-Go) in males and in females.  Age explains
23.2% of the variation in the dependent variable in males, but 3.7%
in females.  Solid square symbols denote males.
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Fig. F-5.  Bivariate plot between chronological age and z-score of
corpus length (Go-Pg)  in males and in females.  Age explains
19.1% of the variation in the dependent variable in males, but 3.9%
in females.  Solid square symbols denote males.
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Fig. F-6.  Bivariate plot between chronological age and z-score of
mandibular body length (Go-Me) in males and in females.  Age
explains 18.0% of the variation in the dependent variable in males,
but 8.9% in females.  Solid square symbols denote males.
409
BB
B
B
B
B
B
B
B
B
B B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
-1
0
1
2
3
4
3 5 7 9 11 13 15 17
Z
 S
co
re
Age in Years
Fig. F-7.  Bivariate plot between chronological age and z-score of
Gonial Angle (Ar-Go-Gn) in males and in females.  Age explains
16.5% of the variation in the dependent variable in males, but 0.2%
in females.  Solid square symbols denote males.
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Fig. F-8.  Bivariate plot between chronological age and z-score of
the Y-Axis (Se-Gn to SeNa) in males and in females.  Age explains
12.7% of the variation in the dependent variable in males, but 0.8%
in females.  Solid square symbols denote males.
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Fig. F-9.  Bivariate plot between chronological age and z-score of
the angle between FH and Sella-Nasion in males and in females.
Age explains 23.7% of the variation in the dependent variable in
males, but 2.7% in females.  Solid square symbols denote males.
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Fig. F-10.  Bivariate plot between chronological age and z-score of
the angle of the Occlusal Plane to Sella-Nasion in males and in
females.  Age explains 15.9% of the variation in the dependent
variable in males, but 17.7% in females.  Solid square symbols
denote males.
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Fig. F-11.  Bivariate plot between chronological age and z-score of
the angle of the Palatal Plane to the Mandibular Plane in males and
in females.  Age explains 21.2% of the variation in the dependent
variable in males, but 0.2% in females.  Solid square symbols
denote males.
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